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“Our virtues and our failings are inseparable,
Like force and matter.
When they are separate,
Man is no more.”
Nikola Tesla, 1856 - 1943.
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Abstract
Although considered Gram-negative the outer membrane (OM) of Borrelia is unique,
consisting of a variety of glycolipids, a significant number of surface exposed lipoproteins
and a smaller number of integral membrane-spanning β -barrels. Many of these proteins are
known to act as adhesins and invasins binding to regulators of the host immune response and
extracellular matrix proteins. Many Gram-negative bacteria have the evolutionary conserved
OmpA-like transmembrane domain consisting of an eight-stranded membrane spanning β -
barrel. The prototypical example is E. coli OmpA; a multifunctional protein involved in a
wide variety of physiological and pathological functions. To date the OmpA-like
transmembrane domain has not been identified in the Spirochaete phylum. An approach
based on hidden Markov models and topology and fold prediction identified a group of
homologous genes in the genus Borrelia (BAPKO_0026, BAPKO_0422, BAPKO_0423 and
BAPKO_0571), which are predicted to form an eight stranded OM-spanning β -barrel
structure with similar structure to E. coli OmpA/W. One of these orthologues in B. afzelii
(BAPKO_0422) has been expressed, purified and characterised in vitro; circular dichroism
studies show a large percentage of β -strand. A low resolution molecular envelope generated
from small-angle X-ray scattering data is consistent with an eight-stranded β -barrel.
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Chapter 1. Introduction
1.1 Lyme disease
1.1.1 History
Lyme disease, also known as Lyme borreliosis (Franz and Krause, 2003) is a tick-borne
zoonosis that affects multiple systems in mammalian hosts; the etiological agent being three
species of the Borrelia genus: B. afzelii, B. burgdorferi s.s. and B. garinii (Burgdorfer et al.,
1982, Franz and Krause, 2003, Kurtenbach et al., 2006, Rupprecht et al., 2008). The initial
symptom, an erythema migrans rash was first described in Europe in 1910 and was identified
to be caused by an organism transmitted by ticks, while the common later stage symptoms of
Lyme disease were first characterised in Europe in 1883. Later in 1922 symptoms related to
the CNS were recorded, again in Europe (Athreya and Rose, 1996) (Franz and Krause, 2003).
The recent history of Lyme disease began with an outbreak in the early 1970’s in the USA
(Steere et al., 1977, Steere et al., 2004). The transmission vector was identified as species of
the Ixodes tick around the same time (Steere et al., 1978, Alitalo, 2004) although it was not
until 1982 however that the responsible Spirochaete B. burgdorferi s.s. was first isolated,
identified and confirmed as the cause of Lyme disease (Burgdorfer et al., 1982, Hayes et al.,
1983, Johnson et al., 1984, Burgdorfer et al., 1986).
Lyme disease is the most prevalent tick-borne disease in humans in the Northern Hemisphere
with 100-130 reported cases per 100,000 people in the UK and 20-100 reported cases per
100,000 people in the US (Rupprecht et al., 2008). The disease was named after the town of
Old Lyme, Connecticut, U.S.A. where seemingly epidemic outbreaks of juvenile rheumatoid
arthritis had been occurring annually in the summer and autumn since at least 1972 (Steere et
al., 1977). The results of a thorough clinical investigation into the outbreak revealed that a
number of patients had a bulls-eye-like rash known as an erythema migrans (EM) and had
been bitten by a tick prior to the onset of arthritis (Steere et al., 1978). As the disease
progressed, more severe symptoms presented such as the aforementioned arthritis, skin
conditions, and neurological and cardiac symptoms (Steere et al., 1977, Steere et al., 1978,
Burgdorfer et al., 1982, Franz and Krause, 2003). It was from this and several other studies
that the agent responsible for the outbreak was identified as a Spirochaete of the genus
Borrelia and named after Dr Willy Burgdorfer, one of the discoverers (Steere et al., 1977,
Steere et al., 1978, Burgdorfer et al., 1982, Johnson et al., 1984). Species of Borrelia have
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also been found in the midgut of mosquitoes, Culex Pipiens and Aedes vexans (Krupka et al.,
2007).
1.1.2 Symptoms
Lyme disease caused by mammalian infection with species of Borrelia produces a wide
variety of symptoms that differ depending on the species and strain of bacteria causing the
infection (Rosa et al., 2005, Hildenbrand et al., 2009). The symptoms exacerbate over time
affecting multiple tissues and systems in the hos’ts body, notably joints, the CNS and
myocardium (Comstock et al., 1993, Kurtenbach et al., 2006, Rupprecht et al., 2008). Lyme
disease has three stages of infection: initial, acute and persistent (or chronic) (Rosa et al.,
2005).
During the initial infection phase of Borrelial infection of a human host the first symptom to
be presented is an erythema migrans (EM), a characteristic round/elliptical bulls-eye like rash
that occurs at the site of first infection/the site of the tick bite (Figure 1.1) (Rosa et al., 2005).
This occurs in 60 to 80 % of confirmed infected patients (Alitalo, 2004, Auwaerter, 2007,
Krupka et al., 2007, Rupprecht et al., 2008, Fallon et al., 2010) and can last up to twelve
weeks (Franz and Krause, 2003). This initial localised symptom is common to the three major
Lyme disease causing species of Borrelia with the exception that an EM from B. burgdorferi
s.s. has been known to clear in the middle, leaving a ring shaped rash (Franz and Krause,
2003). Other initial symptoms are flu-like in nature, ranging from fever and chills to
headaches, lasting up to several weeks (Hyde and Johnson, 1984, Athreya and Rose, 1996,
Hildenbrand et al., 2009), although these are most common in the USA (Steere et al., 2004).
Half of the patients infected with B. burgdorferi s.s. develop multiple secondary EMs similar
to the initial rash but smaller (Franz and Krause, 2003).
Figure 1.1. Erythema Migrans. An image of an erythema migrans with a clear region in the centre. File licensed under the
Creative Commons Attribution-Share Alike 2.5 Generic license.
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If left untreated, symptoms of the second (acute) stage of infection begin to manifest several
weeks to months after first infection once the Spirochaete has disseminated to tissues
throughout the body (Steere et al., 2004, Hildenbrand et al., 2009). Broadly, symptoms
include inflammation in: joints (arthritis), muscles including the heart (carditis), both the
central and peripheral nervous systems, and Bell’s palsy, musculoskeletal pain and acute
lymphocytic meningitis (Athreya and Rose, 1996, Steere et al., 2004, Fallon et al., 2010).
Unlike the initial stage of infection, the symptoms presented during the second stage of
infection show greater differentiation between the Borrelial species (Franz and Krause,
2003), with arthritic symptoms most common in the USA (B. burgdorferi s.s.) and
neurological symptoms more prevalent in Europe (B. afzelii & B. garinii) (Rosa et al., 2005).
Lyme arthritis is the most common symptom of the second and third stages of infection in the
USA with approximately 60 % of patients developing symptoms (Steere et al., 2004)
compared to a much smaller proportion of patients in Europe (Franz and Krause, 2003). In
contrast, Lyme carditis has only been reported in a minority of cases of Lyme disease, typical
symptoms include atrial fibrillations and tachycardia (Franz and Krause, 2003).
Neurological symptoms (known as neuroborreliosis) that occur in the second stage of Lyme
disease are most commonly caused by the European strains of Borrelia: B. afzelii and B.
garinii (Franz and Krause, 2003). Symptoms include Bannwarth’s syndrome (radiculo
neuropathy with meningitis), cranial neuropathy, Bell’s palsy, encephalitis and inflammation
in the CNS (Kalish et al., 1993, Franz and Krause, 2003, Livengood and Jr, 2006, Fallon et
al., 2010).
Stage three of infection (chronic or persistent infection) presents the most severe symptoms,
often second stage symptoms become chronic and much more serious. Chronic Lyme arthritis
can occur in joints, lasting up to a year or longer. Synovial lesions that are similar to other
forms of chronic inflammatory arthritis including rheumatoid arthritis have been found to be
present in patients (Kalish et al., 1993).
The skin condition acrodermatitis chronic atrophans has been found in patients years after
they were infected with B. afzelii (Steere et al., 2004, Krupka et al., 2007). Neuroborreliosis
can progress to a chronic illness, the symptoms of which include dementia, mental disorders,
cranial neuropathy, synovial lesions, cognitive abnormalities and chronic encephalitis and
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encephalomyelitis, leading to hemiparesis (Kalish et al., 1993, Franz and Krause, 2003,
Fallon et al., 2010). Lyme encephalopathy, a syndrome that causes spinal radicular pain and
cognitive disturbances has been described to occur in rare instances (Steere et al., 2004). It
has been shown that a small number of patients may develop post-Lyme disease syndrome
(or chronic fatigue borreliosis); an ailment similar in nature to chronic fatigue syndrome or
fibromyalgia and includes symptoms such as severe musculoskeletal pain and fatigue (Steere
et al., 2004). A summary of symptoms is included in Table 1.1.
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Table 1.1. Various presentations of Lyme disease at each stage of infection. Initial data acquired from (Athreya and Rose, 1996) with additional data compiled from a variety of
sources as detailed in the table. The species of Borrelia primarily responsible for the symptoms has been included: Ba = B. afzelii, Bb = B. burgdorferi s.s., Bg = B. garinii, Bv = B.
vincenti.
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Figure 1.2 shows confirmed cases of Lyme disease in England and Wales over a twelve year
spell in the 1980’s and 1990’s. The majority of confirmed cases is in a forested are in the
South, this is due to the Ixodes tick’s preferred habitat being forested areas (section 1.3), the
slightly warmer climate in the South and the abundance of wildlife in forests providing a
natural host reservoir.
Figure 1.2. Lyme disease in England. Highlighted on the map is the Hampshire/New Forest area, the region with the most
reported cases of indigenously acquired Lyme disease in England and Wales from 1986 to 1998. Data acquired from (Smith
et al., 2000).
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1.1.3 Diagnosis, treatment & vaccines
Diagnosis of Lyme disease is a challenging proposition due to (with the exception of EM) the
similarity of the initial symptoms to other diseases; in particular chronic fatigue syndrome, of
which Lyme disease can be a cause (Kaiser et al., 1997). Lyme disease is sometimes
indistinguishable from other diseases such as Bannwarth’s syndrome, hence Lyme disease
has been referred to as the new ‘great imitator’ (Pachner, 2006). The diagnosis is made more
clear by the presence of a visible EM and accompanying symptoms, however the diagnosis
can be highly subjective (Aronowitz, 2012). In order to diagnose Lyme disease in the absence
of a visible EM, the patient needs to produce a positive antibody response on a whole-cell B.
burgdorferi lysate ELISA and Western Blot, be recognised as having symptoms characteristic
of Lyme disease (Steere et al., 2004) and show an increased white blood cell count (~ 100
white blood cells per cubic millimetre) in the cerebrospinal fluid (pleocytosis) (Alexander
and Cox, 1995, Mygland et al., 2010). An enzyme-linked immunosorbent assay has been
developed to recognise several Borrelial proteins including: DbpA, BBK32 and OspC
(sections 1.2.4.4 & 1.2.4.5), providing an overall sensitivity of 80 % and a specificity of 100
% (Skogman et al., 2008).
If the infection is diagnosed in the early stage of infection or dissemination (less than 6
months), the recommended EFNS treatment is an oral course of doxycycline or an
intravenous (IV) course of ceftriaxone in adults and amoxicillin in children (Steere et al.,
2004, Mygland et al., 2010) over a period of two to four weeks (Rosa et al., 2005), although
if administered within 72 hours a single dose of doxycycline reduces the risk of Lyme disease
by around 87 % (Nigrovic and Thompson, 2007). Chronic Lyme disease has been shown to
require multiple, long term courses of antibiotics (Aronowitz, 2012), although even this may
not be effective due to the Spirochaetes ability to invade the CNS (Livengood and Jr, 2006).
Early CNS Lyme disease should be treated with a course of IV ceftriaxone (Mygland et al.,
2010). If symptoms persist for over six months, the disease is classified as post-Lyme disease
syndrome; on which antibiotics have no effect (Mygland et al., 2010).
Vaccines for Lyme disease have not successfully been produced due to the high variance in
expression of antigenic Borrelial surface lipoproteins throughout infection (Krupka et al.,
2011). Two anti-OspA (see section 1.4.2.4) vaccines for B. burgdorferi s.s were developed in
the early 1990’s (Burkot et al., 1994, Li et al., 1997, Steere et al., 1998) with the intention of
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preventing Spirochaete transmission from arthropods to humans (Aronowitz, 2012). Both
were found to be effective in animals and were deemed safe for humans and although one of
these did not make it past phase III testing, the other was approved for general use (Steere et
al., 1998, Nigrovic and Thompson, 2007, Aronowitz, 2012). Mice immunised with
recombinant B. burgdorferi s.s. OspA were protected against infection by the Spirochaete
(Burkot et al., 1994, Li et al., 1997); additionally, monoclonal antibodies for the C-terminal
end of the protein were also shown to protect the mouse from Borrelial invasion, which
suggested that OspA binding was important for survival in mammalian invasion (Huang et
al., 1998) although it has been shown that this is not the case (Comstock et al., 1993, Schwan
and Piesman, 2000, Yang et al., 2004, Pal et al., 2004a). This vaccine did not make it to
production.
The commercially available OspA vaccine was developed in 1998 (Steere et al., 1998) and
comprised full-length recombinant OspA with the lipid-chain added post-translation and an
aluminium adjuvant added. The vaccine was administered in three 30 µg doses (initial, one
month and twelve months); one month after the second dose 95 % of patients tested positive
for an OspA antibody. One month after the third and final injection (13 months after the
study began) 99 % of study participants tested positive for the OspA antibody. The study
found that the three injections of OspA vaccine had an efficacy of approximately 76 %
against B. burgdorferi s.s. (Steere et al., 1998, Nigrovic and Thompson, 2007).
The vaccine had to be withdrawn three years later due to a decrease in sales following
controversy over side effects (Krupka et al., 2011); these included musculoskeletal pains and
arthritis, thought to be due to a cross-reactive autoimmune response to OspA (Nigrovic and
Thompson, 2007). A study in 2005 identified three cross-reactive neuronal human epitopes
that shared identical amino-acid sequences with BbOspA; antibodies generated against these
OspA homologous peptides reacted with human neurones in the brain spinal cord and dorsal
root ganglia (Alaedini and Latov, 2005). As the perception of risks associated with the
vaccine was high, the demand for the vaccine decreased (Nigrovic and Thompson, 2007). In
addition, Borrelia downregulate OspA before entering the mammalian host, hence removing
the antigenic surface that the antibodies stimulated by the vaccine would recognise (Cassatt et
al., 1998, Pal et al., 2000, Schwan and Piesman, 2000, Yang et al., 2004).
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1.1.4 Relapsing fever
Relapsing fever (RF) is a tick and louse-borne zoonosis, caused by B. hermsii, B. duttonii and
B. recurrentis. The two former species are spread by ticks of the genus Ornithodoros, while
the latter is louse-borne and spread by P. humanus (Ras et al., 1996), although there is
phylogenetic evidence to suggest that B. duttonii and B. recurrentis are the same species
(Cutler et al., 1997). RF is characterised by recurring bouts of high bacteraemia, each caused
by distinct populations of Spirochaete generated by the rearrangement of the genes for outer
surface virulence proteins (Vuyyuru et al., 2011). RF has been shown to recur at least 10
times without treatment (Bryceson et al., 1970) and has an incubation period of 4 to 18 days;
characteristic symptoms include headache, myalgia, chills, vomiting and abdominal pains
(Schwan et al., 2003). Secondary symptoms of RF include abdominal pains, tachycardia and
tachypnoea (a high respiratory rate).
1.2 The genus Borrelia
The genus Borrelia, named after the French bacteriologist Amédée Borrel was first identified
in 1834 by Ehrenberg under the name Spirillum giganteum. The name was changed to
Borrelia in 1907, and was conferred by the Dutch bacteriologist Nicholas Swellengrebel
(Wright, 2009). Species of Borrelia are the etiological agents of two major diseases in
humans: the zoonosis Lyme disease (also known as Lyme borreliosis) and Relapsing Fever
(also known as Relapsing fever borreliosis) (Cutler, 2009). Borrelia burgdorferi was named
for the scientist Willy Burgdorfer, who, along with Allen Steere recognised that Borrelia was
the causative agent of Lyme disease (Steere et al., 1978, Burgdorfer et al., 1982, Burgdorfer
et al., 1986, Burgdorfer, 1984). There are upwards of thirty known species of Borrelia
detailed in various publications (Figure 1.3); and new species such as B. americana sp. nov.,
B. kurtenbachii sp. nov. and B. carolinensis sp. nov. have been identified in recent years
(Rudenko et al., 2010, Rudenko et al., 2011, Margos et al., 2011). B. afzelii, B. burgdorferi
s.s and B. garinii, collectively known along with fifteen other species as B. burgdorferi s.l.
(Rizzoli et al., 2011), are the main species responsible for Lyme Disease in humans, while B.
duttonii, B. recurrentis and B. hermsii are the main species known to cause Relapsing Fever
(Schwan et al., 2003, Bárcena-Uribarri et al., 2010), although there is evidence that B.
recurrentis is actually a strain of B. duttonii with a genome that appears to be decaying and
losing proteins (Lescot et al., 2008). Borrelia species responsible for causing Lyme Disease
are transmitted to mammalian hosts during tick feeding, primarily by ticks of the Ixodes
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genus: I. ricinus, I. pacificus and I. dammini (Burgdorfer et al., 1982, Burgdorfer et al.,
1986). Relapsing fever Spirochaetes have been shown to be transmitted by hard ticks of the
genera Dermacentor, Amblyomma and Ornithodoros (Athreya and Rose, 1996), the most
common of which appear to be B. hermsii and B. parkeri transmitted by the tick species O.
hermsi and O. parkeri respectively (Schwan et al., 2003). Other species of Borrelia known to
cause Relapsing Fever include: B. turicatae, B. anserine, B. coriaceae, B. persica, B.
hispanica and B. crocidurae (Ras et al., 1996). It is important to note however, not all strains
of Borrelia are infectious in humans.
The phylum Spirochaetes consists of only one class and this class of one order.
Differentiation of the Spirochaetes begins when the order is divided into three families -
Spirochaetaceae, Brachyspiraceae and Leptospiraceae (Rosa et al., 2005). Borrelia are
classified as part of the Spirochaetaceae family along with Treponema pallidum, the
causative agent of syphilis and yaws (Fraser et al., 1998, Paster and Dewhirst, 2000) Other
disease causing bacteria are present in the other two families; Leptospiraceae contains
Leptospira, which is responsible for leptospirosis, while Brachyspiraceae encompasses B.
aalborgi and B. pilosicoli which causes intestinal spirochaetosis. (Peruzzi et al., 2007)
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Figure 1.3. 16s rRNA Phylogenetic tree of Spirochaetes. Phylogenetic tree adapted from (Paster and Dewhirst, 2000). B.
burgdorferi s.s. are closely related to Cristispira, a Spirochaete found in the digestive tract of oysters (Paster and Dewhirst,
2000, Madigan and Martinko, 2006) and Treponema and Spirochaeta. Brachyspira and Leptospira are further removed from
Borrelia.
Borrelia are microaerophilic obligate parasites, requiring an environment with lower than
atmospheric oxygen levels and are therefore unable to survive outside a host (Fraser et al.,
1997, Paster and Dewhirst, 2000, Neelakanta et al., 2007). In addition, Borrelia have a
minimal genome (Moran, 2002) and lack a respiratory electron transport chain, thus relying
on substrate level phosphorylation mechanisms. Borrelia are therefore dependent on either
the mammalian or arthropod host for their survival, nutritional requirements and transmission
(Fraser et al., 1997, Steere, 2001). The Spirochaetes have evolved and adapted complex
mechanisms for long term survival in each host environment (Purser et al., 2003). Natural
transmission of Borrelia usually involves warm blooded mammals, birds and rodents as
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hosts, enabling Borrelia to spread to and infect the non-infected tick, furthering the bacterial
enzootic cycle (Alitalo, 2004).
The three species that will be focused on throughout this research are the major species
responsible for causing Lyme Disease in humans: B. afzelii, B. burgdorferi s.s. and B. garinii
(Kurtenbach et al., 2006). B. afzelii and B. garinii are most common in Europe and Asia,
although B. burgdorferi s.s. is present (Bunikis et al., 1995, Wang et al., 1999, Rosa et al.,
2005, Casjens et al., 2011) (Figure 1.4). Whilst all three species cause Lyme Disease, the
latter stage symptoms that occur are dependent on the species of the infecting Spirochaete
(section 1.1.1) (Kalish et al., 1993, Pal et al., 2000). The difference in symptoms is
potentially due to the different species of Borrelia evolving in different climates and
environments, using different mammalian species with varying immune systems as host
reservoirs.
Figure 1.4. Geographical distribution of various Borrelia species. The above figure shows the distribution of the major
disease causing species of Borrelia in North America and Europe/Russia. Solid red circles show areas where the presence of
B. burgdorferi s.s. has been confirmed, the green dotted line encircled area shows the region where B. afzelii has been found
and the blue dash encircled area highlights confirmed B. garinii presence. Data adapted from (Kurtenbach et al., 2006), map
licensed under the Creative Commons Attribution-Share Alike 2.5 Generic license.
1.2.1 The genetics of Borrelia
Since the first sequencing of a whole B. burgdorferi s.s. genome (strain B31) (Fraser et al.,
1997), the whole-genomes of fourteen strains of B. burgdorferi s.s. (Casjens et al., 2000,
Schutzer et al., 2011), two strains of B. afzelii (PKo and ACA-1) and two B. garinii strains
(PBr and Far04) have been sequenced (Casjens et al., 2011). B. burgdorferi s.s. (B31) was
the third ever bacterial genome to be sequenced following H. influenza and M. genitalium
(Fleischmann et al., 1995, Fraser et al., 1995).
Borrelial DNA is composed of a linear chromosome, and both closed hairpin and circular
plasmids, a phenomenon which is unique among bacteria (Barbour, 1993, Fraser et al., 1997,
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Krupka et al., 2007, Lescot et al., 2008). The genome of Borrelia is unusually A-T-rich,
approximately 71 % of the entire genome is composed of either adenine or thymine (Hyde
and Johnson, 1984, Fraser et al., 1997, Howe et al., 2003). As Borrelia are dependent on the
host for survival and nutrients, it has been proposed that an A-T rich genome is a result of a
trade-off to incorporate ATP and TTP nucleotides rather than the more energetically
expensive and less readily available GTP and CTP counterparts, due to the lower energy cost
of producing ATP (Rocha and Danchin, 2002). It is also speculated that G-C content is
related to phylogeny; 5s rRNA analysis suggested A-T/G-C pressure acts on the whole
genome during evolution (Muto and Osawa, 1987), potentially as a result of the easier
availability of ATP rather than GTP, which results in modification of components of DNA
synthesis biased mutation rate towards A-T or methylation and deamination of DNA bases
results in accumulation of A-T pairs (Muto and Osawa, 1987).
The A-T content of genes is up to 5 % less than that of the overall genomic content, but is
still unusually high (Howe et al., 2003). The genome of B. burgdorferi s.s. is 1.44 Mbp in
length (Madigan and Martinko, 2006), Approximately 93 % of the Borrelial chromosome
codes for essential proteins such as DNA replication, transcription, translation, solute
transport and energy metabolism, but very few homologues to other eubacterial regulatory
proteins have been identified in the Borrelial genome (Fraser et al., 1997).
Borrelia have the largest number of known extrachromosomal DNA (ecDNA) fragments of
any bacteria. The strain B. burgdorferi B31 has a total of 21 extrachromosomal elements
ranging in size from 9 to 56 Kbp comprised of - 9 circular and 12 linear plasmids with
covalently closed hairpin telomeres (Casjens et al., 2000, Purser et al., 2003, Rosa et al.,
2005). Only 71 % of the DNA encodes for putative genes, due to the presence of intergenic
regions and a significant number of pseudo-genes in a state of decay with frameshifts and
stop-codons (Fraser et al., 1997). The B. afzelii and B. garinii strains sequenced in 2011
(Casjens et al., 2011) established that the number of plasmids present in those strains varied
from 7 to 17. Only approximately 8 % of the putative genes encoded in ecDNA were shown
to be similar to genes in other bacteria, however none of these similar genes were virulence
factors. This suggests that either the Spirochaete has evolved with different virulence and
pathogenic proteins, has remote homologues, or both (Casjens et al., 2000). Plasmids appear
to be consistent in a variety of Borrelial species and strains, which implies that they are
important for survival, infectivity and propagation (Purser et al., 2003). Sixty three putative
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membrane lipoproteins have been identified as being plasmid-encoded, providing evidence
for the differential expression of proteins in various hosts (Fraser et al., 1997). A study of B.
burgdorferi s.s. indicates that when cultured in-vitro the bacteria are prone to losing plasmids.
This has been shown to have minimal effect on propagation, but does result in a loss of
infectivity in mice (Ristow et al., 2012) as a significant number of outer membrane proteins
(Steere, 2001), several virulence and infective proteins (PncA, OspA-D, DbpA and DbpB,
VlsE) are plasmid-encoded (Comstock et al., 1993, Fraser et al., 1997, Roberts et al., 1998,
Kumaran et al., 2001, Hübner et al., 2001, Purser et al., 2003, Stewart et al., 2005). For
example, the removal of plasmid lp25 encoding a cytoplasmic nicotinamidase (PncA) was
sufficient to knock out Borrelial infectivity in rats, replacement of the gene via
transformation was sufficient to restore infectivity (Purser et al., 2003).
1.2.2 The ultrastructure of Borrelia
Borrelia are tightly coiled and highly motile Spirochaete bacteria (Figure 1.5) (Madigan and
Martinko, 2006). Borrelia were initially assumed to be Gram-negative due to the presence of
both an outer and inner (cytoplasmic) membrane. However as techniques advanced and more
detailed analyses of the genetics, molecular architecture and biochemical workings were
undertaken on Borrelia and other Spirochaetes (including Spirochaeta, Leptospira and
Treponema) a clear difference was seen and a new eubacterial phylum was created (Paster et
al., 1991). Unlike Gram-negative bacteria, Borrelia and Treponema lack lipopolysaccharide
(LPS) on the outer surface of the membrane (Takayama et al., 1987), although Leptospira
and Brachyspira do synthesise LPS (Saier, 2000). From the phylogenetic tree (Figure 1.3) it
is apparent that Borrelia and Treponema are more closely related to each other than
Leptospira and Brachyspira. Another major difference is the OM proteome, Gram-negative
bacteria contain a high number of transmembrane proteins, with few exposed lipoproteins, in
Borrelia the opposite is true (Cox et al., 1996). Borrelia vary in length from 10 – 30 μ m in
length and approximately 0.2 to 0.3 μ m in diameter (Krupka et al., 2007).
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Figure 1.5. Basic diagram of the ultrastructure of a Borrelia Spirochaete Diagram adapted from (Rosa et al., 2005). The
bacterium has both an outer and a cytoplasmic membrane, with multiple endoflagellum present within the periplasmic space
between. All the other cellular components such as DNA are contained in the protoplasmic cylinder.
The motility of Spirochaetes differs from that of bacteria with extracellular flagella; one end
of each endoflagella is attached to the cytoplasmic membrane of the protoplasmic cylinder
towards the terminus of the Spirochaete, extending along the Spirochaete and overlapping
with endoflagella attached at the other terminus (Madigan and Martinko, 2006, Charon et al.,
2009). The endoflagella are anchored at one terminus into the cytoplasmic membrane as
shown below (Figure 1.6 & Figure 1.7). Borrelia contain between 7 and 11 endoflagella per
origin (Hovind-Hougen, 1984, Motaleb et al., 2000). The flagella also play a vital role in the
skeletal structure of Borrelia as flagella deficient Borrelia are rod-shaped, this is unusual as
bacterial shape is normally dictated by the layer of peptidoglycan (Motaleb et al., 2000,
Charon et al., 2009).
Figure 1.6. Basic diagram showing the anchoring points of endoflagella. Highlighted are the discs and hooks (D and H
respectively) present at each terminus of the flagella. Only one end of each endoflagella is anchored in the protoplasmic
cylinder and endoflagella from each terminus of the bacteria overlap in the centre. Diagram based on an SEM image from
(Hovind-Hougen, 1984).
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Figure 1.7. Anchoring of endoflagella in the cytoplasmic membrane of Borrelia The disc and hook that anchor the
endoflagella into the membrane are labelled D and H respectively. Diagram based on (Rosa et al., 2005). Rotation of the
flagella is a result of proton transport-coupled rotation, which causes an element of the disc to spin around a central core
(Berg et al., 2002). The rotation is capable of changing direction rapidly, which is useful for chemotaxis (Berg et al., 2002).
Co-ordinated rotation of the endoflagella in the same direction causes the protoplasmic
cylinder to rotate in the opposite direction while the outer membrane rotates in the same
direction as the endoflagella (Figure 1.8). This places torsion on the cell, conferring motility
through flexing motions; this is useful in highly viscous environments such as cell cytoplasm
and helps with transition between tissues from initial deposition in the skin. The Spirochaete
can reach speeds of 4 µm/sec-1, fast enough to evade phagocytes (Madigan and Martinko,
2006, Radolf et al., 2012). Some components of bacterial flagella (principally flagellin) are
known to stimulate a pro-inflammatory immune response in hosts (Zgair, 2012). The location
of Borrelial flagella within the protoplasmic cylinder means that the antigenic components of
flagella are not normally presented to the immune system.
Figure 1.8. Cross section of a Borrelia bacterium. Based on (Madigan and Martinko, 2006), as the endoflagella rotate in
one direction, the protoplasmic cylinder rotates in the opposite direction. As in a system of cogs, the outer membrane rotates
in the same direction as the endoflagella. The endoflagella are arranged side-by-side as in a ribbon, rather than bundled
together (Charon et al., 2009).
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1.2.3 The outer membrane of Borrelia
Expression of proteins in the outer membrane of Borrelia has been shown to vary according
to many different factors, including: the host species the Spirochaete is occupying,
temperature, the location within the host and the stage of infection (Fraser et al., 1997, Pal et
al., 2000, Babb et al., 2001, Pal et al., 2004b). This is vital to the Spirochaete evading the
immune system responses of the hosts and sustaining an infection. Several types of protein of
known function have been shown to be present on the outer membrane of Borrelia at one
time or another (Figure 1.9); the most prominent of which are a variety of lipoproteins
including decorin binding proteins, outer surface proteins, CRASPs and complement binding
proteins; an enolase and porins (described in section 1.2.4.5) (Skare et al., 1997, Cassatt et
al., 1998, Schwan and Piesman, 2000, Babb et al., 2001, Fikrig et al., 2004, Pal et al., 2004b,
Brooks et al., 2006, Bárcena-Uribarri et al., 2010).
Figure 1.9. Schematic representation of known lipoproteins and outer membrane proteins in Borrelial membranes.
Proteins of known structure are shown in the cartoon form, whilst proteins of unknown structure are shown as solid shapes.
The solid rectangles are representative of lipid anchors. Not all proteins in the diagram are upregulated at the same time, for
example OspA and OspC (Schwan and Piesman, 2000). OspB is represented as a protein with a cleft in the middle as only
the structure of the C-terminus has been solved (Becker et al., 2005). There are three more known Osps (D-F) but these are
not as thoroughly characterised as Osps A-C and so are not included.
As mentioned previously (section 1.2.2), unlike Gram-negative bacteria, lipopolysaccharide
(LPS) is not expressed by Borrelia; it has been speculated that this is part of the Spirochaetes
immune system evasion. LPS is readily detectable and highly antigenic (Takayama et al.,
1987, Seemanapalli et al., 2010). Borrelia express the largest number of lipoproteins of any
bacteria, with over 175 known (approximately 10 % of the genome codes for lipoproteins)
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(Fraser et al., 1997, Eicken et al., 2001, Templeton, 2004, Yang et al., 2005) Spirochaetal
lipoproteins are anchored to the outer membrane through lipidation (Seemanapalli et al.,
2010) and are activators of the innate immune response in mammals. These lipoproteins are
differentially expressed depending on the environmental conditions in which the Spirochaete
currently resides (Bunikis et al., 1995).
1.2.3.1 Lipid rafts in the OM of Borrelia
Recently the outer membrane of Borrelia have been shown to contain free cholesterol,
cholesterol esters and three types of glycolipid (Figure 1.10); 6-O-acylated β -D-
galactopyranoside (ACGal), cholesteryl-β -D-galacto-pyranoside (β CGal) and mono-α -D-
galactosyldiacylglycerol (MGaID) (Ben-Menachem et al., 2003, Schröder et al., 2003, Stübs
et al., 2009, LaRocca et al., 2010).
Figure 1.10. Glycolipids present in the OM of Borrelia. ACGal (Stübs et al., 2009); MGaID (Ben-Menachem et al.,
2003); β CGal (Dorasamy et al., 2012). Both ACGal and MGaID have a similar length alkyl chain with a double bond
present and have antigenic properties (Crowley et al., 2012). β CGal contains a cholesterol group (highlighted by the black
circle).
This is unusual in that aside from a small number of prokaryotes; Mycoplasma, Helicobacter,
Ehrlicha, Anaplamsa and Brachyspira, only eukaryotic cells have previously been shown to
contain free cholesterol (LaRocca et al., 2010). Glycolipids and cholesterol make up a
significant volume of the outer membrane of the Borrelia (LaRocca et al., 2010); this varies
between 56.6 and 51.8 % of the total lipids depending upon the species (Stübs et al., 2009).
Despite containing cholesterol and cholesterol glycolipids, Borrelia lack the ability to
synthesise cholesterol or indeed any long chain fatty acids, both saturated and unsaturated
(Crowley et al., 2012). It has been shown that two-way lipid exchange between the
Spirochaete and host occurs, resulting in acquisition of cholesterol by Borrelia and transfer of
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midgut have been shown to increase markedly after the completion of a bloodmeal, and
decrease before the arthropod moults to the next stage in its life cycle (Burkot et al., 1994).
The survival of Borrelia is challenging as the bacteria has to be able to exist in two distinct
host environments, in addition to facing changes within each environment; including the
influx of blood into the midgut and physiological changes caused by tick moulting as well as
the immune responses of both hosts (Schwan and Piesman, 2000).
Borrelial outer membrane proteins are of vital importance to both the bacteria and the
infected host; they provide both the bacteria with means to evade the immune system and
survive in the host, while at the same time providing the host with targets for bacterial
removal. The two most studied groups of surface exposed Borrelial lipoproteins are B.
burgdorferi complement regulator acquiring surface proteins (BbCRASPs) and lipid-
anchored outer surface proteins (Osps). CRASPs have been shown to bind Factor H and
related proteins, negating activation of the alternative pathway of the complement immune
system (Cordes et al., 2005, Cordes et al., 2006, Kraiczy et al., 2006, Rossman et al., 2006,
Kraiczy et al., 2009). Osps found in Borrelia are genetically and antigenically polymorphic
and have been shown to trigger immune responses in mammals (Bunikis et al., 1995). Six
Osps named A through F are known (Lam et al., 1994, Bu et al., 1998, Babb et al., 2001,
Becker et al., 2005, Hovis et al., 2006, Li et al., 2007). Osps aid the Spirochaete in
transmission to, and establishment of the initial infection in mammals and persistence in
arthropod vectors (Cassatt et al., 1998, Burkot et al., 1994, Pal et al., 2000, Pal et al., 2004a,
Pal et al., 2004b). It has also been shown that Osps can be localised on the cytoplasmic
membrane (CM), protruding into periplasmic space and it is speculated that the CM can be
used as a ‘holding area’ (Cox et al., 1996) meaning that the proteins can rapidly be
transported to the outer membrane in response to specific environmental triggers.
1.2.4.1 BbCRASPs
B. burgdorferi s.s. Complement Regulator Acquiring Surface Proteins (BbCRASPs) are
plasmid encoded lipid-anchored proteins expressed on the surface of the outer membrane that
play a role in Borrelial complement evasion (Coleman et al., 2008). Five have been identified
in both B. burgdorferi s.s. and B. afzelii (Hovis et al., 2006, Rossman et al., 2006, Kraiczy et
al., 2001a, Brooks et al., 2005). CRASPs bind mammalian complement regulating proteins
Factor H, Factor H-like protein (FHL-1) and Factor H-related protein (FHR-1), which are
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BbCRASP-2, like BbCRASP-1 is known to bind Factor H and FHL-1 (Kraiczy et al., 2006,
Coleman et al., 2008, Kraiczy et al., 2008), though studies have shown that BbCRASP-2
deficient B. burgdorferi s.s. have no loss of infectivity or diminished survival rates. It is
therefore likely that BbCRASP-2 is not essential for effective immune evasion and
colonisation of mammalian hosts, but does, however, play a role (Coleman et al., 2008). This
is supported by evidence that BbCRASPs 1 and 2 bind factor H and factor H-like protein
through SCR-7 (Reuter et al., 2010).
BbCRASPs 3, 4 and 5 all have very similar amino-acid sequences and are distinctly different
from BbCRASPs 1 and 2, hence being known collectively as OspE (Coleman et al., 2008)
and OspE related proteins (Erps). (McDowell et al., 2003, Kraiczy et al., 2006). OspE are
lipoproteins (Lam et al., 1994) are expressed during the initial stages of mammalian infection
(Babb et al., 2001) and have been shown to bind complement regulating Factor H and Factor
H-related protein (FHR-1). (Hovis et al., 2006, Coleman et al., 2008, Kraiczy et al., 2009).
The structures have not yet been solved.
1.2.4.2 Outer Surface Protein A
OspA is a dumbbell shaped immunogenic lipoprotein anchored in the outer membrane of
Borrelia by a lipidated N-terminal cysteine (Bu et al., 1998, Huang et al., 1998). It is
composed of 273 amino-acids (including signal sequence) and has a molecular weight of 28
kDa (Huang et al., 1998). The protein forms a twenty one stranded anti-parallel β -sheet with
a single α -helix at the C-terminus (Figure 1.13) (Huang et al., 2001). Each end of the β -sheet
forms a globular domain, linked by a non-globular region in the middle (Bu et al., 1998). The
central β -sheet is exposed on both sides to any external influences on the protein, including
any from a solvent during crystallisation. This tertiary structure of OspA is unusual in regards
to the exposure of polar residues in the central sheet to solvent, in general proteins containing
anti-parallel β -sheets are amphipathic, with the hydrophobic amino-acids sheltered in a
hydrophobic core (Li et al., 1997, Bu et al., 1998), however it appears that the hydrophobic
residues in the central β -sheet are protected by an abundance of amino-acids with long side
chains, increasing the thickness of the β -sheet (Huang et al., 2001). SAXS (Bu et al., 1998)
solution NMR studies (Huang et al., 1998, Huang et al., 2001) have shown that OspA exists
in solution as a monomer, and is in agreement with the solved structure that the protein
consists of two globular domains linked by a stable central β -sheet, hence does not have a
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It is also feasible that OspA-OspA binding could also facilitate the binding of Borrelia to
each other, aiding the establishment of B. burgdorferi s.s. in the tick midgut (Pal et al., 2000).
Both deficiencies in TROSPA in the tick, and OspA in the Spirochaete resulted in reduced
colonisation (Pal et al., 2000, Pal et al., 2004a).
Downregulation of OspA by the Spirochaete, and TROSPA by the tick during a bloodmeal
potentially aids the Spirochaete in detaching from the tick midgut for transmission to the
mammalian host (Pal et al., 2004a). This would prevent the bacteria from binding to each
other and facilitate easier translocation to the salivary glands and therefore transmission to
the mammalian host (Burkot et al., 1994, Cassatt et al., 1998, Pal et al., 2000). OspA is not
expressed on the surface of Borrelia when the Spirochaete is present in mice; this is likely
due to the protein having an function in ticks but not mammals, hence downregulation to
prevent immune response targeting (Liang et al., 2004).
It has recently been shown that B. burgdorferi s.s. form biofilms (Sapi et al., 2012), which
may be a factor in the development of Lyme arthritis. It is possible that OspA-OspA binding
may play an important role in facilitating Borrelia-Borrelia binding and formation of
biofilms. OspA has been shown to be continually repressed in mammalian host to prevent
host antibodies binding and eliciting an immune response (Schwan et al., 1995, Pal et al.,
2000, Schwan and Piesman, 2000), however evidence is present that OspA can be expressed
in the mammalian host; antibodies for OspA have been identified in the cerebrospinal fluid of
patients with neuroborreliosis (Liang et al., 2004) and joints of patients with Lyme arthritis
(Kalish et al., 1993). The latter study monitored immune responses to fifteen patients infected
with Borrelia over a period of months and years. Antibodies for both OspA and OspB were
found in eleven patients just prior to the onset of arthritis, having not been present in the
months and weeks before (Kalish et al., 1993, Pal et al., 2000), antibodies for OspA and
OspB were found in the remaining four patients as the symptoms progressed. This may be
another indicator of OspA importance in biofilm formation, and of biofilm importance in
arthritis.
1.2.4.3 Outer Surface Protein B
OspB is a 296 residue, 31 kDa protein lipid-anchored protein present on the outer membrane
of Borrelia when in the arthropod midgut (Becker et al., 2005) that is closely related in both
sequence and structure to OspA (Neelakanta et al., 2007). The overall shape of OspB is
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OspA and OspB genes are encoded by a single operon on an extrachromosomal plasmid
(Fikrig et al., 2004, Becker et al., 2005, Neelakanta et al., 2007) and it has been shown that
OspA and OspB are transcribed together due to a shared promoter. OspB is primarily
expressed while the Spirochaete is present in the midgut of unfed Ixodid ticks, but
downregulated upon commencement of a bloodmeal (Becker et al., 2005) and not expressed
in mammals (Cassatt et al., 1998). Like OspA, OspB has been shown to bind to the tick
midgut (Fikrig et al., 2004, Yang et al., 2004, Neelakanta et al., 2007). A study found that
OspB specific antibodies inhibited the Spirochaete binding (Fikrig et al., 2004), while
another found that OspB deficient B. burgdorferi s.s. had an impaired ability to bind to the
midgut of ticks upon commencement of the bloodmeal, but could still infect mice
(Neelakanta et al., 2007). These findings indicate that OspB is an important contributor to
survival of Borrelia in ticks, but is downregulated in mammals to minimise potential
antigenic surfaces presented to the mammalian host.
OspB, like OspA has also been implicated in Lyme arthritis (Kalish et al., 1993). Prior to the
onset of arthritis 73 % of patients developed a response to both OspA and OspB antibodies
(Kalish et al., 1993). In a different study, this provided further evidence for the presence of
OspA and OspB prior to the onset of arthritis, however it also found that in mice OspB was
expressed at considerable levels four months after developing arthritic symptoms (Liang et
al., 2004).
1.2.4.4 Outer Surface Protein C
OspC is a 23 kDa lipoprotein expressed on the surface of Borrelia (Babb et al., 2001,
Kumaran et al., 2001, Pal et al., 2004b) that contains four long anti parallel α -helices and one
short α -helix (Figure 1.16 A & B), it is likely that the dimer shown in Figure 1.16 C and
Figure 1.16 D is biologically relevant due to the formation of a four helix hydrophobic core,
extending almost the whole length of the protein (Eicken et al., 2001, Seemanapalli et al.,
2010). OspC has a strong negative electrostatic potential, potentially involved in binding
charged host ligands – indicative of causing human disease; in addition, OspC is highly
polymorphic (especially the surface exposed residues) making it difficult to design antibodies
for (Wikel, 1996, Eicken et al., 2001, Kumaran et al., 2001).
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OspC has been shown to bind tick salivary protein 15 (Salp15) both in vivo and in vitro.
(Ramamoorthi et al., 2005). The effect of Salp15 on Borrelial dissemination and infection of
mice was studied and it was found that Salp15 binding significantly increased the
survivability of B. burgdorferi s.s. in mice, along with protecting the Spirochaete from being
by OspA antibodies (Ramamoorthi et al., 2005). OspC antibodies have been detected in
humans patients prior to onset of Lyme arthritis (Kalish et al., 1993), this is not unexpected
as OspC is an important virulence factor when present in mammals.
1.2.4.5 Other surface exposed proteins
OspD is a 28 kDa surface exposed lipoprotein that, like Osps A-C is located on a linear
plasmid (Li et al., 2007) OspD appears to be largely downregulated upon the temperature
shift associated with the influx of warm mammalian blood when a tick takes a bloodmeal.
This suggests that OspD, like OspA and OspB is present on the surface of Borrelia when
present in the midgut of a tick, and not in mammals. OspD was found to bind the midgut of
ticks, and B. burgdorferi s.s. deficient in OspD was shown to be less able to colonise ticks,
but this didn’t have an effect of infectivity on mice (Li et al., 2007).
OspF is another plasmid encoded surface exposed lipoprotein from Borrelia (Lam et al.,
1994), only it has been shown to not bind Factor H or related proteins (Hovis et al., 2006).
OspF is poorly understood and the current function is unknown.
VlsE is a 35 kDa variable surface lipoprotein expressed on the surface of Borrelia, the loss of
which reduces infectivity (Eicken et al., 2002). VlsE is a predominantly α -helical protein,
consisting largely of a variable cassette region, flanked by the C and N termini of the
polypeptide chain. Segments of a silent cassette region can recombine with the cassette
region through gene conversion, with nine to thirteen recombination events occurring every
four weeks. (Eicken et al., 2002) This is thought to hinder the hosts ability to generate an
effective immune response and thus aids the Spirochaete in evasion.
Decorin and fibronectin (Fn) binding proteins (DbpA, DbpB and BBK32) are expressed in
early mammalian infection (Guo et al., 1998, Pal et al., 2004a). Fn is a multifunctional
dimeric glycoprotein present in blood plasma and on the surface of mammalian cells. Cell
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bound Fn aids tissue repair and promotes cell-cell adhesion, (Proctor, 1987, Potts and
Campbell, 1996, Mosher, 2001, Kim et al., 2004, To and Midwood, 2011) the binding of
which facilitates Borrelial transmission into the cell (Steere et al., 2004). Decorin is a
glycosaminoglycan present on collagen fibrils (Bunikis et al., 1995, Steere et al., 2004), the
binding of which by DbpA & B facilitate the adhesion of the Spirochaete to the mammalian
extracellular matrix (Hübner et al., 2001). The Dbps are differentially expressed on the
surface of Borrelia in response to changes in environmental conditions (Pal et al., 2000, Kim
et al., 2004). When Borrelia are present in the midgut of tick, neither BBK32 or DbpA or
DbpB are expressed, however they are upregulated upon the increase in temperature and pH
change that occurs with the influx of mammalian blood during a tick bloodmeal (Neelakanta
et al., 2007) and are prominent on the outer when the Spirochaete is present in mammals (Pal
et al., 2004b).
A small number of putative porins have been identified to be present in the outer membrane
of Borrelia; P13 (Skare et al., 1997, Bárcena-Uribarri et al., 2010), Oms28, P66 and a protein
homologous to Oms38 in Relapsing fever Borrelia (Bárcena-Uribarri et al., 2010, Ristow et
al., 2012). P13 and Oms28 are poorly characterised and are only speculated to be porins. P66
is a 66 kDa porin and adhesion present in the outer membrane of Borrelia (Skare et al., 1997,
Bárcena-Uribarri et al., 2010) that is expressed during mammalian infection (Defoe and
Coburn, 2001). P66 is a putative β -barrel with surface exposed domains, potentially
conferring immunogenicity, and is capable of binding β 3-integrin chains found on activated
immune cells, platelets and endothelial cells (Defoe and Coburn, 2001, Ristow et al., 2012),
therefore mediating interactions between host cells and Borrelia. As was earlier described,
P66 is present in lipid rafts present on the surface of Borrelial outer membranes (LaRocca et
al., 2010).
Enolase is a moonlighting protein; these proteins exist in many varied locations in cells,
fulfilling a variety of roles (Jeffery, 1999). Borrelial enolase (also known as phosphopyruvate
dehydratase (Nogueira et al., 2012)) is surface exposed, known to bind plasminogen, play an
important role in enhancing dissemination of Borrelia in mammals (Floden et al., 2011) and
aid the survival of Borrelia in ticks; immunisation with recombinant enolase was shown to
reduce Spirochaetal acquisition in feeding ticks (Nogueira et al., 2012). Plasminogen is an
inactive single chain glycoprotein present in the hosts serum; and upon binding to Borrelia it
is cleaved to form plasmin (Toledo et al., 2011); Borrelia with plasmin bound on the surface
Page | 48
are capable of degrading Fn and cellular matrices, and penetrating endothelial cells (Floden et
al., 2011, Toledo et al., 2011).
1.2.5 Borrelia implicated with Alzheimer’s disease.
While it is known that Borrelia cause Lyme disease and Relapsing fever, Spirochaetes
including Borrelia and Treponema have, along with other pathogens been implicated to be
involved in Alzheimer’s disease (Miklossy et al., 2005). Although it is not clear whether
Spirochaetes are present in the brain before or after the disease is developed there are
apparent links between the two. The clinical and pathological characteristics of Alzheimer’s
disease are comparable to those present in dementia paralytica (the tertiary stage of syphilitic
infection) caused by T. pallidum which is akin to the manner in which B. burgdorferi s.s is
capable of causing dementia in late stages of Lyme disease (Miklossy et al., 2005, Swerdlow,
2007, Miklossy, 2008, Miklossy, 2011). Degeneration of the cortex associated with dementia
also occurs in the late stages of B. Burgdorferi s.s. induced Lyme disease (Miklossy, 1993)
The pathogenic bacteria Chlamydia pneumonia and herpes simplex virus type I have also
been implicated in infiltrating the central nervous system and causing a neuroinflammatory
response, possibly triggering Alzheimer’s disease pathology, or bi-polar disorder (Itzhaki et
al., 2004, Miklossy, 2008).
Alzheimer’s disease is the most common form of dementia in which cognitive and memory
functions gradually deteriorate over time. At least part of the cause is suspected to be the
accumulation of a 4.2 kDa amyloid beta peptide (A β ) in plaque-like structures, and the
formation of neurofibrillary tangles in the brain. The cause of this is as yet unidentified
(Miklossy, 2011). The Spirochaetes Borrelia and Treponema have been shown to be present
in significant numbers in the brains of deceased Alzheimer’s disease sufferers (Itzhaki et al.,
2004, Riviere et al., 2002, Miklossy, 2008). It is however, known that OspA present on the
outer membrane of Borrelia has the capacity to induce amyloid fibres, which are similar to
human amyloid (Miklossy et al., 2005, Miklossy, 2011). Several studies have been conducted
in an attempt to determine a possible link between Borrelia and Alzheimer’s disease.
It has been shown that A β formed plaque-like structures in several types of mammalian brain
cell once exposed to Borrelia for up to eight weeks (Miklossy et al., 2005, Miklossy, 2008).
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Another study also utilised dark field microscopy show Spirochaetes present in the blood,
cerebrospinal fluid and cerebral cortex of 14 Alzheimer’s disease patients (and the absence of
Spirochaetes in 13 control patients). Peptidoglycan from the Borrelial cell walls was co-
localised along with the Aβ  plaques in 17 Alzheimer’s patients, but were again absent in
control samples. This, along with the finding of Borrelial antigens and genes again co-
localised with Aβ  plaques provides further evidence for the involvement of Borrelia in
Alzheimer’s disease (Miklossy, 2008).
A study was conducted (Riviere et al., 2002) on the presence of oral Treponema and Borrelia
in the brain and trigeminal nerve in order to investigate the hypotheses that the trigeminal
nerve was a route of translocation of Treponema to the brain, and whether there was a
statistically significant difference in the numbers of Alzheimer’s disease/control patients with
Spirochaetes present in the brain. Brain sections (frontal lab cortexes and trigeminal ganglia)
of donors were tested for seven Treponema species and B. burgdorferi by the PCR
amplification of species-specific 16S rRNA sequences and Treponema specific antibodies.
PCR found that the brains of fourteen of sixteen patients with Alzheimer’s disease were
positive for at least one species of Treponema, compared to four of eighteen negative
controls. Five Alzheimer’s patients were found to have Borrelia, while all control samples
were negative. All five trigeminal ganglia samples also tested positive. Antibodies detected
Treponema in fifteen of the sixteen patients with Alzheimer’s disease. (Riviere et al., 2002).
The geographical distribution of Borrelia compared with Alzheimer’s disease however,
suggests that Borrelia cannot be a factor in all cases of Alzheimer’s disease. This, along with
the presence of Treponema in the brains and CNS of patients with Alzheimer’s disease may
imply that it is not Borrelia, but many genera of Spirochaetes that are involved with
Alzheimer’s disease. The hypothesis that bacteria (Spirochaetes) play a role in the
development of Alzheimer’s disease is complementary to the hypothesis that genetic defects
occur in Alzheimer’s disease patients, indeed it is speculated that genetics control
susceptibility to bacterial infection (Miklossy, 2008).
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1.3 Ixodid ticks
Borrelia.use hard ticks as reservoirs to maintain their natural enzootic cycle and vectors for
transmission to mammalian hosts (Steere et al., 2004). Ticks transmit the greatest number of
Spirochaetes and viruses of all blood-feeding arthropods (Heinze et al., 2012) and are second
only to mosquitoes as vectors of human disease (Parola and Raoult, 2001). The most common
Borrelial tick reservoirs are species of the Ixodid tick: I. pacificus and I. scapularis (known
as the black-legged or deer tick), which are prevalent mainly in North America, and I.s
ricinus, prevalent mainly in Europe (Figure 1.17) (Steere et al., 2004). In the United States
the distribution of reported cases of Lyme disease corresponds closely with that of I.
scapularis and I. pacificus (CDC, 2011). It has also been shown that I. scapularis can spread
other bacteria and diseases such as Babesia microti, causative protozoan of human babesiosis
and Anaplasma phagocytophilum, causative agent of Human granulocytic anaplasmosis
(Stafford, 2001) (Liu et al., 2012, Horowitz et al., 2012). Ixodes ticks are also responsible for
the spread of viruses such as tick-borne encephalitis and Powassan encephalitis. (Parola and
Raoult, 2001). Other species of tick known to spread Lyme disease Spirochaetes are soft ticks
of the genera Argas and Ornithodoros (Vatandoost et al., 2003).
Figure 1.17. Ixodes ricinus suitable habitats in the UK and Europe. Red shaded areas of the map shows suitable tick
habitation. Image adapted from (Gray et al., 2009). Map licensed under the Creative Commons Attribution-Share Alike 2.5
Generic license.
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1.3.1 Tick life cycle
Ixodes ticks have a life cycle which encompasses four stages: egg, larva, nymph and adult
(Figure 1.18). The Ixodid tick life cycle takes place over the course of approximately two
years (Figure 1.19), and begins in the late Spring and early Summer months when females,
fresh from a blood-meal lay their eggs. The eggs hatch into larvae over the course of late
Summer and the larvae take their first blood-meal, usually on small rodents (in particular the
white-footed mouse), lizards or birds before moulting to nymphs over the course of late
Autumn through to early Spring (Stafford, 2001). Once Spring has ended, the nymphs take
their blood-meal, again on small mammals etc, and moult to adults. These adult ticks feed for
the final time on larger mammals such as deer (Schwan and Piesman, 2000) over the course
of late Autumn to early Summer, when the engorged females lay their eggs on the ground,
thus beginning the cycle again. Whilst some species of tick are known to only feed on
specific hosts, Ixodes scapularis and ricinus feed on a variety of hosts such as small
mammals, reptiles and birds when in the first two developmental stages, and large mammals
such as deer and dogs (and humans) when adults (Stafford, 2001, Couper et al., 2010,
Taragel'ová et al., 2008).
Figure 1.18. A female and male I. ricinus. Left to Right; Adult female, adult male. The arrow highlight the scutum; this
covers the entire dorsal surface in the adult male, however in other developmental stages it is confined to the anterior region
of the tick. The adult female is larger than the adult male; this is also true for Ixodes scapularis and pacificus. Image licensed
under the Creative Commons Attribution-Share Alike 2.5 Generic license.
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Figure 1.19. The two year life cycle of an Ixodes tick. Data and images obtained from (Athreya and Rose, 1996, Stafford,
2001)
Ixodid ticks have a large (for a tick) body size, varying from 2-30 mm. At the adult and
nymphal stages of development, the ticks have four pairs of walking legs, whilst the larval
stage has three. Ticks also do not have a distinct head, thorax or abdomen. The mouthparts,
along with the hypostome and cutting organs are present on the anterior part of the tick body,
also known as the capitulum. The hypostome, labelled H on the scanning electron
micrographs (Figure 1.20), has numerous ’barbs’ that act as an anchor once the hypostome
has penetrated the skin. This makes it difficult to remove the entire tick without the anterior
part of the tick body breaking off and remaining lodged in the mammal’s skin. Adult ticks
can become considerably engorged during a blood meal (Stafford, 2001) with the tick’s
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weight capable of increasing up to 1000 fold compared to the initial size (Ribeiro et al.,
2006).
Figure 1.20. The anterior morphology of I. ricinus. Labelled are: BC - basis capituli, H - external surface of the
hypostome, P - palp. Image licensed under the Creative Commons Attribution-Share Alike 2.5 Generic license.
I. scapularis feeds at three points during its lifetime, once during each of the three stages
shown in Figure 1.19. Each blood meal lasts for several days and it is during this time that
ticks infected with Borrelia burgdorferi s.s. transmit the bacteria to a mammalian host. The
most common feedings at which transmission occurs are the nymph and adult stages, as the
tick first has to become infected by feeding on a small infected mammal (Stafford, 2001).
Once feeding is complete, the tick detaches to complete digestion and either moult to the next
stage, or enter a state of reduced metabolism, known as a dispause.
1.3.2 The influence of tick saliva on survival of Borrelia in hosts
Many host defences must be overcome by the tick in order to feed, and for successful
transmission of the Spirochaete to the mammalian host. The initial obstruction is the
mammal’s skin; this forms a physical barrier that needs to be penetrated in order to allow
access to the bloodstream. The tick achieves this with the hypostome (Figure 1.21).
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P
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Figure 1.21. Ixodid tick hypostome. The ‘barbs’ on the hypostome are present all around the upper half of the hypostome,
which are responsible for anchoring the tick into the skin. Image from {Moorhouse, 1981 #554}, licensed under the Creative
Commons Attribution-Share Alike 2.5 Generic license.
Once the hypostome has penetrated the skin and has access to the host’s blood supply (a pool
of blood formed by laceration of the skin), the tick secretes a cement like substance, to, in
conjunction with the hypostome, anchor the tick in the feeding site and prevent detachment
(Ribeiro et al., 2006). Once anchored, the tick starts to salivate. Among the first compounds
to be released are proteins and enzymes that alleviate host pain and irritation at the binding
site (Tyson et al., 2007), the tick also releases a variety of antihaemostatic compounds to
maintain a supply of blood to the feeding site (Chmelar et al., 2012). The vasodilators
prostaglandin E2 (PGE2) and prostacyclin (PGI2) have been shown to be present in the
saliva/salivary glands of several species of Ixodes tick, and are postulated to increase flow of
blood to the tick mouthparts through dilation of host blood vessels, promoting feeding. PGI2
is also known to inhibit platelet aggregation, as is apyrase, an enzyme present in significant
amounts in tick saliva. Apyrase is responsible for the hydrolysis of ATP and ADP (required
for platelet aggregation) to AMP and orthophosphate. These two enzymes combined with
PGE2 are effective at disrupting haemostasis (Ribeiro, 1987, Chmelar et al., 2012).
Once anchored into the host’s skin, and with a steady flow of blood, the tick has to negotiate
the varied and rapid immune responses at the host’s disposal. This includes, but is not limited
to, the various pathways of the complement immune system and several types of adaptive
immune cell that reside within the skin. Dendritic cells capture and process antigens, and in
turn stimulate B and T lymphocytes and initiate immune responses by secreting cytokines
(Banchereau and Steinman, 1998). Mast cells are the primary responders to allergic reactions,
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along with being shown to activate inflammatory responses and T-cells (Crivellato et al.,
2003, Crivellato et al., 2004). Lymphocytes directly kill microbe infected cells (Brossard and
Wikel, 2004). Eosinophils are a source of cytokines and growth factors that display both pro
and anti-inflammatory responses such as wound healing (Munitz and Levi-Schaffer, 2004).
Macrophages, which are white blood cells responsible for phagocytosis of foreign bodies
within the cell (Sarantis and Grinstein, 2012). Keratinocytes compose approximately 95 % of
the outer layer of the skin and form the physical barrier to pathogens and non-biological
factors such as UV-radiation, and repair of wounds (Nakamizo et al., 2012).
Tick saliva is a well-characterised, complex cocktail of different proteins, enzyme and
inhibitors that plays a vital role in circumventing and modulating the host’s immune
response, facilitating and enhancing not only the tick’s ability to feed as described above, but
also the conditions for viral infection and dissemination (summarised in Figure 1.22) (Guo et
al., 2009, Heinze et al., 2012). Tick saliva contains an arsenal of anti-complement proteins
including Ixodes ricinus anti-complement proteins (IRAC) I and II (Gillet et al., 2009),
Salp15 (Anguita et al., 2002, Juncadella et al., 2008), Salp20 (Tyson et al., 2007), TROSPA
(Pal et al., 2004a), vasodilators, immunosuppressive, anti-inflammatory, anti-haemostatic
substances and anti-clotting proteins all of which play a role in enabling tick feeding and
pathogen transmission (Ribeiro et al., 1985, Ribeiro, 1987, Burkot et al., 1994, Ribeiro et al.,
2006, Skallová et al., 2008) Borrelia are transmitted from the tick to the host through the tick
salivary glands and benefit from tick anti-complement activity. Salivation is not a continuous
process throughout the blood meal, taking place every five to fifteen minutes and alternating
with ingestion of blood (Ribeiro, 1987). This minimises the formation of antigen-antibody
complexes and interactions with complement components in the host blood, which would be
deposited at the feeding site, promoting lesions and an immune response (Wikel, 1996). The
protein content of saliva varies throughout salivation, allowing the feeding site to be ‘primed’
prior to the introduction of infectious agents (Heinze et al., 2012); not all pathogens are
transmitted at the same time point during the feed. B. burgdorferi s.s. is transmitted between
24 and 48 hours after the commencement of the blood meal, whereas other pathogens are
transmitted either earlier or later in the blood meal (Ribeiro et al., 2006)
Tick saliva has been shown to: inhibit the maturation and migration of dendritic cells at the
binding site, production of cytokines, phagocytosis, T and B cell proliferation and activation
of the complement pathway (Skallová et al., 2008, Heinze et al., 2012). Dendritic cell
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maturation, differentiation, migration, Th1 and Th2 cytokine production and activation of T-
lymphocytes have been shown to be inhibited by proteins in tick saliva, including PGE2
(Hannier et al., 2003, Skallová et al., 2008, Guo et al., 2009). Proteins in tick saliva have also
been shown to reduce proinflammatory responses and Toll-like receptor signalling in
macrophages – Salp15 has been shown to bind TLRs. (Anguita et al., 2002, Chen et al.,
2012). Mast cells are manipulated by the tick to increase the blood flow to the feeding site;
histamine-releasing factor is secreted, triggering mast cells to release histamine and increase
vasodilation of surrounding blood vessels (Chmelar et al., 2012). Polymorphonuclear
leukocytes have been shown to have inhibited binding of Spirochaetes when pre-treated with
tick saliva (Guo et al., 2009).
Tick salivary gland protein Salp15 is a 15 kDa immunomodulatory protein, known to inhibit
early events in CD4+ T-lymphocyte activation (Figure 1.22). It has been shown that Salp15
treated T-cells have reduced calcium signalling within the cell, due to a capability to bind
CD4+ at specific domains (D1 & D2) preventing differentiation into effector T-cells
(Paveglio et al., 2007, Juncadella et al., 2008). It is also know to inhibit T-cell and B-cell
proliferation, IL-2 production and Natural Killing cell function (Paveglio et al., 2007,
Slámová et al., 2011). Salp15 has been shown to bind B. burgdorferi OspC and significantly
enhance transmission of the Spirochaete during tick feeding, it was also shown that Salp15
secretion is increased when Borrelia infected ticks are partaking in a bloodmeal, compared to
uninfected ticks (Ramamoorthi et al., 2005, Yang et al., 2005).
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Figure 1.22. Tick protein interactions with Borrelia and mammalian host evasion. In the unfed midgut of the Ixodes
tick, Borrelia expresses OspA, which binds TROSPA and OspA. Once the tick commences a bloodmeal OspA is
downregulated and OspC upregulated for transmission to the salivary gland where Salp15 is acquired. Salp15 inhibits the
activation of CD4+ T cells (Anguita et al., 2002). The binding of Salp15 prevents the recognition of antigenic OspC by TLRs
and antibodies. The binding of fH and fHL-1 prevents complement activation.
Salp20 inhibits the alternative pathway of the complement immune system by dissociating
components of C3 convertase, preventing cleavage of C3 to C3b and therefore deposition of
C3b on foreign cell surfaces and therefore lysis, in a similar role to factor H and factor H-like
protein 1. This is two-fold in effect, aiding both the tick and any disseminating Borrelia by
disrupting the complement alternative pathway. It was shown that B. garinii incubated with
Salp20 had a survival rate of approximately 70 % when faced with alternative pathway
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activated complement mediated killing. Salp20 was, however, ineffective against
complement activation by the classical pathway. (Tyson et al., 2007).
1.4 The Complement System
1.4.1 Activation of the complement system
The complement system was discovered in the 1890’s as a component of the immune system
found to assist antibody mediated killing of bacteria (Sarma and Ward, 2011). The
complement system is a factor of both the innate and adaptive immune responses (Fujita,
2002, Schifferli, 2005, Lambris et al., 2008, Sarma and Ward, 2011), capable of swiftly
responding to invading pathogens and assisting in long-term immunity. The complement
immune response is activated by three distinct pathways; the classical, the alternative and the
lectin (Fujita, 2002, Lambris et al., 2008), each of which results in a proteolytic cascade and
formation of the membrane attack complexes (MAC) which act to lyse foreign cells (Figure
1.23) (Fujita, 2002). The cascade is a well-controlled network comprised of over thirty
proteins that are either present on the cell membranes, or free in plasma (Fujita, 2002,
Lambris et al., 2008, Schneider et al., 2009, Sarma and Ward, 2011). In addition to cell lysis
by the MAC, activation of the complement system also results in clearance of pathogens by
opsonisation (marking pathogens for phagocytosis) and triggering phagocytosis (engulfing
and destruction of foreign bodies by phagocytes) (Sarma and Ward, 2011). The complement
system also fulfils other functions such as communication with, and activation of adaptive
immunity and assisting in the removal of cellular debris (Herbert et al., 2006, Lambris et al.,
2008).
The classical pathway is triggered when protein complex C1q recognises antigen-antibody
complexes on the surface of a foreign cell (Lambris et al., 2008). The C1q complex
comprises one molecule of C1q, two molecules of C1r (a serine protease) and two C1s
molecules. Upon binding of C1q to foreign antigens, C1r cleaves C1s, resulting in an
activated form that cleaves C2 and C4 (Fujita, 2002).
Activation of the lectin pathway is prompted by recognition and binding of microbial
carbohydrate moieties by mannose-binding lectin (MBL) and Ficolin (F). MBL and F are
bound to MBL-associated serine proteases (MASPs) present in serum (Fujita, 2002). Some of
these MASPs undergo changes in their conformation as a consequence of binding to
Page | 59
pathogens. These changes result in auto activation of MASP2 which is responsible for the
cleavage of C4 and C2 (Schifferli, 2005, Sarma and Ward, 2011).
Activation of the complement system by the classical and lectin pathways converge with the
degradation of C2 and C4 to produce active fragments C2a, C2b, C4a, and C4b. C4b and C2a
combine to form the enzyme complex C4bC2a, known as classical pathway (CP) C3
convertase (Fujita, 2002, Sarma and Ward, 2011). It is at this point that the alternative
activation pathway converges with the classical and lectin pathways.
The alternative pathway provides the broadest specificity against pathogens and is not reliant
on immunisation or production of antibodies (Pangburn, 2000). Activation of the alternative
pathway is selective - host cells and tissues do not trigger activation, whereas foreign
organisms do (Sarma and Ward, 2011). The recognition of, and discrimination between host
cells and foreign bodies is possible due to a complex set of proteins such as Factor H (fH) and
Factor H-like protein (fHL-1). Factor H has multiple sites which can recognise and bind host-
like features on the surface of microorganisms and has been shown to have three C3b binding
sites. C3 is constantly being hydrolysed at a slow, steady rate, producing small concentrations
of C3b, which is capable of binding surfaces lacking FH and fH-like proteins (Sarma and
Ward, 2011). The accumulation of C3b on foreign surfaces along with the spontaneous
hydrolysis of C3 triggers the alternative pathway of the complement system (Lambris et al.,
2008, Sarma and Ward, 2011). As the alternative pathway does not depend on activation by
antibodies it is capable of being activated in less than 20 minutes (Lambris et al., 2008).
Each of the complement initiation pathways result in the hydrolysis of C3 to form C3b, which
is deposited onto bacterial surfaces (Okemefuna et al., 2008, Sarma and Ward, 2011). Factors
B and D bind to the surface C3b, which results in factor D cleaving factor B. One of the
products, factor Bb forms a complex with C3b to form C3 convertase, which is stabilised by
the binding of properdin, preventing binding and degradation by factors I and H. Meanwhile,
the concentration of C3b on the cell surface is increased by continuing hydrolysis of C3.
Alternative pathway (AP) C5 convertase is formed by the addition of a further C3b fragment
to C3 convertase (C4bC2aC3b). This degrades C5 to produce C5a and C5b. C5b induces the
formation of a multi-protein pore-forming membrane attack complex (MAC), incorporating
C6 - 9 (C5bC6C7C8C9), which forms a hole in the membrane, lysing the cell (Sarma and
Ward, 2011).
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C5a, C4a and C3a are anaphylatoxins produced as a result of the activation of the
complement cascade. These glycoprotein fragments activate cellular responses such as the
release of phagocytes and an inflammatory response (Lambris et al., 2008, Sarma and Ward,
2011).
Figure 1.23. Activation of the complement immune system by three different mechanisms. The classical pathway is
activated by antibody complexes on the pathogen cell surface, the lectin pathway by recognition and binding of microbial
carbohydrate ligands by mannose-binding lectin (MBL) and Ficolins (F) and the alternative pathway by spontaneous and
induced hydrolysis of C3. Each of the three activation pathways result in the cleavage of C3 to C3a and C3b. Amplification
of C3b amplifies the cascade, mediates immune response by binding complement receptors. C3b build-up and accumulation
leads to the assembly of C5 convertase which activate C5a and C5b; the latter of which is responsible for the formation of
the membrane attack complex (MAC). Figure adapted from (Lambris et al., 2008)
Each of the complement initiation pathways result in the cleavage of C3 and generation of
C3a and C3b. Antibody-antigen complexes recognised by C1q and terminal mannose
recognised by MBL trigger the activation and degradation of C4 into C4a and C4b.
Regulation of the complement proteins is vital as accumulation of protein complexes can
result in injury to the host tissue (Sarma and Ward, 2011). Complement-mediated lysis of
cells is regulated in a multitude of ways, primarily through the rapid inactivation and
degradation of components in the presence of cofactors and peptidases and through the
prevention of construction and activation of convertases and the MAC. For example, in the
presence of factor H, the protease factor I degrades C3b and C4b into several inactive
fragments (Okemefuna et al., 2008, Sarma and Ward, 2011). Factor H, in addition to decay
acceleration factor (DAF) and C4 binding protein (C4BP) inhibits the assembly and activity
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of C3 convertase (Sarma and Ward, 2011). Cell-bound proteins CR1, CD59 and MCP assist
in regulating the complement response, protecting host tissues and cells from complement
lysis (Pangburn, 2000). Anaphylatoxins C3a and C5a are inactivated by cleavage at a C-
terminal arginine, drastically reducing biological activity (Sarma and Ward, 2011).
1.4.2 Evasion of the complement system by Borrelia and other
bacteria
Bacterial human pathogens are known to have complement evasion mechanisms, and these
mechanisms are frequently associated with the OmpA-like transmembrane protein family
(Vogt and Schulz, 1999). Evasion of complement-mediated killing is vital for bacterial
survival in mammalian hosts, and as such various evasion strategies have evolved to interfere
and inhibit each aspect of activation, regulation and activity (Figure 1.24) (Sarma and Ward,
2011). Immune evasion of Borrelia is one of the primary focal points of this research.
Figure 1.24. Evasion of complement response by pathogens. Evasion of the CP is accomplished through the acquisition of
C1 inhibitor (C1-INH) which is endogenous to the host and through the capturing of antibody Fc regions. Many bacteria
including Borrelia acquire regulators of the complement response (RCA) (such as fH and fHL-1) to prevent activation of the
AP through the use of CRASPs. S. aureus is known to directly inhibit C3, C5, C3 & C5 convertases and the C5a receptor
(C5a). Pathogenic bacteria are also known to contain proteases of proteins that capture proteases; which degrade components
of the complement cascade including C3 and C3b. Increased and decreased activity is represented by thick and thin arrows
respectively. Figure based on (Lambris et al., 2008).
Borrelia minimise any antigenic proteins on the surface (see section 1.2.4), presenting as few
targets to the hosts immune system as possible. Borrelia do not express LPS (Takayama et
al., 1987), antigenic Osps such as OspA and OspB that are not required for mammalian
infection are downregulated (Burkot et al., 1994, Cassatt et al., 1998, Schwan and Piesman,
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2000, Liang et al., 2004) and any proteins expressed on the surface when present in
mammalian hosts have an important function in survival and/or immune evasion (Cassatt et
al., 1998, Hübner et al., 2001, Kim et al., 2004, Pal et al., 2004b, Krupka et al., 2011).
Surface exposed proteins involved in Borrelial immune evasion include: OspC, which binds
Salp15, a CD4+ and lymphocyte inhibitor that also prevents recognition by TLRs and
antibodies (Anguita et al., 2002, Juncadella et al., 2008), DbpA, DbpB, enolase and BBK32
which facilitate the binding to, and penetration of mammalian extracellular matrices (Potts
and Campbell, 1996, Guo et al., 1998, Brown et al., 1999, Schwarz-Linek et al., 2003).
CRASPs (OspE), which bind fH and fH-like proteins are vital to Borrelia preventing AP
activation of the complement cascade; with fH and fHL-1 bound C3b deposition and
accumulation on the cell surface is prevented along with the consequent complement
activation (Kraiczy et al., 2006, Rossman et al., 2006, Bhide et al., 2009, Kraiczy et al.,
2009, Sarma and Ward, 2011). Many different bacteria bind Factor H, through a variety of
proteins (Shaughnessy et al., 2009) and additional Factor H binding proteins of unknown
structure have been identified in B. afzelii and B. garinii (Bhide et al., 2009). It has been
shown in vitro that Borrelia can switch form from spiral shape to a cystic shape when
environmental conditions are unfavourable, switching back to the spiral motile form when
conditions are once again favourable; these cystic forms have been found in the brains of
deceased Alzheimer’s sufferers (Krupka et al., 2011).
Borrelial immune evasion is not accomplished entirely by the Spirochaete itself. As was
mentioned previously (section 1.3.2), Borrelial survival in the mammalian host is aided by
several proteins present in tick saliva: Salp20, IRAC, ISAC, which inhibit the formation of
C3 convertases and aid in removal of C3b deposits from cell surfaces (Valenzula et al., 2000,
Schroeder et al., 2007, Tyson et al., 2007, Gillet et al., 2009).
1.4.2.1 Human factor H
Human factor H (fH) is a 155 kDa glycoprotein (Figure 1.25) (Herbert et al., 2006,
Okemefuna et al., 2008, Shaughnessy et al., 2009) composed of 20 short consensus repeat
(SCR) domains (Kraiczy et al., 2009) responsible for protecting the host cells from self-
inflicted damage from the immune system (Coleman et al., 2008). Each SCR domain
comprises approximately 60 amino acids, including four conserved disulphide bridge forming
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cysteines which are essential for the correct folding of the domain (Prosser et al., 2007,
Shaughnessy et al., 2009).
Figure 1.25. Representation of the domain structure of factor H. The locations of three C3b binding sites are highlighted
(Pangburn, 2000). Factor H is also known to bind heparin in SCRs 7, 9 and 20 modulating attachment to the extracellular
matrix. Apoptotic or necrotic cells bind fH through a number of ligands to protect the cells from autoimmunity; Histones for
example bind SCRs 1-4, 6-8 and 8-15 (Kopp et al., 2012). It is the four N-terminal SCR domains (1-4) of fH that play a role
in the regulating complement responses such as cofactor activity and degradation activity, SCRs 19 and 20 allow attachment
of factor H to host cells for inhibition of complement activation at the cell surface (Kopp et al., 2012).
Factor H (along with fHL-1) is the major soluble regulator of the AP of complement
activation (Kraiczy et al., 2009, Shaughnessy et al., 2009), and one of the major components
of blood plasma, present at a concentration of 200 - 300 µg/ml. The only complement protein
present in a higher concentration is C3 (1200 µg/ml). fHL-1 has seven SCR domains and is
derived from the fH gene (Kraiczy et al., 2006); these seven domains are identical with the
exception of the four C-terminal residues (Pandiripally et al., 2002) fH and fHL-1 degrade
and inhibit the formation of C3 convertases, and are cofactors of factor I-mediated
degradation of C3b (Bhide et al., 2009, Kraiczy et al., 2009, Shaughnessy et al., 2009). In
addition to controlling interactions between C5 and C9 on the cell surface. As was described
in the previous section, acquisition of fH is an important feature of bacterial complement
evasion and many bacteria have evolved proteins with this function. Borrelia are known to
bind fH and fHL-1 through CRASPs, Erps and OspEs (Hovis et al., 2006, Kraiczy et al.,
2009).
Certain SCRs have been identified as being targeted for pathogenic binding; SCR4 by S.
pyogenes (Reuter et al., 2010), SCR6 in N. meningitidis and N. gonorrhoeae (Schneider et
al., 2009, Shaughnessy et al., 2009) and SCRs 19-20 in S. aureus (Haupt et al., 2008). It is
known that Borrelia bind fH using BbCRASPs 1 and 2 through SCR 7 (Reuter et al., 2010).
One study (Bhide et al., 2009) found that B. garinii contained a novel ~19 kDa protein that
bound human fH, identified as ‘BG0407’. In silico analysis conducted by the original authors
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evidence for this protein containing two coil-coiled formations, although our research
indicates that the protein is a TM β -barrel (chapter 3).
1.5 Outer Membrane Proteins
Outer membrane proteins (Omps) are β -Barrel proteins that span the outer membranes of all
Gram-negative bacteria, mitochondria and chloroplasts (Schulz, 2000). The number of β -
stands varies between eight and twenty two (Khalid et al., 2006). There are multiple types of
TM β -barrel OM protein, all of which follow the same basic principles of construction as set
out below (Schulz, 2000). Aromatic amino-acids form an ‘aromatic girdle’ which sits in line
with the phosphorous hydrophilic outer layers of the membrane and ‘protects’ the inner core
of hydrophobic amino-acids in the centre of the strands (Arora et al., 2000).
• Both the N and C termini are located at the periplasmic end of the barrel
• The number of strands in a β -barrel is even
• The β -strands are tilted at an angle of approximately 45 °; only one direction is
assumed in each protein as the other is not energetically favoured
• The shear number of a β -barrel is the generally n + 2, where n = the number of strands
• All strands are connected to neighbouring chains and are anti-parallel to each other
• The connections between the strands at the periplasmic end are designated as turns
and numbered T1, T2 etc; each turn is usually only a couple of residues long
• The connections between the strands at the external barrel end are usually longer
loops and are designated L1, L2 etc
• The surface of the β -barrel in contact with the non-polar interior of the membrane
mostly consists of residues with non-polar side chains
• Around this non-polar section of the barrel, are hydrophilic side chains that contact
the area of the membrane where the non-polar interior meets the polar exterior
• β -barrel proteins have high evolutionary sequence variability
• The external loop regions of the protein are mobile and have very high sequence
variability
In addition to the principles laid out above, for β -barrel formation at least four of the five
residues with side chains pointing towards the membrane must be hydrophobic, with none of
the three central residues charged and residues on the inside of the barrel must have small
side chains (Koebnik, 1999).
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thought to be due to a conformational change (denaturing) when boiled and the native protein
binding excess amounts of SDS (Freudl et al., 1986). E. coli OmpA is a known bacteriophage
(Fernández et al., 2001) and colicin receptor (Beher et al., 1980, Prasadarao et al., 1996)
through the outer loops (Buchanan, 1999).
The structure of the N-terminal β -barrel domain has been solved by both X-ray
crystallography (Pautsch and Schulz, 1998, Pautsch et al., 1999, Pautsch and Schulz, 2000)
and NMR spectroscopy (Arora et al., 2001), with the structures agreeing to a high degree.
Minor differences are found in the length of the β -sheets of OmpA in solution compared to
crystals, but the overall barrel shape remains the same (Arora et al., 2001). Previous analysis
of the peptide sequences has found that the β -strands are well conserved, whereas the loop
regions are highly variable (Power et al., 2006). The C-terminal domain of OmpA is
composed of residues 172-325 and is known to interact with periplasmic peptidoglycan
(Buchanan, 1999, Power et al., 2006), helping maintain the structural integrity of the cell
(Hong et al., 2006).
It has been shown that OmpA has multiple functions in E. coli: in addition to aiding structural
integrity and maintaining shape (Prasadarao et al., 1996, Jeannin et al., 2002), it plays an
important role in mediating pathogenesis and virulence of bacteria in humans (Fernández et
al., 2001). This includes adherence to, and invasion of mammalian cells (Fernández et al.,
2001, Jeannin et al., 2002) and facilitating translocation of the blood-brain barrier (BBB)
through brain microvascular endothelial cells (BMECs) (Kim, 2001). Translocation of the
BBB has been shown in neonatal meningitis-causing E. coli (Prasadarao et al., 1996). E. coli
OmpA is known to bind the 96 kDa glycoprotein Ecgp present on the surface of mammalian
cells (Niemann et al., 2004), which is a potential as a trigger for the accumulation of cellular
actin under the host cell surface, and the endocytic process by which translocation occurs
(Prasadarao et al., 1999). OmpA in Cronobacter has been shown to aid invasion of human
intestinal epithelial cells (Kim et al., 2010). The membrane spanning domain of E. coli
OmpA has sequence homology to one protein expressed on the surface of N. gonorrhoeae
thought to be involved in epithelial cell invasion, while the periplasmic C-terminal domain
shares sequence homology to a complement resistance protein also in N. gonorrhoeae
(Prasadarao et al., 1996) suggesting a similar role in E. coli pathogenesis. OmpA has been
shown to exhibit large ion channel conductance in vitro, potentially due to the presence of
hydrophobic residues lining the centre of the barrel (Hong et al., 2006). This is in contrast to
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the crystal structure, which shows no continuous channels consistent with a transport
function. A possible explanation for this would be a molecular ‘gate’, initially formed by
strong electrostatic interactions between residues Arg138 and Glu52 blocking ion transport.
This ‘gate’ is speculated to be ‘opened’ by formation of electrostatic interactions between
Glu52 and Lys82 instead of Arg138 (Smith et al., 2007). V. cholera have been shown to
control the release of OM vesicles by limiting expression of OmpA as a mechanism of
defence against UV damage; repression of OmpA expression results in an increased number
of vesicles being produced, providing further evidence for the role of OmpA stabilising the
OM (Song and Wai, 2009). Small TM β -stranded proteins have also been implicated with
lipid metabolism in the OM of bacteria (Hong et al., 2006).
E. coli, N. meningitides, H. influenza type b and S. pneumoniae meningitis causing pathogens
are able to pass from the blood of the infected host to the central nervous system (CNS)
without affecting the structure and reliability of the BBB (Kim, 2001). It has been shown that
the N-terminal loop regions of OmpA that protrude from the surface of the bacterium
contribute to invasion of brain micro vascular endothelial cells (BMECs) and that OmpA
positive (OmpA+) strains of E. coli were 25-50 fold more efficient than OmpA- strains at
invading BMECs in vitro (Prasadarao et al., 1996). It was also found that BMECs incubated
with purified OmpA, synthetic OmpA loop regions and OmpA antibodies prior to the
introduction of OmpA+ E. coli caused significant inhibition of the invasion of OmpA+ strains
of E. coli (Prasadarao et al., 1996). OmpA from E. coli have been shown to induce humoral
and cytotoxic responses, and it was found that OmpA deficient E. coli have reduced virulence
and capacity to invade mammalian cells (Jeannin et al., 2002). OmpA from E. coli has been
shown to bind complement binding protein 4 (C4bp), which is an inhibitor of C3b activation
via the classical complement activation pathway and to aid in biofilm formation (Smith et al.,
2007).
1.5.2 OmpW
OmpW is a 192 residue, 21 kDa β -barrel protein that spans the outer membrane of E. coli
(Figure 1.27) (Albrecht et al., 2006). OmpW has been shown to display the properties of a
hydrophobic channel (Hong et al., 2006). The centre of the barrel of OmpW is largely
hydrophobic and has a large hydrophobic binding pocket in the centre of the extracellular
loop regions which extends towards the centre of the barrel. This ends at a ‘gate’ comprised
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it is likely that some of these proteins might closely resemble the prototypical OmpA-like
membrane spanning domain described previously (section 1.5.1) due to its simplicity and
high conservation among other proteobacteria. The fact that this protein has not been
identified to date is likely due to the difficulties in predicting β -barrels, which are much
harder to identify than lipoproteins, and the fact that Borrelia as Spirochaetes are not closely
related to Gram-negative bacteria. It also hints at low levels of expression.
OmpA is known to have multiple important cellular functions and be expressed in numerous
Gram-negative bacteria throughout mammalian infection. The ability to evade the
complement immune system is common to all Gram-negative bacteria and is known to be
connected with the OmpA-family of proteins (Vogt and Schulz, 1999). Spirochaetes have a
double membrane structure like E. coli, although very few TM spanning proteins have been
identified to date. It is known that Borrelia has a BamA orthologue (Lenhart and Atkins,
2009), used in E. coli to assemble the β -barrel at the OM. The results from study (Prasadarao
et al., 1996) clearly highlight the important role that outer membrane proteins, and in
particular OmpA plays in the invasion of the CNS in E. coli. As it has been shown that
Borrelia also translocate across the BBB to invade the CNS (Athreya and Rose, 1996,
Kurtenbach et al., 2006) it is highly possible that OmpA-like proteins are present in Borrelia
and that they play a similar role. As OmpA from E. coli interacts with the peptidoglycan layer
and Borrelia is structured differently it is more likely that Borrelia contain OmpX or OmpW
than OmpA, hence our protein is named OmpB. As OmpW functions as a transporter of
hydrophobic molecules across the outer membrane it can be reasoned that Borrelia should
contain OmpW.
In summary the aims of this research were:
• To conduct bioinformatic analysis of the Borrelial genome and identify any potential
OmpA-like genes.
• Characterise and determine if the protein coded for resembled an OmpA-like protein
• Identify any binding (such as fH or the extracellular matrix)
• Identify any roles with the bacteria.
• Characterise the structure of the protein through various methods such as CD, SAXS
and X-Ray crystallography
• Determine if the protein(s) were most similar to OmpA, OmpX or OmpW.
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Chapter 2. Materials & Methods
2.1 Materials
DNA samples of B. garinii (71186B) and B. afzelii (70250B) were supplied by Dr Gabi
Margos (The University of Bath) in the form of whole DNA extracted from infected I.
ricinus. Samples of DNA from B. burgdorferi s.s. PKa2, B. afzelii PKo and B. garinii PRef
were supplied by Dr. Volker Fingerle and Cecilia Hizo-Teufel, National Reference Centre for
Borrelia, LGL, Germany. Cell stocks were purchased from New England Biolabs (Hitchin,
UK) and Merck (Merck Serono Ltd, Middlesex, UK). Plasmids were purchased from
Novagen (Merck Serono Ltd, Middlesex, UK). All standard lab reagents were purchased
from Fisher Scientific UK (Loughborough, UK) or Sigma-Aldrich Company UK
(Gillingham, UK).
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2.1.1 Reagents, buffers and purchased media
Chemical or Reagent Abbreviation Supplied by
Acrylamide: Bis-Acrylamide 37.5 : 1 (40 % v/v solution/electrophoresis) Bis-Tris Fisher
Agar - Fisher
Agarose (DNase and RNase free) - Fisher
Ampicillin sodium salt Amp Fisher
Ammonium persulphate APS Sigma
L (+) arginine hydrochloride Arg Fisher
β -mercaptoethanol β ME Fisher
Bovine Serum Albumin BSA Sigma
Bradford Reagent - Invitrogen
5-Bromo-4-chloro-3-indoyl- β -D-galactopyranoside X-Gal Fisher
3-[(-Chloamidopropyl)dimethylammonio]-1-propanesulphonate CHAPS Fisher
Chloramphenicol Chl Fisher
L(+) cysteine - Fisher
Dimethyl sulphoxide DMSO Fisher
Disodium hydrogen orthophosphate - Fisher
Dithiothreitol DTT Fisher
DNase - Sigma
Ethanolamine - Fisher
Ethidium Bromide Et-Br Fisher
Ethylenediaminetetraacetic acid EDTA Fisher
Guanidine hydrochloride GuHCl Fisher
HEPES crystals - Fisher
Imidazole - Fisher
Isopropyl β -D-1-thiogalactopyranoside IPTG Fisher
Kanamycin sulphate Kan Fisher
Lauryldimethylamine-oxide LDAO Sigma
Lysozyme - Sigma
Monoolien MO Sigma
n-octyl- β -D-glucoside OG Sigma
n-octyltetraoxyethylene C8E4 Sigma
Polyethylene glycol 8000 PEG 8000 Fisher
Potassium phosphate monobasic - Fisher
Protease inhibitor cocktail (EDTA free) - Sigma
Sodium dodecyl sulphate SDS Sigma
Sodium phosphate monobasic - Fisher
SYBR-Safe - Intvitrogen
Tetramethyethylenediamine TEMED Sigma
Tris(hydroxymethyl)aminomethane-base Tris Fisher
Tris(hydroxymethyl)aminomethane-HCl Tris-HCl Fisher
Triton X-100 - Fisher
Tryptone - Fisher
TWEEN-20 - Sigma
Urea - Fisher
Yeast extract - Fisher
Table 2.1. Chemicals and reagents used in this research. Standard chemicals not listed were purchased from either Fisher
Scientific or Sigma-Aldrich.
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Table 2.2. Buffers and Media used throughout this research. BSK-H media was purchased from Sigma-Aldrich
Company Ltd, SLS from Invitrogen and SOC from NEB.
Buffer / Media Composition
50x 5052 25 % (w/v) α -lactose, 2.5 % (w/v) glucose, 10 % (w/v) glycerol
Agar plates LB with 1.5 % (w/v) agar
Agar-Kan plates LB-Kan with 1.5 % (w/v) agar
Agar-Kan/Chl plates LB-Kan/Chl with 1.5 % (w/v) agar
Agar-Amp/X-gal plates LB-Amp with 1.5 % (w/v) agar and 40 µg/ml X-gal
Agar-Amp/Chl/X-gal plates LB-Amp/Chl with 1.5 % (w/v) agar and 40 µg/ml X-gal
Autoinduction media 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 1x NPS, 1x 5052
BSK-H medium, complete -
Coomassie Blue stain 0.1 % w/v Coomassie R250, 10 % v/v glacial acetic acid, 40 % methanol
Coomassie Destain 10 % (v/v) glacial acetic acid, 20 % (v/v) methanol
Elution buffer 0.5 M NaCl, 0.5 M imidazole, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
FPLC Buffer A 6 M GuHCl, 0.5 M NaCl, 50 mM Tris, pH 8.0
FPLC Buffer B 6 M GuHCl, 0.5 M NaCl, 50 mM Tris, 0.5 M imidazole, pH 8.0
Lysis buffer 500 mM NaCl, 50 mM Tris, 0.4 µg/ml lysozyme, 10 mM β -mercaptoethanol, 0.1 %
(v/v) Triton X-100, pH 8.0
Lysogeny Broth (LB) 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl
Lysogeny Broth-Amp (LB-Amp) 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 100 μ g/ml Amp
Lysogeny Broth-Amp (LB-Amp/Chl) LB-Amp with 34µg/ml Chl
Lysogeny Broth-Kan (LB-Kan) 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 50 μ g/ml Kan
Lysogeny Broth-Kan (LB-Kan/Chl) LB-Kan with 34µg/ml Chl
MES running buffer -
20x NPS 1 M Na2HPO4, 1 M KH2PO4, 0.5 M (NH4)2SO4
PBS (1x) 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4
PBS-TWEEN (0.05%) 1x PBS, 0.05% (v/v) TWEEN-20, pH 7.4
Refolding buffer 1 (RF1) 4 M GuHCl, 0.5 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
Refolding buffer 2 (RF2) 2 M GuHCl, 0.5 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
Refolding buffer 3 (RF3) 1 M GuHCl, 0.5 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
Refolding buffer 4 (RF4) 0.5 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
Resolubilisation buffer 8 M Urea, 0.1 M Tris, 1 mM EDTA, 2 mM DTT, pH 8.0
Transfer buffer 1.45% (w/v) Tris, 7.2 % (w/v) glycine, 20 % (v/v) methanol
Tris/borate/EDTA (TBE) Supplied as 10x and diluted to 0.5x in distilled water
TBS (1x) 0.15 M NaCl, 20 mM Tris-HCl, pH 7.4
TBS-TWEEN 1x TBS, 0.05 % (v/v) TWEEN-20, pH 7.4
TSS Buffer 10 % (w/v) PEG 8000, 30 µM MgCl2.6H2O, 1.25 % (v/v) DMSO, LB up to volume
SAXS 0.1 % LDAO buffer 0.3 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
SAXS 0.01 % LDAO buffer 30 mM NaCl, 5 mM Tris, 0.01 % (w/v) LDAO, pH 8.0
Sample Loading Solution (SLS) -
Size exclusion buffer 0.5 M NaCl, 50 mM Tris, 0.1 % (w/v) LDAO, pH 8.0
Source Outgrowth Control (SOC)
Media
-
Salt buffer 0.3 M NaCl, 50 mM Tris-HCl, pH 8
Wash buffer 6 M GuHCl, 0.3 M NaCl, 50 mM Tris-HCl, 20 mM imidazole, pH 8
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Table 2.3. PCR reagents, enzymes and buffers used in this work. T4 DNA Ligase was diluted in nuclease free water to a
concentration of 1 U/µl before use. All enzymes were used neat.
2.1.2 Primers
All of the primers used in this work were designed using OligoExplorer 1.2 and
OligoAnalyzer 1.2 (Genelink) (Table 2.4, Table 2.5 & Table 2.6). Primers were purchased
from Eurofins MWG Operon (Ebersberg, Germany). Primers were supplied lyophilised and
were diluted to a concentration of 100 pmol/µl using nuclease free water.
Target Primer Sequence (5’-3’) Length (bp) Tm (°C)
PepX PepXIF TTA TTC CAA ACC TTG CAA TCC 21 55.1
PepXIR TGT GCC TGA AGG AAC ATT TG 20 56.1
PepXOF ACA GAG ACT TAA GCT TAG CAG 21 55.9
PepXOR GTT CCA ATG TCA ATA GTT TC 20 51.2
UvrA UvrAIF GCT TAA ATT TTT AAT TGA TGT TGG 24 52.5
UvrAIR CCT ATT GGT TTT TGA TTT ATT TG 23 51.7
UvrAOF GAA ATT TTA AAG GAA ATT AAA AGT AG 26 52.2
UvrAOR CAA GGA ACA AAA ACA TCT GG 20 53.2
Table 2.4. Primers for the nPCR amplification of housekeeping genes PepX and UvrA. The primers amplify
housekeeping genes as positive controls. The sequences supplied by Dr. G. Margos (University of Bath). The first four
letters of the primer designation refer to the gene being amplified, and the last two letters of detail that primers function: O is
a primer used in the first (outer) amplification of the target gene and a selection of the surrounding sequence, whereas I is
used in the second (inner) amplification of the target gene alone. The letters F and R respectively denote whether the primer
is forward or reverse.
Borrelial UvrA is a homologue of a DNA repair protein found in E coli and many other
bacteria; that is in conjunction with several other proteins responsible for repairing DNA
damage through excision of nucleotides (Sambir et al., 2011).
PCR, restriction digest and ligation reagents Supplied by
BamHI (20,000 U/ml) NEB
BenchTop 1000 bp DNA Ladder Promega
BglII (10,000 U/ml) NEB
6X Blue/Orange Loading Dye Promega
DNA Step Ladder (50 bp increments) Promega
dNTP mix (10 mM each) Promega
EcoRI (20,000 U/ml) NEB
GoTaq Flexi Green Buffer (5 x) Promega
GoTaq Hot Start Polymerase (5 U/μ l) Promega
HindIII (20,000 U/ml) NEB
MgCl2 (25 mM) Promega
NEBuffer 2 NEB
NEBuffer 3 NEB
NEBuffer EcoRI NEB
T4 DNA Ligase (400,000 U/ml) NEB
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PepX is a dipeptidyl aminopeptidase commonly used along with UvrA and several other
proteins as a housekeeping gene in evolutionary genetic studies of Borrelia (Margos et al.,
2008).
Table 2.5. Primers for the amplification of target genes. The primers were named according to the species of bacteria – A
for Borrelia afzelii and G for Borrelia garinii, followed by the locus name – e.g. 0407, after which is the stage of nPCR –
Inner or Outer, then the direction the primer will amplify – Forward or Reverse. In each instance, multiple primers were
designed to screen for optimal combinations. This is indicated by the final number in the primer designation.
Restriction enzymes to be used in cloning were selected to be compatible in sequential
digests. Before primer design the genomic sequence was checked to ensure the recognition
sequence of chosen enzymes was not present at any point in the gene. The gene sequences to
be targeted were run through a web server (NEBcutter v2.0) on the New England Biolabs
website to determine which recognition sites were naturally present in the genetic sequence
(Figure 2.1).
Target Primer Sequence (5’-3’) Length(bp) Tm (°C)
BAPKO_0026
(Q0SPD7)
A0026IF1 CAA GGG TAA TAA TTT TAA AAG AAT GGA G 28 57.8
A0026IF2 ACA AGG GTA ATA ATT TTA AAA GAA TGG AG 29 58.2
A0026IR1 GTT TTC ATA TTT TTG TTT CAT TTT TAT CC 29 55.4
A0026IR2 AGT TTT CAT ATT TTT GTT TCA TTT T 25 49.9
A0026OF1 TTC AAA ATA TGC CTC TTA AAC CCA ATA AGG 30 61.3
A0026OF2 CAA AAT ATG CCT CTT AAA CCC AAT AAG G 28 60.7
A0026OR1 GGA TTC GCT TGA GCA TGC TAG TAG 24 62.7
A0026OR2 AAT ATG GAT TCG CTT GAG CAT GCT AGT AG 29 63.9
BG0027
(Q662Y5)
G0027IF1 CAA GGA TAG TAA TTT TAA AAG AAT GGA G 28 57.8
G0027IF2 GGA TAG TAA TTT TAA AAG AAT GGA GA 26 55.3
G0027IR1 GTT TTC ATA TTT TGT TTC ATT TTG TC 26 53.8
G0027IR2 TTC ATA TTT TTG TTT CAT TTT TGT C 25 51.5
G0027OF1 GAT TCT CAA TAT AAG AAA AGC TAA GCT AC 29 59.6
G0027OF2 GGA TAG TAA TTT TAA AAG AAT GGA GA 30 59.9
G0027OR1 CCT CTT GGA TTG AAC TGC CTA AAA TG 26 61.6
G0027OR2 CTA GTT GGG AAA ATA TGG ATT CGC TTG AGC 30 65.4
BAPKO_0422
A0422IF1 TTG AAT ATA AAA AAG GAG AAT TTC A 25 51.5
A0422IF2 ATA AAA AAG GAG AAT TTC AAT GAG 24 52.5
A0422IR1 TTT AAA ATT TTT TAT CAT TTA TTC TCCA T 29 52.5
A0422IR2 TTT ATC ATT TAT TCT CCA T 19 43.7
A0422OF1 ATA CAG TCA AGT AGT ATA ATA ATA CCT GT 29 61.2
A0422OF2 ACA GTC AAG TAG TAT AAT AAT ACC TGT AT 29 61.1
A0422OR1 GAT TGC CTA TTC CAA TAC CCA TTG 24 61.3
A0422OR2 GGA TTG CCT ATT CCA ATA CCC A 22 60.7
BG0407
GO407IF1 TAT AAA AAA GGA GAA TTT CAA TGA GA 26 53.8
G0407IF2 GGA GAA TTT CAA TGA GAA TGC 21 54.0
G0407IR1 TTT TAA AAT TTT TTA TCA TTT ATT CTC CAC 30 54.5
G0407IR2 CCA CTA TAT ATA TAT TTT GAT AAA GCC TG 29 58.2
G0407OF1 AAG ATT AAC ATC AAT ACC CAG TCA AGT AGT 30 61.3
G0407OF2 ACC CAG TCA AGT AGT ATA ATA ATA CCT AT 29 59.6
G0407OR1 GAT GCA AAA GAA AGG TGT GCT ACA CC 26 63.2
G0407OR2 CTT CTT CCT TGC TGC ATC TGA CC 23 62.4
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Figure 2.1. Restriction sites present throughout the gene BAPKO_0422. Graphical output from NEBCutter v2.0. Each
enzyme present in the figure above digested the expected genomic sequence at some point, making it unsuitable for use in
the project.
From analysis of the genetic sequences to be targeted, BamHI and HindIII were chosen for
use in restriction digestion as the restrictions sites were not present at any point in the gene.
Primers were designed for the addition of these restriction sites to PCR product (Table 2.6).
Table 2.6. Primers for the addition of restriction sites. Bases highlighted in red show the restriction sites. The four bases
at the beginning of each primer were added to increase restriction enzyme efficiency. The calculated Tm does not include the
bases for digestion or those prior. Tm calculations carried out using the Applied Biosystems Tm calculator
(http://www6.appliedbiosystems.com/support/techtools/calc/).
2.1.3 Plasmid vector
For cloning of genes, the plasmid pET-47b(+) was selected. pET-47b(+) was chosen for a
variety of factors, including the presence of; a T7 promoter site, N-terminal histidine tag and
a HRV-3C cleavage site (Figure 2.2 & Figure 2.3). pET-47b(+) also has a kanamycin
resistance gene for selective growth.
The T7 RNA polymerase gene only allows transcription of DNA downstream with a low
error rate; T7 RNA polymerase is highly selective for its promoter sequence and synthesises
RNA many times more efficiently than E. coli RNA polymerase (Tabor, 2001). Induction by
Target Primer Sequence (5’-3’) Length(bp) Tm (°C)
BAPKO_0026 A0026CF GCA TGG ATC CGC ACG CAG TTA TTG ATA GA 29 50.71A0026CR ATC GAA GCT TCT ACA ATT TAT TTA CAT TTA CTG 33 45.71
BG0027 G0027CF GCA TGG ATC CGG CAG TCA ACA TTG ATA 27 45.60G0027CR ATC GAA GCT TCT ACA ATT TAT TTA CAT TTA CT 32 42.19
BAPKO_0422 A0422CF GCA TGG ATC CGC AAT CAA AAA GCA AAA CTA T 31 52.67A0422CR ATC GAA GCT TTC ATT TAT TCT CCA TTA TAT ATA 33 44.85
BG0407 G0407CF GCA TGG ATC CGA CCA ATC AAA AAG CAA ATC T 31 54.57G0407CR ATC GAA GCT TCT ATA TAT ATA TTT TGA TAA AGC C 34 44.82
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IPTG for expression by a T7 promoter is generally believed to produce the best expression
for membrane proteins (Hunte et al., 2003).
This plasmid also has a wide selection of restriction sites available and a HRV-3C cleavage
site to remove the His-tag if required. The His-tag was selected to enable IMAC purification.
Figure 2.2. Plasmid map of pET-47b(+) (Novagen). Visible are the Kanamycin resistance gene, the T7 promoter and the
lac operon. (useful for autoinduction).
Figure 2.3. The cloning and expression region of pET-47b(+) (Novagen). The restriction sites chosen for use in this
research – BamHI and HindIII are highlighted in red. Also highlighted in blue are the His-tag and HRV-3C cleavage sites.
The T7 promoter can be seen upstream of the His-tag
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2.2 Methods
2.2.1 Nested PCR amplification and cloning of targets
A master mix containing all reagents, with the exception of DNA and both primers was
prepared before each set of PCRs. This master mix contained enough reagents for all the
planned PCRs plus one extra to allow for unavoidable pipetting errors. Each PCR master mix
contained: 1 unit Taq polymerase, 10 µl reaction buffer (1x), 2 mM MgCl2 and 0.25 mM of
each dNTP. This was added to tubes containing 2 µl of DNA (or initial reaction) and 2 µM of
each primer. The DNA used for amplification was that supplied by Dr Gabi Margos, this was
diluted 1:5 in nuclease free water prior to amplification.
The first stage of nPCR uses template gDNA and a set of primers encompassing a target
approximately 150-300 base pairs larger than the fragment. This followed the protocol laid
out for twenty cycles. The second stage of nPCR uses 2 μ l of reaction from the initial
amplification as a template and primer pairs much closer to (and sometimes overlapping) the
target gene. The heating procedure for the first step was applied again, with thirty five cycles
used. The annealing temperature was again adjusted based on the Tm of the primers used.
Initially nested PCR was used to amplify the UvrA/PepX housekeeping genes from B.
garinii.
Once the amplification of the target genes was complete, the genes were purified using a
Qiaquick PCR Purification kit purchased from Qiagen (Manchester, UK). PCR using
overhang primers designed for the specific restriction enzymes BamHI and HindIII was
carried out on the targets in preparation for restriction digests.
2.2.2 Restriction digest and production of DNA constructs
The restriction enzymes BamHI and HindIII were used for digesting pET-47b(+) and
prepared genes Following an enzyme compatibility chart on the New England Biolabs
website (New England Biolabs) the restriction digests were carried out sequentially. The
reaction mix for the initial digest consisted of 3 μ l DNA, 1 μ l neat enzyme, 2 μ l of
appropriate NEBuffer and nuclease free water up to a total volume of 10 µl. The second
digest reaction mix consisted of: the 10 μ l first reaction, 1 μ l of enzyme, 4 µl NEBuffer, 1x
(40 ng) BSA (required for BamHI digests) and nuclease free water up to a total volume of 20
μ l. Each restriction digest was incubated at 37 °C for one hour with gentle shaking (120 rpm).
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Once the digest was complete the DNA was purified using a QIAquick PCR Purification kit
(Qiagen, Crawley, UK) and eluted in 30 µl nuclease free water. This produced pure
insert/plasmid DNA ready for cloning. In addition to removing any enzymes and buffer
components present in the samples, the purification step also removes small unwanted
fragments of DNA, for example the extra bases next to each restriction site and the small
fragment produced by the digestion of pET-47b(+).
DNA concentrations were determined using the absorbance at 260 nm and the equation
below (equation 1). The number 50 is used as a DNA concentration of 50 µg/ml produces an
absorbance of 1 at 260nm.
Concentration (μg/ml) = (A260 − A320) x 50 x dilution factor
Equation 1. Calculating the concentration of DNA.
The A280 was then used in conjunction with the A260 to calculate the purity of the DNA
sample as shown below (equation 2). For the sample to of an acceptable purity, the ratio had
to be above 1.5.
Sample purity = AA
Equation 2. Calculating DNA purity.
To have a large enough sample volume for use in a low capacity cuvette (70 µl capacity) the
sample was diluted by a factor of 3. Both the concentration and the purity ratios were
calculated.
The volumes required for ligation were determined by: calculating the volume of plasmid
DNA required to give 1 ng of DNA, then calculating the difference in size of the insert and
plasmid as a ratio, before using that to deduce the volume of insert DNA to use.
The ligation reaction protocol went through several iterations before one was found that
produced gene constructs. The concentration of ligase was increased 10 fold (to the neat
solution), and the ATP concentration was increased to 2 mM (from 1 mM in the initial
buffer). These incorporated changes were not successful either in conjunction or separately.
Different ligation temperatures and incubation times were trialled. 23 °C for one hour with
shaking at 120 rpm produced DNA constructs. The final ligation mix used pET-47b(+):gene
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ratios of 1:1, 1:3, 1:6 and 1:10, mixed with 1 U T4 ligase, 1 mM ATP, 1 μ l ligation buffer,
with the volume being made up to 10 μ l total with nuclease free water. This was incubated at
23 °C for one hour at 120 rpm.
2.2.3 Agarose gels.
Products of the PCR amplifications and restriction digests were run on an agarose gel to
determine a) the success of the amplification and b) success of the digestions. 1.5 % (w/v)
agarose gels were prepared by melting 1.5 g agarose in 200 ml 0.5x TBE in a 250 ml conical
flask, to which 20 μ l SYBR safe DNA stain was added once the flask was cool enough to
touch. This was set and once loaded, run for 4 hours at 125 kV and 200 mA in 0.5 x TBE
buffer. As PCR amplifications were conducted in Green GoTaq Reaction Buffer (Promega),
the crude samples were ready to load. Purified samples (after restriction digest) had 6x
Blue/Orange loading dye added in the required ratios, as did purified digested plasmid. The
DNA ladder was chosen depending on the size of products expected; if plasmids were
involved, both ladders (max 800 and 10,000 bp) were run, if the gel was for amplified genes
only, only the 800 bp ladder was run. The 10,000 bp ladder was provided ready to use,
whereas the 800 bp ladder (2 μ l) required Blue/Orange loading dye (2 μ l) and nuclease free
water (8 μ l) to prepare. If greater resolution of bands was required, the gel was run for 6
hours at 90 kV, 200 mA.
2.2.4 Competent cell preparation
The E. coli strain chosen for plasmid maintenance was NEB Turbo Competent E. coli (High
efficiency) from New England Biolabs (NEB, Hitchin, UK). 50 µl of cells were spread onto
an agar plate with no antibiotic and incubated at 37 °C overnight. Of the colonies that grew,
one was selected, transferred to 5 ml sterile LB and incubated at 37 °C overnight. This
culture was transferred to 50 ml sterile LB, incubated at 37°C with gentle (120 rpm) shaking
and the OD600 monitored until it reached 0.4, upon which the culture was split and incubated
on ice for 5 minutes before being centrifuged at 10,000 g for 30 minutes. Each pellet was
resuspended in 2.5 ml chilled TSS buffer and 20 µl aliquots frozen -70 °C.
2.2.5 Transformations
20 μ l aliquots of competent cells were thawed on ice, and either purified ligation reaction mix
or 10 ng construct DNA added. Mixing was induced by gentle flicking of the tube and the
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cells incubated on ice for 15 minutes before being transferred to a 42 °C water bath for a 45
second heat shock, after which they were returned to ice for 5 minutes. 80 μ l SOC was added
and the cells were incubated at 37 °C for one hour. The entire volume of cells was spread on
a pre-warmed agar selection plate (containing appropriate antibiotic) and incubated at 37°C
overnight
Control transformations were carried out at all times:
• Positive control 1 – unaltered plasmid DNA
• Positive control 2 – plasmid DNA digested with a single restriction endonuclease and
re-ligated
• Negative control 1 – No DNA
• Negative control 2 – plasmid DNA digested with a single restriction endonuclease (no
DNA ligase added)
• Negative control 3 – plasmid DNA digested with both restriction endonucleases (no
DNA ligase added)
2.2.6 Extraction of plasmid constructs
From cells cultured on LB-agar-antibiotic plates, one of the colony was selected and cultured
overnight in 5 ml sterile LB with appropriate antibiotic(s) at 37 °C with gentle shaking. The
following morning construct DNA was extracted using a QIAprep Spin Miniprep Kit
(Qiagen, Crawley, UK) according to the manufacturer’s protocol and eluted in 50 µl nuclease
free water before being stored at -20°C.
Four different strains of competent expression E. coli were screened for best production of
protein. The three strains selected were:
• T7 Competent E. Coli (High efficiency) (NEB, Hitchin, UK)
• E. coli BL21 (University stock)
• E. coli BL21 (DE3) (NEB, Hitchin, UK)
• E. coli Rosetta (DE3)
Stocks of all four strains were prepared using the same procedure as used for preparing the
maintenance strain.
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2.2.7 Expression of protein in inclusion bodies
2.2.7.1 Expression of protein using IPTG induction
One colony from the selection-plates was selected and sequentially cultured at 37 °C in 5 ml,
50 ml and (and in the case of larger-scale expression, 500 ml) LB with antibiotic, with the
OD600 being monitored in both the 50 and 500 ml cultures until it reached 0.6. Once the
critical OD600 was reached a 1 ml sample was taken for pre-expression SDS-PAGE analysis.
To induce expression IPTG was added to a working concentration of either 1 or 0.1 mM and
the cultures incubated at 37 °C with vigorous shaking for three to four hours, upon
completion a further 1 ml sample was taken for post expression SDS-PAGE analysis. Other
expression conditions included expression at 18 and 20 °C overnight.
2.2.7.2 Expression by autoinduction
Autoinduction media was prepared following the recipe detailed in the buffers and media
(Table 2.2). The base media containing tryptone and yeast extract was autoclaved before
sterile NPS, 5052 and antibiotic (0.45 μ M filtered) were added to the media. These
components had to be added after autoclaving to prevent the sugars caramelising and
compounds degrading. A small volume of construct-containing expression cells was
introduced to the media (~1 ml) and the culture incubated at 37 °C for between 18 and 24
hours. Initially the cultures were shaken at 120 rpm, after experimentation this was increased
to 200 rpm.
2.2.8 SDS-PAGE and Western Blot analysis
2.2.8.1 Preparation of samples
Whole cell samples to be run on an SDS-PAGE were harvested by centrifugation for 5
minutes at 14,000 rpm before being resuspended in 100 μ l of either salt or urea buffer. The
samples were then sonicated for a total of 30 seconds (4 second pulse, 5 second rest, 75 %
amplitude). Once the samples were ready, a small volume (5 – 10 μ l) was taken, SLS added
to a working concentration of 1x, along with 3 µl 1 M DTT the volume made up to 25 μ l with
ultrapure water and the sample boiled at 95 °C for 5 minutes. Protein samples containing
guanidine-HCl to be analysed by SDS-PAGE and Western Blot had to be extracted from the
denaturant due to guanidine precipitating upon mixing with SDS. To each sample 9 volumes
of 100 % (v/v) ethanol was added and the solution incubated at -20 °C for one hour. Protein
was harvested by centrifugation at 14,000 rpm for fifteen minutes in a bench-top centrifuge
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and the pellet resuspended in 100 µl 70 % (v/v) ethanol before being centrifuged for a further
five minutes at 14,000 rpm. The final pellet was resuspended in 100 µl of either salt buffer or
8 M urea.
2.2.8.2 SDS-PAGE & Western Blot
Both pre-cast and in-house cast gels were used throughout this research. 4-12 % (w/v)
Bis/Tris pre-cast gels were purchased from Invitrogen (Paisley, UK), 10 % (w/v) Bis/Tris
gels were cast using a water cooled PerfectBlue Dual Gel Twin S gel tank (Peqlab, Sarisbury
Green, UK). A 10 ml gel was prepared using the following recipe: 7.35 ml ultrapure water,
3.75 ml 1 M Tris-HCl (pH 8.8), 75 µl 20 % (w/v) SDS, 3.75 ml Bis/Tris acrylamide (40 %
w/v), 75 µl 10 % (w/v) APS and 10 µl TEMED. The stacking buffer was prepared as follows:
3.25 ml ultrapure water, 1.25 ml 1 M Tris-HCl (pH 8.8), 25 µl 20 % (w/v) SDS, 0.5 ml
Bis/Tris acrylamide (40 % w/v), 25 µl 10 % (w/v) APS and 5 µl TEMED 20 μ l of protein
sample was loaded into the wells. 7.5 μ l Novex Sharp Pre-stained protein standards
(Invitrogen, Paisley, UK) was run for mw comparison with each gel. Pre-cast gels were run at
200 kV, 400 mA for 35 – 40 minutes. In-house cast gels were run at 175 kV, 400 mA until
the loading dye reached the bottom of the gel. All gels were stained for one hour using
Coomassie Blue stain before destaining over the course of several hours. It is important to
note that due to the presence of hydrophobic regions in membrane proteins there is the
potential for anomalous migration on an SDS-PAGE; either due to the protein binding
excessive amounts of SDS or the improper unfolding of hydrophobic regions (Hunte et al.,
2003).
Western blotting was carried out using an XCell II Blot module (Invitrogen, Paisley, UK).
The primary antibody was selected to be specific for the his-tag; a mouse monoclonal anti-his
(IgG1-kappa isotype). The secondary antibody used was a goat anti-mouse polyclonal Alexa
Fluor 680 antibody. Both antibodies were purchased from Invitrogen (Paisley, UK). Prior to
use the primary antibody was diluted 1:1000 (1 µg/ml) in PBS-TWEEN and the secondary
antibody diluted 1:5000 (1 µg/ml).
In preparation for Western blotting, four blotting pads and two sheets of filter paper cut to the
correct size were soaked in transfer buffer for several minutes. The PVDF transfer membrane
was pre-wet in methanol for 30 seconds before being rinsed with dH2O and soaked in transfer
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buffer. Once electrophoresis was complete, the gel had the wells and foot removed before the
membrane was placed on one side and the pair sandwiched between two pieces of filter
paper. This ‘gel-membrane sandwich’ was placed on top of two blotting pads in a blotting
module, taking care to ensure that the gel was underneath the membrane and closer to the
cathode. Another two blotting pads were placed on top as shown below (Figure 2.4). This
was transferred to the running tank and the middle chamber was filled with transfer buffer,
whilst the outer chamber was filled with deionised water. The running tank was surrounded
by ice to keep the apparatus cool. Blotting was run for 90 minutes at 30 V, 400 mA.
Figure 2.4. Western blot module set up. A) Single membrane transfer, B) transfer of two membranes simultaneously
Once the transfer was complete, the membrane was removed and washed for one hour in
blocking solution (2 % w/v milk powder in PBS) at 4 °C. The membrane was then probed
with primary antibody for one hour at 4 °C before being probed with the secondary antibody
for a further hour at 4 °C. Between each step the membrane was washed three times with
PBS-TWEEN for 5 minutes each.
Once the final wash had been completed, the membrane was scanned using a LI-COR
Odyssey infrared imaging system (LI-COR Biosciences) at a wavelength of 680 nm. The
intensity, brightness and contrast were adjusted to give the best view of the bands present.
2.2.9 Purification of inclusion bodies from autoinduction cultures.
Cell pellets harvested from expression were resuspended in a volume of lysis buffer 1/20th the
original volume and incubated on ice for one hour before sonication for a total of 1 minute
(11 second pulse, 49 second rest, 95 % amplitude), after which the insoluble fraction was
separated by centrifugation at 12,000 g for 20 minutes at 4 °C. The supernatant containing
soluble proteins and cellular debris was poured off and stored at – 20 °C. The insoluble pellet
Blotting pad
Filter paper
Transfer membrane
Gel
+
Cathode core (-)
+
Cathode core (-)
+
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was resuspended in salt buffer and centrifuged again and the supernatant poured off, washing
the pellet. This was repeated once. After the pellet had been washed it was resuspended in
FPLC Buffer A (containing 6 M GuHCl) and centrifuged for 1 hour at 25,000 g, 4 °C. A
protease inhibitor cocktail (containing no EDTA) (Sigma) was added to the supernatant (now
containing insoluble proteins) which was stored at -20 °C. Initially all denaturing buffer
systems were urea based (8 M), however, once the purification was switched to using 6 M
GuHCl, the resolubilisation buffer was too.
2.2.10 Immobilised Metal Affinity Chromatography
Immobilised Metal Affinity Chromatography (IMAC) is usually carried out using buffers
with pH between 6 and 8.5 depending on the protein. Optimal separation of protein generally
occurs in the presence of 0.1 – 1 M NaCl, this is known to reduce the potential for membrane
protein aggregation in addition to eliminating ion exchange effects and improve solubility.
Detergents are required to solubilise the protein, neutral detergents don’t interfere with
binding and elution and a wide variety of buffer conditions can be used. Elution is carried out
by competitive elution through a reduction in pH or the addition of imidazole (Hunte et al.,
2003). Aggregation is a factor when working with membrane proteins as it occurs even in the
presence of detergents, reducing the efficiency of all separation techniques (Hunte et al.,
2003). This is accounted for by optimising the pH for solubilisation and stability, and
optimisation of detergent concentrations.
IMAC was carried out on an Äkta Prime FPLC (GE Healthcare, Amersham, UK) using a 5
ml HisTrap HP Ni-NTA column (GE Healthcare, Amersham, UK) and a variety of buffers,
dependant on whether on-column refolding was being carried out. A three buffer method was
developed for the purification of insoluble BAPKO_0422 and a seven buffer system was
developed for the purification and on-column refolding. All buffers were made fresh before
each purification and were vacuum filtered using a 0.45 μ m filter.
2.2.10.1 Purification of insoluble BAPKO_0422
The purification system and column were equilibrated in the buffers to be used (a minimum
of 6 column volumes for the column), the pipelines were washed until the absorbance and
conductivity baselines stabilised. The sample was loaded onto the column and FPLC Buffer
A pumped through to wash off any unbound proteins until the absorbance returned to the
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baseline. FPLC Wash Buffer containing 20 mM imidazole was pumped through the column
to elute any proteins that had weakly bound to the Ni-NTA due to exposed histidine residues,
until the baseline again returned to zero. Bound proteins were eluted using gradient elution
over either 50 or 100 ml with the concentration of FPLC Buffer B (containing 0.3 M
imidazole) increasing from 0 to 100 % over this time.
2.2.10.2 Benchtop refolding of BAPKO_0422
BAPKO_0422 was adjusted to a concentration of 1 mg/ml using 0.1 % (w/v) LDAO, 0.3 M
NaCl and 50 mM Tris (pH 7) and added over a period of ten minutes to a volume of SEC
buffer 50 x larger than the protein volume (McConnell and Pachón, 2011). The protein
solution was left to refold at room temperature whilst being continuously stirred using a
stirrer hotplate for one hour. The dilute refolded protein was concentrated first by IMAC
purification using non-denaturing buffers before being concentrated in a 10,000 mwco
concentrator.
2.2.10.3 On-column refolding of BAPKO_0422
For on-column refolding of BAPKO_0422, the preparation and protein loading procedure is
identical to that detailed in section 2.2.10.1 up to and including the low-concentration
imidazole wash. Once this was complete, four buffers were used to lower the concentration of
GuHCl and introduce LDAO to the protein, this reduction in denaturant in the presence of
0.1% (w/v) LDAO would allow the protein to refold into detergent micelles; the CMC of
LDAO is 0.023 % (w/v) (Herrmann, 1966). RF1 (4 M GuHCl) was pumped through at a flow
rate of 2 ml/min for three column volumes (15 ml), after which the instrument paused and
RF2 (2 M GuHCl) pumped through for the same volume at the same flow rate. This was
repeated with buffers RF3 (1 M GuHCl) and RF4. The final refold buffer contained no
GuHCl and is the same buffer used for size exclusion chromatography. The protein was then
eluted by gradient elution from RF4 to elution buffer over the course of 50 ml and purity
assessed by SDS-PAGE.
2.2.11 Size Exclusion Chromatography
Size exclusion chromatography (SEC) was used to further purify the protein and provide an
initial estimation for the size of molecule produced. When purifying membrane proteins
using SEC it is important to keep the concentration of detergent above the CMC but below 5
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% (w/v), and the protein concentration below 10 mg/ml. Detergent bound to the protein can
increase molecular weight (eg Triton X-100 micelles add 90 kDa to the molecular weight)
(Hunte et al., 2003). SEC was carried out using a Superdex™ 75 10/300 GL column (GE
Healthcare), which was stored in 20 % (v/v) ethanol when not in use. The column was
washed through with water to remove all traces of ethanol, before being equilibrated with
SEC buffer. The SEC buffer for BAPKO_0422 consisted of 0.5 M NaCl, 50 mM Tris, 0.1 %
(w/v) LDAO at pH 8.0. A calibration curve (Figure 2.5) was produced using four protein
standards:
• 0.5 ml BSA (67 kDa) 8 mg/ml
• 0.5 ml Ovalbumin (43 kDa) 2.5 mg/ml
• 0.5 ml Ribonuclease (13.7 kDa) A 5 mg/ml
• 0.5 ml Vitamin B12 (1.35 kDa) 12 mg/ml
Standards were selected based on the manufacturers specifications. The elution times agreed
approximately with those provided from the manufacturer.
Figure 2.5. SEC calibration curve. Produced using four protein standards as detailed above. BSA eluted first, followed by
ovalbumin, ribonuclease A and finally vitamin B12.
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Between 0.3 and 0.5 ml concentrated BAPKO_0422 was manually loaded onto the column
using a 1 ml syringe. The absorbance of the flow through was monitored at 280 nm
throughout. Small membrane proteins bind more detergent per gram than larger proteins,
masking differences in size, mass and moiety. Therefore techniques based around
differentiation of molecular mass and sizes (such as SEC) have lower resolution (Hunte et al.,
2003).
2.2.12 SEC-MALLS
Size-exclusion chromatography linked with multi-angle laser light scattering (SEC-MALLS)
was used to estimate the molecular weight of protein in the protein-detergent micelle. SEC-
MALLS was carried out using Astra software version 5.3.4.20 monitoring three conditions:
• Differential refractive index (Optliab rEX detector)
• Light scattering (DAWN EOS instrument)
o Cell type - K5
o Laser wavelength - 690 nm
o Calibration constant - 6.0520 x10-6 1/(V cm)
• Ultraviolet absorbance (Providence UV/Vis SPD-20A)
o Wavelength 280 nm
Three Agilent PL Aquagel-OH (40, 50 and 60) SEC columns (1.5 µm id) were linked in
sequence before being linked in series to the LS and UV detectors. The system was
equilibrated using SEC buffer at 0.45 ml/min until the light scattering baseline variance was
acceptable.
150 µl 8 mg/ml BSA was run as a positive control. Analysis of the data assuming a dn/dc
value of 0.187 ml/g gave a molecular weight of 60 kDa ± 15 % without manual background
adjustment. As the molecular weight of monomeric BSA is 66 kDA, this was deemed
acceptable. A 300 μ l BAPKO_0422 sample of approximately 5 mg/ml was used for analysis.
After the run had completed the baselines were manually adjusted, the peak manually
selected and the molecular weight protein of the protein calculated by the software using a
standardised dn/dc value of 0.187 ml/g (Slotboom et al., 2008).
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2.2.13 Circular Dichroism
Two criteria should be met to obtain a good CD spectra: the total absorbance of the sample
should remain below 1.0 and the High Tension (H[T]) voltage should not exceed acceptable
parameters (instrument variable) as this decreases the reliability of the results (Kelly et al.,
2005). The main processes of meeting these criteria are altering the sample concentration or
the cell path length. The signal/noise ratio can be lowered by conducting repeat
measurements. For the JASCO J-810 instrument that was used in this research, the maximum
acceptable H[T] value is 600 V, above which the CD spectra generated becomes unreliable.
The percentage secondary structure composition (helix, strand, turn or unordered) of proteins
can be determined from the CD due to absorption of polarised light by peptide bonds at
wavelengths below 240 nm, aromatic side chains between 260 and 320 nm and disulphide
bonds at around 260 nm (Kelly et al., 2005). Different secondary structures exhibit
characteristic peaks at certain wavelengths: α -helical proteins have negative peaks at 208 and
222 nm and a positive peak at 193 nm and proteins containing β -sheets have a positive peak
at 195 nm and a negative peak at 218 nm (Greenfield, 2006). Calculation of the secondary
structure proportions is done by a variety of algorithms such as SELCON, CONTIN and
CDSSTR. The online server DichroWeb (Lobley et al., 2002, Whitmore and Wallace, 2004,
Whitmore and Wallace, 2008) uses these along with a variety of reference CD spectra to
calculate the secondary structure composition (Janes, 2008).
Circular dichroism was carried out at the University of York on a Jasco J-810
Spectropolarimeter with the assistance of Dr Andrew Leech. An air background spectra as
initially taken, followed by the buffer background spectra in triplicate. Measurements were
taken over a wavelength range of 190 – 260 nm using a cuvette with a path length of 0.2 mm.
Samples were prepared for circular dichroism by dilution in the SEC buffer to approximate
concentrations of 0.166 and 0.33 mg/ml. The CD signal was measured at various
temperatures from 260 to 190 nm. All experimental data was acquired in triplicate.
Data obtained were analysed using the DichroWeb online CD server (Lobley et al., 2002,
Whitmore and Wallace, 2004, Whitmore and Wallace, 2008) using the following parameters:
• File format: JASCO 1.30
• Input units: millidegrees / theta (machine units)
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• Initial wavelength: 260 nm
• Final wavelength: 190 nm
• Wavelength step: 0.5 nm
• Lowest data point to use: 190 (DichroWeb would not accept higher to discount
unreliable data as the reference datasets were optimised to 190 nm)
• Analysis program: CDSSTR or SELCON3
• Reference set: 4 or 7 (both optimised for 190 – 240 nm)
• Output units: mean residue ellipticity
• Mean Residue weight (Da): 112
o Calculated by: mw (inc his-tag) / no. of residues – 1
• Protein concentration: 0.33 mg/ml or 0.166 mg/ml
• Path length: 0.2 cm.
2.2.14 Small Angle X-Ray Scattering
2.2.14.1 Collection of data
Background data sets were collected for a period of 24,000 seconds (approximately 3 hours,
40 minutes) and 65,000 seconds (18 hours) on a Bruker NANOSTAR. Scattering data for the
following buffers was acquired:
• SAXS Salt Buffer (SSB) - 0.3 M NaCl, 50 mM Tris, pH 8.0
• SAXS LDAO buffers containing 0.01 % (w/v), 0.05 % (w/v) and 0.1 % (w/v) LDAO
in addition to the salts in SSB
o Low composition SAXS LDAO buffer - 0.01 % (w/v) LDAO, 50 mM NaCl,
20 mM Tris-HCl, pH 8.0
• SAXS CHAPS buffers containing 0.01 % (w/v), 0.05 % (w/v) and 0.1 % (w/v)
CHAPS in addition to the salts in SSB
The CMC of LDAO, like all detergents varies with salt concentration, values found in the
literature quote approximately 0.046 % (w/v) (SIBYLS Beamline) to 0.023 % (w/v) in water
and approximately an eighth of this in 0.1 M NaCl (Herrmann, 1966). Hence the LDAO
concentration was expected to be above the CMC.
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Scattering data was acquired for lysozyme (10 mg/ml) and BAPKO_0422 (6 and 10 mg/ml )
samples in SAXS LDAO Buffer containing 0.1 % (w/v) LDAO using the same method of
collection as for background data. Acquisition times were 65,000 seconds. BAPKO_0422
data was collected at two different concentrations to provide information about the state of
the sample. Lysozyme was used as a positive control, and in conjunction with the collection
of background detergent data sets this ensured that protein scattering could be detected above
detergent scattering, whilst providing a valuable example of data analysis. Background
subtraction was conducted using water and buffer background scattering using the software
provided.
2.2.14.2 Analysis of data
PRIMUS is a data manipulation program with an automatic function for producing Guinier
plots and evaluating parameters from Guinier and Porod plots using SAXS data sets
(Konarev et al., 2003). The raw data file is input into the program and automatically plotted.
The Rg can also be calculated automatically.
There are several parameters to be set when running GNOM. Most were left as the default
setting, however some were adjusted and are listed below.
• Angular scale – 2. units of 4.π .sin(θ )/ λ (units that the data uses - nm-1)
• Type of system – 0. calculation of distance distribution function for a monodisperse
system. The function P(r) = γ (r)*r2 is evaluated, where γ (r) is the characteristic
function of the particle.
• Zero condition at r=Rmin – yes.
• Zero condition at r=Rmax – yes.
• Rmax for evaluating P(r) – 50. expected maximum size of particle (Å)
DAMMIF is a high-speed version of DAMMIN (25-40 times faster) that performs shape
determination from small angle X-ray data ab initio by simulated annealing using a single
phase dummy atom model (Franke and Svergun, 2009). A particle is represented as a
collection of a large number of beads, each of which belongs to the molecule or the solvent.
This program uses the output file from GNOM
• Angular unit – n (data is in nm)
• Mode – slow (fast is used to get a preliminary idea of the molecular envelope)
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• Anisometry – prolate
The program then builds a model of the molecular envelope using small spheres and
measuring the fit of the data after each step. The lower the fit, the better match the model.
DAMMIF was run ten times to produce a set of molecular envelopes for averaging. These
molecular envelopes were read into DAMSEL which aligned and compared the models using
Normalised Spatial Discrepancy (NSD) values to find the most probable real-world solution;
if the NSD for two models was less than 1, they were considered similar. The mean NSD and
variance is automatically calculated and any solutions that were outside of acceptable limits
(2 x variation either side of the mean) were discarded (Volkov and Svergun, 2003).
Solutions accepted by DAMSEL were then read into DAMSUP. This superimposes each of
the molecular envelope structures onto each other using SUPCOMB, producing models of the
superimposition (Volkov and Svergun, 2003).
DAMAVER, takes the models aligned by DAMSUP and averages them to create a
probability map (aligns the solutions to give the best overlap). This remaps the .pdb files onto
a grid of densely packed beads to compute a frequency map, which is then processed to
provide a filtered model using DAMFILT. It should be noted that the DAMAVER file will
not be a good fit to the data (Volkov and Svergun, 2003).
The DAMAVER averaged file was then processed by DAMFILT. This filters the
DAMAVER model at a given cutoff and removes low occupancy and loosely connected
atoms, producing a compact and most probable core model (Volkov and Svergun, 2003). This
is again not expected to fit the data, but is instead used as a starting point for DAMMIN to
produce a molecular envelope using this and the experimental data. All parameters are left as
default when producing, refining and averaging molecular envelopes.
The fit of the expected scattering patterns of the molecular envelope solutions generated by
DAMAVER, DAMFILT and DAMMIN were compared to the experimental data by
CRYSOL and fits plotted (Svergun et al., 1995).
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2.2.15 X-Ray crystallography
2.2.15.1 In surfo crystallisation
There are various methods of crystallisation, in one of which the proteins (in this case
detergent-solubilised membrane proteins) are utilised directly in crystal trials. In surfo
methods include vapour diffusion and batch-phase (or micro-batch) crystallography
(Cherezov et al., 2006). Vapour diffusion crystallography takes place in 24, 48 or 96 well
trays. In the bottom of each well is a reservoir of precipitation solution and buffer, or ‘mother
liquor’. One drop of mother liqueur (from 0.1 – 0.5 µl in 96 well trays to 1 - 2 µl in 24 well
trays) is added to similar volumes of protein (concentration varies depending upon solubility)
in a sealed environment set up as either a hanging or sitting drop (Figure 2.6). The tray
incubated at approximately 18 °C for a number of weeks. The concentration of precipitants in
both the drop and the well gradually equilibrates over time, while water in the drop
evaporates, steadily increasing the protein concentration and causing precipitation (Rhodes,
2000).
Figure 2.6. Vapour diffusion setups. Left - the hanging drop method, right – the sitting drop set-up. One major advantage
of this method is the ease at which the drop can be accessed for harvesting crystals. The sitting drop techniques lends itself to
96 well automated setup in very small volumes and the entire tray is generally sealed with sealing film. The hanging drop
method lends itself to 24 well screens and manual setups, with cover slips sealing each individual well.
In this research the hanging drop method was used in 24 well trays. In the case of CSS
screens I and II, the reservoir was filled with 0.9 ml precipitant and 0.1 ml pH buffer (either 1
M Tris at pH 8 or 1 M sodium acetate at pH 4.5). For the Memb-PASS screen 0.4 ml
precipitant was used. The protein and precipitant drops were mixed in various ratios on the
surface of a cover slip, which was placed drop down on top of the well with a layer of
vacuum grease in between as a seal. Trays observed under a microscope and notes taken with
regards to the drops before being stored in a polystyrene box in a 20 °C incubator.
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2.2.15.2 Detergents
Membrane proteins are challenging proteins to work with, both in crystallography and
structural studies due to presence of the hydrophobic TM region. These regions can be
stabilised through the use of detergents in various conformations (Figure 2.7) and/or lipids,
thereby preventing aggregation.
The choice of which detergent to use is an important one and factors such as hydrophobic
chain length, critical micelle concentration (CMC – the concentration at which the detergent
spontaneously forms micelles) and cost must all be taken into consideration. A selection of
detergents were chosen for use in this research based on a number of considerations. Table
2.7 shows detergents and lipid chosen for stabilising and crystallising the protein.
Figure 2.7. Detergent binding by membrane proteins. The dark grey section is the hydrophobic membrane-spanning
region. A) shows a micellar arrangement of detergent molecules around the TM domain that has dimensions approximately
the same as the detergent micelle. B) shows the TM domain is covered by detergent molecules in a layer that leaves the
hydrophobic region of detergent exposed. C) represents an arrangement in which the hydrophobic regions of both the protein
and detergent are shielded, similar to a micelle, but smaller. D) shows a micelle of pure detergent and E) represents detergent
at an air-water interface. Diagram adapted from (LeMaire et al., 2000).
A. Micelle binding B. Monolayer binding C. Prolate ring
D. Micelle E. Air-water interface
Detergent Structure
C8E4
CHAPS
DDM
LDAO
OG
Lipid -
MO
Table 2.7. Detergents and lipid comm
table was obtained from various sourc
VanAken et al., 1986, Lorber et al., 19
Brunger, 2005)
Mw (Da) CMC(mM
306.44 8
614.9 8
510.62 0.120.17
229.4 1-2
292.4 18 - 30
356.54 -
only used in membrane protein purification and crys
es (Herrmann, 1966, Hjelmeland et al., 1983, Chattopadh
90, Cortes and Perozo, 1997, LeMaire et al., 2000, Lipfert
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)
CMC
(%)
Micelle
size
(kDa)
0.25 25
0.49 6
- 0.0087 72
0.023 -
0.14
17 -
21.5
0.53 7 - 29
- -
tallisation. Data for this
yay and London, 1984,
et al., 2007, Strop and
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LDAO was chosen as the primary detergent as it had previously been used to crystallise
OmpA-like membrane proteins (Pautsch et al., 1999, Pautsch and Schulz, 2000, Hong et al.,
2006) and due to the relatively small micelle size, the relatively low cost and low CMC.
DDM, OG and C8E4 were chosen as membrane proteins have been crystallised using these
detergents previously (Pautsch and Schulz, 1998, Pautsch et al., 1999, Pautsch and Schulz,
2000, Albrecht et al., 2006, Hong et al., 2006). CHAPS was chosen as it is non-denaturing.
MO was purchased for use in lipid cubic phase crystallography.
2.2.15.3 In meso crystallography
Lipid cubic phase (LCP) crystallography (also known as in meso crystallography) utilises a
stable lipid cubic phase as a basis for formation of protein crystals (Caffrey and Cherezov,
2012). The lipid cubic phase consists of monoolein hydrated with 40 % (w/w) water. This is
formed by the combination of protein detergent solution at a concentration of 10 mg/ml with
molten monoolein (MO) in a ratio of 2:3 (Caffrey, 2000, Caffrey, 2003, Cherezov et al.,
2006, Caffrey and Cherezov, 2012). Molten MO was prepared by dissolving 6 mg in an
excess of chloroform (> 200 μ l), before the majority of chloroform was evaporated by a
nitrogen stream. The remainder was evaporated using a rotary evaporator over a period of
four hours. Precipitant is added in excess ( >10 parts with respect to the previous ratio) and
incubated at 20 °C (Ai and Caffrey, 2000, Caffrey, 2000). The mixing of MO and protein
solution forms the cubic phase spontaneously (Caffrey, 2000).
The initial LCP method used a piece of double-sided tape with holes punched in to form
wells. A small volume of LCP with protein was deposited into each well. A 1 μ l precipitant
solution drop was applied to each LCP-protein deposit and the well sealed with a coverslip.
This was carried out for all conditions in the Memb-PASS screen. The slides were incubated
at 20 °C and checked after two weeks.
The second version of LCP crystallography used ‘wells’ made from a layer of grease on a
microscope slide and covered with a cover slip.
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Chapter 3. Identification and bioinformatic studies of potential OmpA-like
proteins in Borrelia.
Attempts were made to identify OmpA-like membrane spanning domains in Borrelia using
BLAST searches of the sequences of OmpA (N-terminal domain), OmpW and OmpX
proteins (1BXW, 2F1T and 1Q8J respectively) against the proteomes of B. afzelii, B.
burgdorferi s.s., and B. garinii (BLAST search hosted on ExPASy (Altschul et al., 1997)).
An example of BLAST search results is shown (Table 3.1) using the N-terminal domain of
OmpA from E. coli (1BXW) searched against the B. garinii proteome.
Accession no. Description Score E-value
Q662Q2_BORGA Putative uncharacterized protein 24 1.4
Q660D1_BORGA Putative uncharacterized protein 23 3.1
Q663A7_BORGA Tryptophanyl-tRNA synthetase 22 5.3
Q661J8_BORGA Sensory transduction histidine/ kinase response regulator 22 5.3
Q661F1_BORGA Putative uncharacterized protein 22 6.9
Table 3.1. BLAST search of 1BXW from E. coli against the B. garinii proteome. The score represents the quality of the
match between two sequences; the higher the score, the better the match. The (Expect) E-value is the number of matches that
can be expected to occur at random. The lower the E-value, the more significant the result; a value between 0.1 and 10
indicates that match is uncertain and a value of 10 or more indicates that there is likely no biological significance (Altschul
et al., 1997). The scores of the potential matches are very low, which is to be expected due to the high sequence variability
of TM β -barrel proteins. The E-values are also high, a positive control search of 1BXW against the E. coli K 12 proteome
returned 1BXW itself as the top hit with a score of 362 and an E-value of e-102. Of the proteins identified, three have known
functions and the remainder have molecular weights more than twice the size of an eight stranded TM β -barrel protein.
No matches were found due to BLAST searches not being sensitive enough to detect the
substantial sequence divergence characteristic of OmpA-like proteins (Schulz, 2000). Hidden
Markov models (HMMs) were used as an alternative (Bernsel et al., 2008), the first step of
which was building a HMM profile of known OmpA-like proteins.
3.1 Classification of known Omps
A list of 167 known OmpA-like transmembrane domains from multiple Enterobacteriacae
(ProDom family PD004606) (Servant et al., 2002) was used to provide a broad reference for
searching the Borrelial genomes for potential OmpA-like proteins. To expedite the search the
list was trimmed to remove any proteins with a sequence more than 40 % identical to any
other protein in the list using the Decrease Redundancy program developed by Cédric
Notredame (unpublished) hosted on ExPASy (Gasteiger et al., 2005). A second list was
produced with a 90 % identity limit.
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The Decrease Redundancy program works by aligning and comparing all sequences pairwise,
before measuring the percentage ID between the first two sequences. When a pair is found
with a percentage identity greater than the specified cut-off, one of the sequences is removed
and the accession number placed in the information line along with the accession number of
the sequence kept upon which the program then moves on to the next sequence in line. This
continues until all of the sequences in the file have been compared and any with a percentage
identity greater than the specified have been removed. The results of both reductions are
included in the appendix 8.1, all similar proteins are displayed as in Figure 3.1.
>Q87JK1_VIBPA Q8D6H3_VIBVU Q7MDC9_VIBVY
Q87GX9_VIBPA
YIGGKVGYNSLNDACYLNEPCDDDSFAAGMHIGYNFNEYVAAEYGVDYLGDFTANFKKPGLN
TVDGDLWALTLAPKFNLPLTDSWNLFAKVGAAYMMAGDEKDFVPTGSLGAEYKINYNWSLRA
EYQRYQDMSDDIVDDMDSDFFGIGFNYKFG
Figure 3.1. An example of a redundancy reduced protein search. Proteins more than 40 % identical to a protein already
observed by the program have the accession numbers included above the sequence of this initial protein, next to its accession
number.
The lists of known OmpA-like proteins produced from both the 40 % and 90 % redundancy
reductions were submitted to the JACOP (Just Another Classification Of Proteins) server
(Sperisen and Pagni, 2005) for classification (Figure 3.2 & Figure 3.3). Through using
random sampling of short sub-sequences and comparing them to the initial input of proteins,
scores bases on similarity are assigned, which are used to classify the proteins and organise
them according to similarity in the form of New Hampshire trees (Sperisen and Pagni, 2005).
Each protein present in the New Hampshire trees was searched in the UniProtKB database to
identify the class of OM protein - OmpA/W/X.
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Figure 3.2. NewHampshire Tree produced using a list of known TM β -barrel proteins reduced by 40 %. Image
generated by JACOP from a list of known TM β -barrel proteins with a redundancy reduction of 40 %. Highlighted are the
two main classes of OM protein in this tree. Proteins within the green box have been identified as OmpA and within the blue
box OmpX. Interestingly no OmpWs were identified. The numbers to the right of the accession numbers signify the
grouping assigned by JACOP.
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Figure 3.3. NewHampshire Tree produced using a list of known TM β -barrel proteins reduced by 90 %. Image
generated by JACOP from a list of known TM β -barrel proteins with a redundancy reduction of 90 %. The classes of OM
protein are highlighted according, and again there were no OmpW proteins identified. The groups of OmpA and OmpX are
both rather larger in the 90 % reduced NewHampshire tree compared to the 40 % due to a higher similarity cut-off. Though
there are 5 numbered groups, it was shown by looking up the accession numbers in the RSCB PDB that groups 1-3 are all
OmpA from various bacteria; the numbered groups signify that some proteins are more closely related than others.
Each of the redundancy reduced protein lists were aligned automatically using ClustalW2
(Goujon et al., 2010, Larkin et al., 2007). The 40 % reduced sequence alignment is included
(Figure 3.4) with conserved residues highlighted.
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Q8XBY9_ECO57#13#177       .......... ..SAGYAQSK VQDFKN.... .IKG.VNLQY RYEWDSP.VS
Q7N5I2_PHOLL#43#182 .......... .......... .......... .LNG.ATLSY RYELDDQ.WG
Q57K85_SALCH#72#178       .......... .......... .......... ...G.S...Q RYSDESS.NG
Q6D3I0_ERWCT#17#171       GAGSAFAGQS TVTAGYAQGD AQGVQN.... KVKG.FNLKY RYEQDNNPLG
Q9XD46_VITS1#32#191       .......... TVSIGYSHGK ISGAD..... KLNG.VTAKY NYQFDQQPWG
Q66AL7_YERPS#27#179       .......ASN TVSFGYAQST LKIDGEKIGK DNKG.FNLKY .RHELDSVLG
Q8X428_ECO57#7#108        .......... SVMAG...PS VRVN...... .......... ..........
O33796_SALTY#23#153       .....AGYKN TVSIGYAYTD LSGWLSGNAN ...G.ANIKY NWEDLDSGFG
Q8ZQG1_SALTY#92#172       .......... .......... .......... .......... ..........
Q8Z920_SALTI#29#174       .......... ..SFGYAQTH LSSLKNSDSK DLRG.FNFKY RYEFNET.WG
Q5FA01_NEIG1#20#175       ....EGASGF YVQADAAHAK ASSS..LGS. .AKG.FSPRI SAGYRINDLR
Q3EI33_ACTSC#24#191       .......... YVEGDAGYSK LRTSGGLSSK ISDGSFSPSV AVGYKVNDWR
Q9RM69_ERWCA#29#207       ..YTGGKLGV SQFHDTGFYG NGYTDVNNNP IKSKLGAGAF VGYQANPYLG
Q8E832_SHEON#33#191       ..YAGAGLG. .....QGHYS NGSNPQSYDS VRDRFAGSVY LGYQVNPYLA
Q5DYH6_VIBF1#21#185       ..YLGGQVG. .....VSHFL GACSSNAIEC KNYVTGGGLY GGYQFNSWFA
O31154_VIBCH#24#173       ..YVGGKVG. ......KSWL DDACLAGQSC EDDDQVVGAF LGYQANKWLS
Q87JK1_VIBPA#26#179       ..YIGGKVG. ......YNSL NDACYLNEPC DDDSFAAGMH IGYNFNEYVA
Q6PSK4_PASTR#28#221       ..YVGAKAGW ASFHDGISQI DHKNGGKYGI NKNSVTYGAF VGYQIIDNLA
P96773_HAEDU#126#257      .......... .......... .......... .......... ..........
Q3QLJ4_9GAMM#38#150       .......... .......... ...ASGDGEG SSDGVGFGAY GGYNFNEWFG
Q3GMA6_9GAMM#36#179       .......... .....YVGAK VGQFDLDVDG ADDPTAYGVY AGYNFDPNFG
Q3QBC3_9GAMM#28#162       .......... ....AKGGYQ WASDDSYKHS NPKGAIFGVS SGLQFSPAWS
Q44GL1_CHRSL#62#200       .......... .......... ........DV DDDDNTFKGF VGYNFNRYFA
Q8XBY9_ECO57#13#177       VVGSFSYMKG DWADSHRDEA DDFYRHQADI KYYSFLAGPA YRLNDY.ISF
Q7N5I2_PHOLL#43#182       LLSSFTFAKG .......DEK ETKYYTGEDL KYYSVMIGPT YRINDY.ISL
Q57K85_SALCH#72#178       RVTT...... .......... .......... RYYSLLAGPS WKINNQ.LSL
Q6D3I0_ERWCT#17#171 VISSFTYLE. ..KN..GSDD GFYS....KG QYMGFTAGPA YRLNDW.ASL
Q9XD46_VITS1#32#191       VMTNLTYMGG KQRNNITSSN QLYEN.DVDV DYYSAGVGPS YRINPN.VNV
Q66AL7_YERPS#27#179       IVASFTHTKQ NYGMPGDSDG K......RKV EYYSLMVGPS WRFNEF.VSA
Q8X428_ECO57#7#108        ..EWFS.... AYAMAG.... .........V AYS....... .RVSTF.XGD
O33796_SALTY#23#153       AMGSVTYTSA DVNNYGYKVG ........DA DYTSLLVGPS YRFNDY.LNA
Q8ZQG1_SALTY#92#172       .......... .......... .......... .......GPS YRFNEY.LNA
Q8Z920_SALTI#29#174       MLGSFTATRN EMENYTWKEG KLHKNGSDSV DYGSLMFGPT YRFNDY.VSL
Q5FA01_NEIG1#20#175       FAVDYTRYKN .......YKQ APST....DF KLYSIGASVI YDFDTQ.SPV
Q3EI33_ACTSC#24#191       FALDYTYYGK GDEGFGDLGG SGEN....EV KAYGFGLAAY YDFDLG.TSL
Q9RM69_ERWCA#29#207       FEMGYDWLGR M.KYAGSTAN PADS.ASLKA QGIQLAAKLS YPVLPD.LDV
Q8E832_SHEON#33#191       PELSYQFLG. ....SAYANY EQGQ.ISGDF QQVVLAARFG YPLTTS.LYP
Q5DYH6_VIBF1#21#185       LEGSWHDYG. ....SPKTFY GVGDGYYSNA TGVDLSVKLS LPVTDN.LDL
O31154_VIBCH#24#173       LEAGYDYLG. ..KFTA.... AGLN..DEKV QAVTLAPKLS IPLTEG.IAL
Q87JK1_VIBPA#26#179       AEYGVDYLG. ..DFTANFKK PGLNTVDGDL WALTLAPKFN LPLTDS.WNL
Q6PSK4_PASTR#28#221       AEVGYEYFGR VRGLEQTKAG GSKKTFRHSA HGTTIALKGN YEVISG.LDT
P96773_HAEDU#126#257      .......... ........KG DLNRQFKHTA HGANLSLKPS YEILPN.LDV
Q3QLJ4_9GAMM#38#150       LEANLFASG. .........D LGEDGVDVGA GALTFTPKFT YHFNDT.FSA
Q3GMA6_9GAMM#36#179       MEAEFVGSD. .........D ADYRGGDIDA KTYGAYGTYR YAFPNTGLYA
Q3QBC3_9GAMM#28#162       WDVGYQYHD. .......DLK ADATSVNVKA GLIESALRYD WYLQDN.LSV
Q44GL1_CHRSL#62#200       TEAFYSDLG. ....RVKLKG NGTANTDLES EAYGVSLVGK LPITQW.FEL
Q8XBY9_ECO57#13#177 YGLVGISHTK AKGD...... .YEWRNSVGA DESDGYLSES VSKKSTDFAY
Q7N5I2_PHOLL#43#182 YGQLGLSRIN DK........ ......ST.A HYSGGYIEKE STSKNT.LGW
Q57K85_SALCH#72#178 YSQVGPVLLH QR........ ......DHGI NESDSKVG.. .......YGY
Q6D3I0_ERWCT#17#171 YGVVGFS... .HGK...... .VTSNNTNGQ DNASNDDYG. .......FTY
Q9XD46_VITS1#32#191 YGVVGVAKAD TKGT...... .QKQNRTGRI YNIDNIDTN. .......VMY
Q66AL7_YERPS#27#179 YALIGAT... .QGK...... .STHTKPRMV SNTVSKTS.. .......MGY
Q8X428_ECO57#7#108 YLRVTDN... .KGK...... .THDVLTGSD DGRHSNTS.. .......LAW
O33796_SALTY#23#153 YVMIGAA... .NGH...... .IKDNW.... GNSDNKTA.. .......FAY
Q8ZQG1_SALTY#92#172 YVMAGLG... .HGH...... .IDDKR.... DNSGKKTG.. .......FAY
Q8Z920_SALTI#29#174 YGNAGIA... .TMK...... .FN....... .KHSKEES.. .......FAY
Q5FA01_NEIG1#20#175       KPYFGARLSL N..R...... .ASAHLG.GS D....SFSKT SAG....LGV
Q3EI33_ACTSC#24#191       TPYLGARISA NHIK...... .VNSDFNNAS DYFHFSNSNT EFG....YGA
Q9RM69_ERWCA#29#207 YTRLGGMVWR VDTH...... .ADRSGNH.L NNDDTGVS.. .......PLA
Q8E832_SHEON#33#191 YVKVGGAGWF GDSE...... .GLRSG.... ..SERGFS.. .......PIV
Q5DYH6_VIBF1#21#185 YAKGGAAYNY LSVS...... .GNDNVHLGM FESDSSID.. .......DIW
O31154_VIBCH#24#173 YGKVGGAYVD YG........ .......... ..SKDDYS.. .......YLG
Q87JK1_VIBPA#26#179 FAKVGAAYMM AG........ .......... ..DEKDFV.. .......PTG
Q6PSK4_PASTR#28#221 YAKAGIALVN NSYK...... TVNVDTKVPT KTSRFQSS.. .......LIL
P96773_HAEDU#126#257 YGKVGMGLVR NDYKFILDLQ SKDQHVKDET KLHTLKPS.. .......LLL
Q3QLJ4_9GAMM#38#150 FAKVGVASMA VVVD...... ......YGPF DADYTGWG.. .......LTW
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Q3GMA6_9GAMM#36#179       KGKLGVARTE IEATG..... ...TSPAGFY NGSNKDTS.. .......LAG
Q3QBC3_9GAMM#28#162 YGRLGVAYWD MEKT...... .....HLSSD KLDATGLS.. .......PLG
Q44GL1_CHRSL#62#200 FAKAGMAKWE TDIDG..... ..NLGGASTD LEDNDGVD.. .......PVY
Q8XBY9_ECO57#13#177 AAGVIINPWG NMSVNVGYEG TKADIYG... .......... ..KHSVNGFT
Q7N5I2_PHOLL#43#182 GAGFIINPTT NTSITAGYEG SRFSIKDGNE K......... .DHLSTNGFN
Q57K85_SALCH#72#178       SAGVAYTPVS NVAITLGYEG ADFDATHNS. .......... .GSLNSNGFN
Q6D3I0_ERWCT#17#171 GAGVQFNPIQ DVALDVGYEQ SRIRS..... .......... ...VDVGAWA
Q9XD46_VITS1#32#191 GAGVQYNPAP NWSVDVGYES SRVNDGYDK. .......... ...RSMNAFN
Q66AL7_YERPS#27#179 GAGLQFNPVK HVAIDTAYEY AKIEDVKIG. .......... ...TWI....
Q8X428_ECO57#7#108 GAGVQFNPXE SVAIDIAYEG SGSGDWRTD. .......... ...GFI....
O33796_SALTY#23#153 GAGIQLNPVE NIAVNASYEH TSF....... .......... ..........
Q8ZQG1_SALTY#92#172 GAGVQINPVE NIAINASYEY SRFSAYDSK. .......... ...VNAGTWV
Q8Z920_SALTI#29#174 GAGVIFNPVK SISIDASWEA SRFFAVDTN. .......... ...TFG....
Q5FA01_NEIG1#20#175       LAGVSYAVTP NVDLDAGYRY NYVGKVNNVK .......... ..NVRSGELS
Q3EI33_ACTSC#24#191       IAGVSYNFAP QWDLNVAAEY NRLGEVRDVK .......... ..VNQYG.AK
Q9RM69_ERWCA#29#207 AIGIEYAIDK NWATRVDYQW VSNIGDA... .......GTV GARPDNMLMS
Q8E832_SHEON#33#191 AAGVEYAFTP RLSGRLEHQY TDSLG.A... .......DSI GYT.DHHLTT
Q5DYH6_VIBF1#21#185       EIGAEYALAP NWSLRFGTSI IDGIG..... .......NAK TGKSDLYFTS
O31154_VIBCH#24#173 AAGLEFNTNH NVTMRLEYQN LTDIN..... .......NDI VR.ARAETAT
Q87JK1_VIBPA#26#179       SLGAEYKINY NWSLRAEYQR YQDMS..... .......DDI VDDMDSDFFG
Q6PSK4_PASTR#28#221 GAGVEYAITP SLGARIEYQW LNNAGKASYA TLRRMGVEGS DYRPDISSVS
P96773_HAEDU#126#257 GTGVEYAITP ELALRTEYQY LNKAGNLYKA AKYKNISTSL AYAPDIHSVS
Q3QLJ4_9GAMM#38#150 GVGVNAALTE KLNLRLSY.. .......... .......... ..........
Q3GMA6_9GAMM#36#179 GVGLGYSVNP NFSVEAEYDK LG........ .......... ...SDADLMT
Q3QBC3_9GAMM#28#162       EVGVNYNFTP NVRLSAGYQY IDSIGESN.. .......... ..........
Q44GL1_CHRSL#62#200 GAGAQFNFKP .FLVRAEYER YDFDS..... .......... ..DYQIDSFT
Q8XBY9_ECO57#13#177 VGVGYRF... ..
Q7N5I2_PHOLL#43#182 ITVGYRF... ..
Q57K85_SALCH#72#178 LGVGYRF... ..
Q6D3I0_ERWCT#17#171 VGVGYRF... ..
Q9XD46_VITS1#32#191 VGVGYRF... ..
Q66AL7_YERPS#27#179 VGVGYRF... ..
Q8X428_ECO57#7#108 VGVGYKF... ..
O33796_SALTY#23#153       .......... ..
Q8ZQG1_SALTY#92#172 LGVGYSF... ..
Q8Z920_SALTI#29#174 VSVGYRF... ..
Q5FA01_NEIG1#20#175       AGVRVKF... ..
Q3EI33_ACTSC#24#191 VGVRYTF... ..
Q9RM69_ERWCA#29#207 VGLSYRFGQD D.
Q8E832_SHEON#33#191 LGLSWRFG.. ..
Q5DYH6_VIBF1#21#185 LGLTYKF... ..
O31154_VIBCH#24#173 LGIAYKFGGS E.
Q87JK1_VIBPA#26#179 IGFNYKFG.. ..
Q6PSK4_PASTR#28#221       AGLTYRFGQG AA
P96773_HAEDU#126#257 VGLSYRFGQG ..
Q3QLJ4_9GAMM#38#150       .......... ..
Q3GMA6_9GAMM#36#179 VGAQLKF... ..
Q3QBC3_9GAMM#28#162       .......... ..
Q44GL1_CHRSL#62#200       ASVGWQF... ..
Figure 3.4. Sequence alignment of <40 % identical known TM β -barrel proteins. This sequence alignment was
produced using ClustalW2 (Goujon et al., 2010, Larkin et al., 2007) from the list of proteins with a redundancy reduction of
40 %. There are a relatively large number of conserved residues (turquoise), which appear to be grouped together (~10 - 20
residues), and large stretches (> 20 residues) of highly variable regions. The conserved regions correspond to TM β -strands,
with the variable stretches being the loop regions. Highlighted in yellow (positive) and red (negative) are conserved charged
residues present within a β -strand.
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3.2 Profile hidden Markov model searches
Hidden Markov model (HMM) profile searching can be used either in place of or in
conjunction with traditional searches such as BLAST to identify homologous proteins. HMM
profile searches were initially applied to speech pattern recognition (Eddy, 1998), but have
since been developed to compare and contrast protein sequences from a multiple sequence
alignment (MSA) to either single sequences or other profile HMMs (Söding, 2005). MSAs of
a protein family highlight the most conserved residues and regions that are more likely to
contain mutations, insertions or deletions (Eddy, 1995, Eddy, 1998), therefore comparing
HMM profiles of MSAs are more likely to result in identification of protein homologues with
large sequence variability than BLAST searches, which compare one sequence directly with
another, affording equal weighting to each residue.
Hidden Markov modelling involves the production of a statistical model of protein structure
consensus (a profile) (Eddy, 1995, Eddy, 1996, Eddy, 1998). A HMM profile is a full
probabilistic primary model (Eddy, 2004) of the structure consisting of position-specific
residue scores modified depending on match, insertion and deletion states along each column
in the MSA (Eddy, 1996). The match state models the distribution of residues present in each
column, while the insert and delete states correspond to the position-specific probabilities for
transition from one state to another (Eddy, 1996); in other words the insertion or deletion of
one or multiple residues between that column and the next (Figure 3.5). Profile HMMs
therefore account for the conservation of residues along with the statistical potential for
variability or insertions/deletions (Eddy, 1996, Eddy, 1998). A HMM profile built from
homologous MSAs contains more information about the family of sequences than could be
obtained from a solitary sequence. Also included in the profile is the individual probability of
each residue being present at each insertion state (Eddy, 1998, Söding, 2005).
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Figure 3.5. A small HMM profile. A) a multiple sequence alignment (MSA), B) Consensus sequence derived from A, C) a
representation of the HMM. The HMM (C) is representative of the small MSA (A). The MSA consists of five sequences,
showing only the first three residues. The HMM has a beginning and an end (‘b’ and ‘e’ respectively). The distribution of
residues in each column in the MSA is modelled by a match state (m1 to m3) in the HMM. The match state has 20 residue
emission probabilities (the black bars above the match state), as does each insert state (i0 to i3). The insertion state takes into
account the insertion of one or multiple residues between columns. The delete states have no inherent emission probabilities
and allow for deletion of the next consensus residue ‘expected’ from the MSA. Arrows represent state transition
probabilities. Image adapted from (Eddy, 1998, Eddy, 1995).
Proteome searching using HMM profiles, like BLAST searches produces an output with two
important values; score and E-value. The score is a measure of the match of a given protein
sequence to the HMM profile, the higher the score the better the match (Eddy, 2010). The E-
value (expectation value) is a measure of the statistical significance of the calculated score of
the match to the sequence (Eddy, 2003, Eddy, 2010). The lower the E-value the greater the
significance of the match. The E-value is related to the number of sequences in the database
being searched and can be interpreted as the expected number of false positives expected to
have that score within the search database (assuming that the sequences are random and non-
homologous) (Eddy, 2010), therefore identical sequences in databases of different size would
have different E-values.
HMMER v2.3.2 was used to build and calibrate HMM profiles of each of the MSAs created
previously (Section 3.1). These profiles were visualised using the online server LogoMat-M
(Schuster-Boeckler et al., 2004) to provide an visual representation of conserved residues
(Figure 3.6).
A C
B 1 2 3
C - FY
1 2 3
C  A  F
C  G  W
C  D  Y
C  V  F
C  K  Y
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Figure 3.6. HMM logo of known TM B-barrel protein sequences with a 40 % redundancy reduction. Image generated
using LogoMat-M (Schuster-Boeckler et al., 2004) and the HMM profile generated from the MSA of 40 % reduced OmpA-
like proteins (Figure 3.4) using HMMER 3.0. The total height of the stack of letters at each position shows the amount of
information, while the relative height of each letter shows the relative abundance of the corresponding amino acid. The
width of the column indicates the relative contribution of the position to the overall protein family (Eddy, 2010). In this case
the narrow columns give evidence for a loop region. Pink columns represent insert state - there is likely to be an insertion of
one or more residues between the two positions either side. There are a number of highly conserved tyrosine and
phenylalanine residues corresponding to the interface between lipid and water, in addition there are several conserved
glycines that are likely to be in the inside of the barrel. There also appears to be a large number of highly variable regions
consistent with being loop regions.
Page | 108
The HMM profiles were then used to search the proteomes of B. afzelii, B. burgdorferi s.s.
and B. garinii for OmpA-like protein homologues, again using HMMER v2.3.2. All HMM
searching was carried out using the eridani cluster at the High Performance Computing
(HPC) at the University of Huddersfield. Results obtained from searching HMMs of known
OmpA-like proteins from each proteome are below (Table 3.2). Proteomes were obtained
from the UniProtKB database (Magrane and Consortium, 2011) and are composed of the
following numbers of proteins: B. afzelii (PKo); 1,695 proteins, B. burgdorferi s.s. (ZS7);
1,223 proteins, B. garinii (PBi); 1,262 proteins.
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Table 3.2. HMM profile search results of Borrelial proteomes. Highlighted in green are the putative proteins with approximately the expected sequence length and molecular weight of
OmpA-like proteins. Reference numbers are taken from the online database BioCyc. All proteins highlighted in the table have a negative score, which is an indication of a sequence that is a
poor match to the profile. Each of the highlighted proteins (with the exception of BAPKO_0026) has an E-value of above 1, which would suggest that the result could be a false positive,
however as stated previously the E-value is subject to the size of database being searched (in this case the proteomes being searched each contain over 1,000 proteins), hence a score of 1
would suggest that out of 1,000 sequences, 1 could match that score by chance. The low scores and relatively good E-values (<10) indicate that the sequences identified are homologous to
the family modelled by the HMM, but not within the family itself, in this case the proteins would be OmpA-like rather than an OmpA, W or X (Eddy, 2003).
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The UniProtKB database was used to assign putative functions to all proteins identified by
HMM searches (Table 3.2). Several proteins are unlikely to be OM-spanning proteins based
on homology to proteins of known function and/or molecular weights considered to be larger
than would be predicted for an eight-stranded membrane spanning β -barrel protein. However
eight proteins have molecular weights comparable to E. coli OmpW/X and are potential
candidates to be OmpA-like. BLAST searches of these candidates showed that BAPKO_6013
is homologous to a VlsE protein and BAPKO_3514 is homologous to a plasmid-encoded
Type I restriction enzyme R and so both are unlikely to be OmpA-like proteins. The other
proteins had no identifiable homologues and are potential candidates to be Borrelial OmpA-
like proteins.
Orthologues in each of the three main Borrelia species were identified using a multi-genome
browser (BioCyc) and the accession numbers displayed below (Table 3.3).
B. afzelii B. burgdorferi s.s B. garinii
BAPKO_0026 BB_0027 BG0027
BAPKO_0387 BB_0378 BG0377
BAPKO_0422 BB_0405 BG0407
BAPKO_0571 BB_0543 BG0553
BAPKO_0423 BB_0406 BG0408
Table 3.3. Summary of potential OmpA-like proteins identified in Borrelia. Putative proteins identified through HMM
searches and manual inspection. BAPKO_3514 and its homologues are not included as this was found to be a type I
restriction enzyme in the UniProtKB database (Magrane and Consortium, 2011). Proteins are identified by the locus name.
Orthologues retrieved from the BioCyc database from proteomes of B. afzelii (PKo), B. burgdorferi s.s. (Zs7) and B. garinii
(PBi) (Caspi et al., 2010). BAPKO_0423, BB_0406 and BG0408 are paralogues of BAPKO_0422, BB_0405 and BG0407,
likely the result of a gene duplication event. These proteins were identified using the genome browser on the BioCyc
webserver (Caspi et al., 2010).
Because of the remote homology and high sequence divergence of OmpA proteins (Schulz,
2000) a high number of false positives is expected, therefore fold prediction algorithms
(FFAS03) and other prediction tools were used to corroborate the results (Section 3.3).
3.3 Topology predictions
Topology predictions were carried out on putative OM spanning β -barrel proteins identified
by HMM searches and genome browsing (Table 3.3) using the online Function & Fold
Assignment (FFAS03) server (Jaroszewski et al., 2005) and transmembrane β -barrel
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prediction server PRED-TMBB (Bagos et al., 2004), along with analysis of the signal
peptide.
3.3.1 FFAS03 assessment
FFAS is a profile-profile and fold recognition algorithm that is capable of identifying
conserved residues and applying this to the detection of remote homologues. A target
sequence (in this case potential TM β -barrel protein) is used to create a profile which is used
to search several protein and domain databases (in this case PDB0113) (Jaroszewski et al.,
2005). Each hit identified in Table 3.3 was searched using FFAS03 to identify remote
homologues. The lower the score reported, the greater the confidence in the result; scores of
lower than -9.5 contain have less than a 3 % chance to be a false positive result (Jaroszewski
et al., 2005). Included (Table 3.4) is an example of results from an FFAS03 search of
BG0407.
# Score Template % ID
1 -9.970 2x27_X OUTER MEMBRANE PROTEIN OPRG 10
2 -9.820 2k0l_A Outer membrane protein A 13
3 -9.250 2f1t_A Outer membrane protein W 9
4 -8.920 1p4t_A outer membrane protein NspA 11
5 -8.010 2lhf_A Outer membrane protein H1 14
6 -7.660 2ge4_A Outer membrane protein A 13
7 -7.560 2jmm_A Outer membrane protein A 17
8 -6.880 1bxw_A PROTEIN (OUTER MEMBRANE PROTEIN A) 13
9 -6.460 2o6l_A UDP-glucuronosyltransferase 2B7 11
10 -6.390 1orm_A Outer membrane protein X 11
Table 3.4. FFAS03 results from BG0407. A score more negative than -9.5 signifies a good result (less than 3 % chance of
being a false positive). The top hits all have very low % sequence identity to BG0407. Nine of the top ten hits are OM
proteins, and the top two hits have a score below -9.5, showing with high probability that BG0407 is highly likely to be an
OM protein. Of interest are the third and eighth hits 2F1T and 1BXW; OmpW and OmpA from E. coli respectively.
FFAS03 analysis was carried out on all proteins in Table 3.3 and the results summarised in
Table 3.5.
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Locus Best score Locus Best score Locus Best score
BAPKO_0026 -36.20 BB_0027 -47.90 BG0027 -40.60
BAPKO_0387 -7.71 BB_0378 -8.72 BG0377 -8.93
BAPKO_0422 -8.94 BB_0405 -10.10 BG0407 -9.97
BAPKO_0423 -9.54 BB_0406 -11.80 BG0408 -12.30
BAPKO_0571 -7.060 BB_0543 -7.33 BG0553 -9.72
Table 3.5. Summary of FFAS03 results. Unless stated the top hit was either an OmpA or OmpW protein and scores more
significant than the -9.5 cut-off are highlighted in bold. BAPKO_0026 and homologues had top hits with very negative
scores, this suggests that they are highly likely to be OmpA-like proteins. Six of the top ten hits for BB_0378 were RNA
polymerase II proteins and only two of the top ten hits for BAPKO_0387 were OM proteins. The high scores suggest that
there is a greater than 3 % chance that the results are false positives, although the abundance of RNA polymerase II proteins
in the top 10 results provides evidence that BAPKO_0387, BB_0378 and BG0377 are not related to the OmpA family. The
top hit for both BB_0543 and BG0553 was OmpX (one with a significant score, one with an insignificant score), however
the vast majority of the rest of the hits were not OmpA-like proteins, and only one of the top ten hits for BAPKO_0571 was
an OmpA-like protein. This provides evidence for these proteins not being related to the family of OmpA-like proteins.
From FFAS03 analysis it appears that BAPKO_0387, BB_0378, BG0377, BAPKO_0571,
BB_0543 and BG0533 were not OmpA-like TM β -barrel proteins. Further analysis was
carried out using signal peptide and TM β -strand prediction.
3.3.2 Signal peptide analysis
Signal peptides are present at the N-terminus of proteins that are functional at specific sites
throughout the cell; the signal peptide facilitates translocation of the protein to its correct
environment, e.g. the outer membrane of a bacteria (Pugsley, 1993) through various
pathways. Each location around the cell has a different signal peptide, enabling recognition of
the proteins function and required location (Pugsley, 1993). The standard signal peptide
consists of three regions, N, H and C (Figure 3.7). The N region contains one or more
positively charged residues, including one or more Lys or Arg and is between two and fifteen
amino-acids in length. This is followed by a hydrophobic ‘H’ region with a high Aln/Leu
content, but no charged residues (Arg, His, Lys, Asp or Glu) and no Pro. This region is
generally greater than eight residues in length. The final region, designated as ‘C’ consists of
residues that are less hydrophobic, and contains signals that are recognised by signal
peptidases (LepA or LepB) (Figure 3.7).
Residues around the cleavage site are numbered according to position; with the cleavage site
as the starting point and numbering outwards residues towards the N terminus of the protein
are negative and positive towards the C terminus. Also visible is the ‘A-A’ box, present at the
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-1 to -3 positions on the amino-acid chain (Nielsen et al., 1997). This is a common
arrangement of residues in signal sequences in Gram-negative bacteria. The Aln residues may
also be Gly or Ser and are considered important for the proper functioning of cleavage
(Pugsley, 1993).
Figure 3.7. Signal peptidases found in Gram-negative bacteria. A typical arrangement of primary features of the signal
peptide located at the N-terminus of a protein sequence. Dark blue coloured circles represent polar and charged residues,
green circles represent hydrophobic residues. The N-region varies in size between 2 and 15 residues and has a net positive
charge. The H-region is longer than 8 residues and generally does not contain any of the following residues P, K, R, D, E or
H, but is usually alanine or leucine rich (Nielsen et al., 1997). The C-region is shorter and less hydrophobic than the H-
region. The A-A box (highlighted in red) is an important indicator of bacterial signal peptides (Nielsen et al., 1997).
Diagram adapted from (Pugsley, 1993). The boxed sequence displays the signal peptide from E. coli OmpA; L-R N-region
(blue), H-region (green), C-region (blue) and the lipid box (red).
SignalP 4.1 (Petersen et al., 2011) was used to predict the presence of signal peptides and the
cleavage site of signal peptidases in putative Borrelial TM proteins (Table 3.3). E. coli OM
proteins were used as positive controls. SignalP is designed to distinguish between signal
sequences and α-helical transmembrane regions using two artificial neural networks, each
‘grown’ with the use of a different data set. Sequences containing transmembrane regions
within the first seventy residues were used to train the SignalP-TM network, while the
SignalP-noTM data set was trained without those sequences, instead using sequences of
cytoplasmic and nuclear proteins (Petersen et al., 2011). The network SignalP-noTM was
used for prediction of signal peptides in the putative OmpA-like proteins. The option was
present to select the type of bacteria (Gram-negative or positive) from which the sequences
originate. As Spirochaetes are more closely related to Gram-negative bacteria than Gram-
positive, this option was selected. The results of SignalP analysis along with positive controls
(the N-terminal domain of E. coli OmpA in addition to OmpW and OmpX were submitted as
positive controls) are displayed in Figure 3.8.
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Figure 3.8. SignalP 4.1 prediction of OmpA-like protein signal sequences. A) 1BXW, B) BB_0027, C) BAPKO_0387,
D) BAPKO_0422, E) BG0408, F) BG0553. The graphical output of one of each protein homologues is included. Images
generated by SignalP4.1 (Petersen et al., 2011). The higher the c-score (red lines), the more greater the likelihood of a
cleavage site at that position, the s-score (green line) represents the probability of the residue being part of the signal
sequence. The y-score (blue line) is a combination of c-score and slope of s-score and is used to predict the cleavage site
more accurately than the c-score alone (Petersen et al., 2011).
SignalP analysis found that BAPKO_0387 and BB_0378 are unlikely to contain signal
peptides as the H-region is not A/L rich, and there is no ‘A-A’ box (Figure 3.8 C). This
concurs with FFAS03 assessment that these are not TM β -barrel proteins. In addition,
C D
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BAPKO_0026 and BG0027 were also predicted to not contain signal peptides by SignalP
(Table 3.6).
3.3.3 β -barrel prediction
The amino-acid sequences of putative OmpA-like proteins identified by HMM searches were
input into the webserver PRED-TMBB (Bagos et al., 2004), which uses a HMM based
method for predicting transmembrane β -barrels in proteins (Figure 3.9). The N-terminal
domain of E. coli OmpA in addition to OmpW and OmpX were submitted as positive
controls.
Figure 3.9. TM β -barrel predictions of OmpA-like proteins. A) 1BXW, B) BB_0027, C) BAPKO_0387, D)
BAPKO_0422, E) BG0408, F) BG0553. Data produced using the web-based server PRED-TMBB (Bagos et al., 2004) using
FASTA sequences with (the signal sequence as predicted by SignalP 4.1 has been removed) obtained from the RCSB PDB
and BioCyc (Caspi et al., 2010). Red signifies a predicted TM β -strand, blue an extracellular loop and green a periplasmic
turn. The score (from 0 to 1) relates to the probability of the region being membrane spanning. Most proteins were predicted
to contain eight TM β -strands, however BAPKO_0571, BG0553 and BG0377 were predicted to have ten β -strands and
BG0027 to have nine.
The results of analysis by PRED-TMBB suggest that all proteins submitted are likely to be
membrane-spanning β -barrel proteins containing between eight and ten strands. BG0027 is
predicted to have nine membrane-spanning β -strands, which is unlikely as there are currently
no known OM-spanning β -barrel proteins with an odd number of strands. It is a possibility
that BAPKO_0571, BG0553 and BG0337 and BG0027 have ten TM β -strands similar to the
E. coli protein OmpT (Vandeputte-Rutten et al., 2001).
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3.3.4 Summary
Table 3.6 summarises the predictions from SignalP4.1 and PRED-TMBB
SignalP 4.1 PRED-TMBB
Protein Position D-score Signal Peptide? Score Β -Barrel?
1BXW 1-21 0.906 YES 2.858 YES
2F1T 1-21 0.873 YES 2.902 YES
1QJ8 1-23 0.863 YES 2.816 YES
BAPKO_0026 1-24 0.504 NO 2.874 YES
BB_0027 1-23 0.863 YES 2.888 YES
BG0027 1-24 0.539 NO 2.876 YES
BAPKO_0387 1-20 0.467 NO 2.876 YES
BB_0378 1-20 0.544 NO 2.913 YES
BG0377 1-19 0.574 YES 2.908 YES
BAPKO_0422 1-19 0.742 YES 2.938 YES
BB_0405 1-18 0.727 YES 2.947 YES
BG0407 1-19 0.743 YES 2.938 YES
BAPKO_0423 1-23 0.752 YES 2.988 NO
BB_0406 1-23 0.819 YES 2.991 NO
BG0408 1-23 0.803 YES 2.989 NO
BAPKO_0571 1-19 0.681 YES 2.887 YES
BB_0543 1-21 0.821 YES 2.860 YES
BG0553 1-19 0.662 YES 2.912 YES
Table 3.6. Results of SignalP 4.0 and PRED-TMBB analysis. Three known proteins from E. coli are included for
comparison. The position is the predicted position for the signal peptide. D-score is a weighted mean of the averaged S and
maximum Y scores and is the distinguishing factor between signal and non-signal peptides, the cutoff for which was 0.570;
scores above indicate a signal peptide (Petersen et al., 2011). From the results obtained it was apparent that the majority of
sequences contained a signal peptide. Scores are the discrimination score reported by PRED-TMBB. The threshold for the
score is 2.965 and any proteins with a score lower than this are likely to be TM β -barrels (reported as YES). All proteins
with the exceptions of BB_0406 and BG0408 were within this score and are therefore considered highly likely to be TM β -
barrel proteins.
BAPKO_0387, BB_0378 and BG0377 were discounted as potential OmpA-like proteins due
to the FFAS03 prediction that they are homologous to RNA polymerase II, and the predicted
absence of signal sequence indicative of cytoplasmic proteins (Figure 3.8 C). Putative
OmpA-like proteins identified are identified below (Table 3.7).
B. afzelii B. burgdorferi s.s B. garinii
BAPKO_0026 BB_0027 BG0027
BAPKO_0422 BB_0405 BG0407
BAPKO_0423 BB_0406 BG0408
BAPKO_0571 BB_0543 BG0553
Table 3.7. Putative small TM β -barrel proteins in Borrelia. These proteins were those identified as likely to be small TM
β -barrel proteins through the combined use of HMM profiling, FFAS03 assessment, SignalP analysis, and TMBB prediction.
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A sequence alignment of putative Borrelial TM β -barrel proteins (Table 3.7) was created
(Figure 3.10) with the structural features predicted by SignalP 4.1 and PRED-TMBB
highlighted. The signal peptide is highlighted gray, the periplasmic turns are green, TM β -
strands are red and extracellular loop regions are blue.
BAPKO_0026 MKKYLFITLIAILLIGVNIKKIEAAV-IDRHTNSTLGIDLSVGIPIFYNDLSKAYPTNLYPGGIGAIKYQYHILNNLAIGLELRYM
BG0027 MKKYFFITLIAVLLIGVNIKKIEAAVNIDRHTNSTLGIDLSVGVPIFYNDLSRAYPTNLYPGGIGAIKYQYHILNNLAIGLELRYM
BB_0027 MRKYIFIILIAVLLIGVNIKKIAAAANIDRHTNSTLGIDLSVGIPIFYNDLSKAYPTNLYPGGIGAIKYQYHILNNLAIGLELRYM
*:**:** ***:********** **. ****************:********:*********************************
BAPKO_0026 FNFDINHSFNILNPDSSVGKIFYSVPITFSINYIFDIGELFQIPVFTNVGFSLNTYGDRNNNITNLRTFDALPTISFGSGILWNFN
BG0027 FNFDINHSFNILNPDSSVGKIFYSVPITFSINYIFDVGELFQIPVFTNIGFSLNTYGDRNNNITNLRTFDALPTIAFGSGILWNFN
BB_0027 FNFDINHSFNILNPDSSVGKIFYSVPITFSINYIFDIGELFQIPVFTNIGFSLNTYGDRNNNITNLRTFDALPTISFGSGILWNFN
************************************:***********:**************************:**********
BAPKO_0026 YKWSFGATTSWWMMFEFGNSAKMAHFAIVSLSVTVNVNKL
BG0027 YKWSFGATTSWWMMFEFGNSAKMAHFALISLSVTVNVNKL
BB_0027 YKWAFGATASWWMMFEFGNSAKMAHFALVSLSVTVNVNKL
***:****:******************::***********
BAPKO_0423 MIKNFKKIHILTLVLGVMHFSFASDNYMVRCSKEEDSTTCIAKLKGIKEKKSYDLFSMGIGIGNPIANIIVTIPYVNID------F
BG0408 MIKNFKKMHILILVLGVAHLSFASDNYMVRCSKEEDSTTCIAKLKGIKEKKSYDLFSMGIGIGNPIANIIITIPYVNID------F
BB_0406 MIKIFKKIYILTLVLGMAHLSFASDNYMVRCSKEEDSTTCIAKLKEIKEKKNYDLFSMGIGIGDPIANIMITIPYINID------F
BB_0405 -MRMLLATIILILTTGLLAAQSKSK------SMTEDDFDFDKLLA--KEESVRRLFGIGFGVGYPLANITISVPYVDID------L
BG0407 -MRMLLATIILILTTGLLTAQSKSK------SMVEDDFDFEKLLA--KEESVRRLFGIGFGVGYPLTNITISVPYVDID------L
BAPKO_0422 -MRMLLATIILILTTGLLTAQSKSK------TMVEDDFDFEKLLE--KEESVRRLFGIGFGIGYPLTNIIISVPYVDID------L
BAPKO_0571 MMRLKVLILCLFGIFVVNGFTNTNFEFNFGGGVAFPVNPFSSFYNEALEINAKLKQDLPSNS-SPIEKEEIVQKFSDLANIAKAGL
BB_0543 MIRLKVLILCLFGIFVLNGFADTNFEFNFGGGVAFPVSPFSSFYNEALEINAKLKQNLPSDL-SPIEKEEIVQNFSDLANIAKAGI
BG0553 MMRLKVLILCLFGIFVVNGFTDTNFEFNFGGGVAFPVNPFSSFYNEALEINAKLKQNLPSDL-SPMKKEDIAQKFSDLANISKSGL
::       *     :      .                        * .     .:  .   *: :  :   : ::       :
BAPKO_0423 GYGGFIGLKSNNFENYLNGGIDIIFKKQIGQYMRIGGGIGIGADWSKTSLIPPDEEEET-----------DYERIGAVIRIPFVME
BG0408 GYGGFIGPKSNNFENYLNGGIDIIFKKQIGQYMRIGGGIGIGADWSKTSLMPPDEEEET-----------DYERIGAVIRIPFVME
BB_0406 GYGGFIGLKSNNFENYLNGGIDVIFKKQIGQYMKIGGGIGIGADWSKTSLIPPNEEEET-----------DYERIGAVIRIPFIME
BB_0405 GYGGFVGLKPNNFLPYVVMGVDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNEKLEEEEENEAQQVASLQNRIGVVIRLPLVIE
BG0407 GYGGFVGLKPNNFMPYVAAGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNEKLEEEEENEAQQVNSLQNRIGIVIRLPLVIE
BAPKO_0422 GYGGFVGLKPNNFMPYVVMGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEG-DVNEDQQT-SLENRIGVVIRLPLVIE
BAPKO_0571 KYGTYAQFG-AKFDDFVSVGFELLFDMNLFKVIKRSDGTAN-ENFSFVMAITPRFYTKLD-----FFVLALAFFTGPKINIATSAA
BB_0543 RYGTYAQFG-AKFDDFVSIGFELLFNINLLKAIKRSDGTAN-ENFSFIMAITPRFYTKLD-----FFVLALAFFTGPKINIATSSA
BG0553 RYGTYAQFG-AKFDDFVSIGCELMFDINLFKVIKRSDGTAN-ENFSFVMAITPRFYTKLD-----FFVLALAFFTGPKINIATAAA
** :      :*  ::  * :::*. :: : ..* .   ::*      .    :                 *  *.:.
BAPKO_0423 YNFAKNL-YIGFKIYPALGPTILLTKPSILFEGIKFNFFGFGF-IKFAFN--
BG0408 YNFAKNL-YIGFKVYPALGPTILLTKPNILFEGIKFNFFGFGF-IKFAFN--
BB_0406 YNFAKNL-SIGFKIYPAVGPTILLTKPSILFEGIKFNFFGFGF-IKFAFN--
BB_0405 YSFLKNI-VIGFKAVATIGTTMLLGSP-MSFEGARFNFLGTGF-IKIYI---
BG0407 YSFLKNI-VIGFKAVATIGTTMLLGGP-MSFEGARFNFLGTGF-IKIYI---
BAPKO_0422 YSFLKNI-VIGFKAVATIGTTMLFGNP-MSFEGARFNFLGTGF-IKIYI---
BAPKO_0571 DSVLAELGTMGWDIGARISFSFLILEGYYVWNIHNAKFSDFKFGIGFEFGIV
BB_0543 DSVLAELGTMGWDIGARLSFSFLILEGYYVWNIKNPKFSDFKFGIGFEFGIV
BG0553 DSVLAEMGTMGWDIGARLSFSFLILEGYYVWNIQNFKFSDFKFGIGFEFGIV
..  :: :*:.  . :. ::*:      ::  . :* .  * * : :
Figure 3.10. Summary of topology prediction. The sequences for four protein orthologues have been aligned using
ClustalW2 (Larkin et al., 2007). The signal sequence has been highlighted where there was predicted to be one (SignalP 4.1
(Petersen et al., 2011) and the sequence coloured to match the PRED-TMBB predictions (Bagos et al., 2004).
BAPKO_0026, BB_0027 and BG0027 have been aligned separately as the sequence appears to differ more than the others. *
= a single fully conserved residue, : = conservation of strongly similar residues, . = conservation of weakly similar residues.
Signal peptide
Signal peptide
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The sequence alignment of putative Borrelial OmpA-like proteins (Figure 3.10) was used to
produce a HMM profile and HMM logo (Figure 3.11) for easy visualisation of residue
conservation. There are a number of highly conserved aromatic residues which indicate the
positions of the aromatic girdle. Towards the end of the HMM logo there are five tyrosine
residues in quick succession, suggesting either mis-alignment of the sequences or a region
rich in tyrosines. One proline residue is conserved almost entirely throughout the alignment,
which is likely to be part of a periplasmic turn. As with the HMM logo of known OmpA-like
proteins (Figure 3.6) there is a large number of conserved alternating glycine residues and
long stretches of variable sequence, which again is indicative of the presence of TM β -strands
and variable extracellular loops. Unlike the known TM β -barrel protein HMM logo (Figure
3.6) there is considerable conservation of several isoleucine and leucine residues, mainly
towards the start of the sequence and a number of conserved phenylalanine residues near the
C-terminus.
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Figure 3.11. HMM logo of putative Borrelial OmpA-like proteins. Generated using LogoMat-M from a sequence
alignment of identified putative Borrelial OmpA-like proteins (Figure 3.10). There are a number of highly conserved
aromatic residues representing the aromatic girdle, in addition to stretches of alternating glycine residues characteristic of a
T β -strand and large variable stretches of residues indicative of extracellular loop regions.
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3.4 Homology modelling of OmpA-like proteins
BAPKO_0422 was modelled using the structures of the β -barrel domain of OmpA, OmpW
and OmpX from E. coli as a template. The TM spanning regions from each of these proteins
were identified along with the predicted TM regions of BAPKO_0422 (PRED-TMBB) and
aligned so that these regions matched as closely as possible. The loop regions of TM β -barrel
proteins are highly variable both in length and sequence; thereby preventing meaningful
sequence alignment. The TM spanning regions however are more consistent; being of
comparable length, containing alternating hydrophobic and small side-chained residues and
flanked by residues with bulky side-chains. These factors make for more readily identifiable
regions and accurate alignments.
Using the sequence alignments (
Figure 3.12) models of BAPKO_0422 were generated (Figure 3.13) using each of the three E.
coli proteins as templates using Modeller v9.11 (Šali and Blundell, 1993).
>1BXW -APKDNTWYTGAKLGWSQYHDTGLINNNGPTHENKLGAGAFGGYQVNPYVG--FEMGYDWLGRMPYKGSVENGAY
>0422 --QSKSKTMVEDDFDFEKLLEK---EESVR-----RLFGIGFGIGY-PLTNIIISVPYVDIDLGYGGFVGLKPNN
>1BXW KAQGVQLTAKLGY-P-I-T-D-D-LDIYTRLGGMVWRAD-TYSNVYGKNHDTGVSPV-FAGGVEYA-I-T-P-EI
>0422 FMPYVVMGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSF
>1BXW ATRLEYQWTNN-IG-DAH-TIGT-RP-DNG--MLSLGVSYRFG
>0422 LKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI
>2F1T -EAGEFFMRAGSATVRPTEGGGFSVTNNTQLGLTFTYMATDNIGVELLAATPFRHKIGTRATGDIATVHHLPPT
>0422 QSKSKTMVEDDFDFEKLLEK-EESVRRLFGIGFGIGY--P-LTNIIISVPYVDIDLGYGGFVGLKPNNFMPYVV
>2F1T LMAQWYFGD-AS-SK-FRPYVGAGINYTTFFDNGFNDHGKEAGLSDLSLKDSWGAAGQVGVDY-LINR-DWLVN
>0422 MGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGD-VNEDQQ-TSLENRIGVVIRLPLVIEYSFLKN
>2F1T MSVWYMDID-TTANYKLGGAQQHDSVRLDPWVFMFSAGYRFH
>0422 IVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI--
>1QJ8 -----ATSTVTGGYAQSDAQGQ-MNKMGGFNLKYRYEEDNSPLGVIGSFTYTEKSRTASSGDY--NKNQYYGITA
>0422 QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGY-PLTN-IIISVPYVDIDLGYGGFVGLKPNNFMPYVVMGI
>1QJ8 GPAY-R-I-N-D-WA-SIYGVVGV-GYGK-FQTTEYPTYKNDT-SDYGFS---YGAGLQFNPMENVALDFSY---
>0422 DLLF--KDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSFLKNIVIG
>1QJ8 ----E-Q-S-R-I-R-S-V-D--VGTWIAGVGYRF-*
>0422 FKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI*
Figure 3.12. Sequence alignments of BAPKO_0422 with known E. coli OM-spanning proteins. Known TM spanning β -
sheets are highlighted (green for OmpA, purple for OmpW and blue for OmpX) and predicted TM spanning β -sheets are
highlighted red (BAPKO_0422). These sequence alignments were used to generate homology models. Alignments in the .pir
format used by modeller are included in appendix 8.2.
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The models produced using 1BWX and 2F1T as templates have longer periplasmic turns than
expected compared to the known structures. Neither model shows the ‘gating’ residues
present in OmpA (Smith et al., 2007) and OmpW (Hong et al., 2006) from E. coli (described
in sections 1.5.1 and 1.5.2 respectively). The model based on 1QJ8 has a loop protruding
from one of the strands and a long flexible region which would extend into the periplasm; in
addition the loops are rather large, which provided evidence for BAPKO_0422 not being an
OmpX-type protein, or the sequence alignment could be in error. The down-the-barrel view
of the H-bonding networks in models produced from 1BWX and 2F1T show minimal
interactions. The H-bonding network in known OM-spanning proteins (Figure 1.29) is
significantly more extensive than in the models. This may be due to the template having a
different shear number to the Borrelial protein, meaning the barrels may actually be more
compact than predicted in Figure 3.13.
3.5 Discussion
The overall sequence identity between E. coli OmpA/X and the Borrelial OmpA-like proteins
identified in this study is very low (between 9-13%, Table 3.4), considered to be in the
twilight zone (Rost, 1999). It is a general rule that for β -barrel formation, at least four of the
five residues forming a β -sheet with the side chains oriented towards the membrane must be
hydrophobic, with none of the three central residues charged, and that residues with side
chains on the inside of the barrel must have small side chains (Koebnik, 1999). The sequence
alignment (Figure 3.4) of known OmpA (TM domains) and OmpX proteins shows high levels
of conservation of alternating hydrophobic and small side-chained residues at regions thought
to be membrane spanning; in particular glycines conserved with the side-chains protruding
inwards from the barrel and aromatic residues (particularly tyrosine) at either end on the TM
spanning domain that form the aromatic girdle. The conservation of residues is highlighted by
the HMM-profile logo (Figure 3.6) where six tyrosines and several phenylalanines are visible
as being highly conserved; these residues are likely to form the aromatic girdle surrounding
the hydrophobic TM region. This conservation highlights the fact that the β -strands are
important to the structure and orientation of the protein in the membrane. The sequence
alignment and HMM-profile logo show that there are some exceptions to this rule as a
glutamic acid residue appears to be present in the centre of one of the strands.
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The final two β -strands appear to be particularly well conserved, in particular the final three
C-terminal residues: tyrosine, a positive residue (most likely arginine but potentially lysine)
and phenylalanine, which are prominent in the HMM-profile logo (Figure 3.6). This
combination of two aromatic and one positively charged residue forms the final three
residues of a consensus sequence common to bacterial OM proteins identified by (Vogt and
Schulz, 1999) - X-Z-X-Z-X-Z-X-Tyr-X-Phe (where X is any amino acid and Z is a nonpolar
residue), which may be important for folding and insertion into the OM (Vogt and Schulz,
1999). Alternatively these residues may play a role in attachment and / or orientation of the
N-terminal domain of OmpA. It is worth noting that the Borrelial proteins predicted to be
OmpA-like do not have a conserved Y-K/R-F region at the C-terminus, suggesting that either
the Y-K/R-F motif is not required in Borrelia or that these proteins are not β -barrels.
In contrast to the conserved OM spanning regions, sequences of the loop regions of known
OmpA-like proteins shows great variability in length and minimal conservation, in agreement
with one of the 10 principles of β -barrel building (Schulz, 2000); this indicates that the loop
regions are not as important to the overall structure of the protein as the TM β -strands are,
and suggests that either they are not as important to the function of the protein, or that the
proteins have slightly varying functions.
HMM searches are more sensitive than BLAST searches for distant homologues, but as a
result produce more false positives, which requires further refinement of the results. For
production of the HMM profiles, 23 and 68 sequences (from the 40 % and 90 % redundancy
reductions respectively) were automatically aligned (ClustalW2). This automatic alignment
does not take into account structural information such as membrane-spanning regions or
turns/loops. Therefore key positions such as the aromatic girdle and alternating aliphatic
residues may be misaligned; small errors in sequence alignment have a significant
detrimental effect to the HMM profile, hence the very low scores obtained.
From the FFAS03 search results (Table 3.5) of putative Borrelial OmpA-like proteins several
matches were obtained, each of which had a very low sequence identity (9 - 13 %) to known
OmpA-like proteins. However this is comparable to the low sequence identity between E.
coli and Borrelial BamA which are expected to have closely related structures and
homologous functions. It is a possibility that both Borrelia and E. coli have these 8-stranded
OM-spanning proteins because of their shared ancestry, or it could be that both bacterial
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species have happened upon the same solution by convergent evolution. The conservation of
a recognisable BamA export machinery may suggest conservation by shared ancestry. This
would suggest that the 8-stranded OmpA-like proteins identified may have existed in an
ancient common ancestor shared between Borrelia and Gram-negative bacteria. The low
sequence identity also provides an explanation for the lack of hits obtained by BLAST
searching using E. coli OmpA as a target.
Five proteins identified by HMM searches had a top FFAS hit with the score less significant
than the cutoff value, meaning that there was a higher than 3 % chance of false results (Table
3.5); for BAPKO_0387, BB_0378 and BG0377 the FFAS scores for the top ten hits were all
insignificant, and six of these were an RNA polymerase II protein; meaning it highly likely
that these proteins were not OmpA-like. The two homologues to BAPKO_0422 both scored
lower than the cutoff and all three had top hits of OmpA-like proteins, BAPKO_0571 and
BB_0543 had top hits of OmpX (though less significant than the score of -9.75) and a
mixture of hits for the rest of the top ten. BAPKO_0026, BB_0027 and BG0027 each had
scores 3-4 times more significant than the cutoff value, representing a high probability that
the OmpA-like protein matches found were accurate. These proteins appeared highly likely to
be OmpA-like proteins in addition to BAPKO_0423, BB_0405, BB_0406, BG0407 and
BG0408 (all with scores more significant than the cutoff).
Analysis of the putative OmpA-like proteins for a signal sequence revealed that four proteins
were predicted to not have signal peptides, compared to eleven that were. It is worth noting
that the network trained to determine signal peptides and cleavage point is designed for
Gram-negative bacteria. Spirochaetes have a double membrane morphology reminiscent of
Gram-negative bacteria, however there are several important differences in the structure and
chemical composition of the Borrelial membrane, for example Borrelia do not express LPS
and are known to contain lipid rafts. Although the SecA-dependant secretory pathway is
highly conserved among Gram-negative bacteria and Spirochaetes, it remains a possibility
that some sequence divergence many have occurred in Borrelia reducing the efficiency of
prediction algorithms such as SignalP, which explains why not all signal sequences are
predicted (Table 3.6). Supporting this, the Spirochaetal lipoprotein signal sequence was
shown to be significantly different to other bacteria (Setubal et al., 2006). The Gram-negative
algorithm implemented by SignalP is based on a training set of 266 experimentally confirmed
Page | 126
secreted proteins (Nielsen et al., 1997, Petersen et al., 2011). SignalP has a reliability of
0.948 for proteins with no TM regions (α -helices) (Petersen et al., 2011).
The four proteins predicted to not contain a signal sequence were BAPKO_0026, BG0027,
BAPKO_0387 and BB_0378. It was interesting that BAPKO_0026 and BG0027 were
predicted to have no signal peptide as these proteins were predicted the most likely to be
OmpA-like from FFAS03 searching. The graphical output for these proteins (not shown)
showed that the S-score was representative of a signal peptide; however a cleavage site (C-
score) could not accurately be determined, resulting in a low Y-score and the resulting
prediction of no signal peptide. The amino-acid sequence shows one common polymorphism
in BAPKO_0026 and BG0027 from that of BB_0027; at position 23 in BB_0027 is an
alanine residue, which in conjunction with the two following alanines forms an ‘A-A’ box
(Figure 3.7) (Pugsley, 1993). Residue 23 in BAPKO_0026 and BG0027 is a glutamic Acid,
whilst residue 26 is a valine, resulting in no ‘A-A’ box. The sequence is EAAV; a mutation
of either the glutamic acid or the valine to an alanine would result in an ‘A-A’ box and the
recognition of a signal peptide. It is possible that the Borrelial machinery recognises the non-
standard ‘A-A’ box, or that this could be a pseudo gene in B. afzelii and B. garinii. Borrelia
contains a SecA homologue responsible for OM protein export that has only 35.0 % to 43.2
% sequence identity to other bacterial homologues, hence it is likely that at least some
components and mechanisms of protein secretion and its regulation will be novel (Guina et
al., 1998). Although there are a large number of pseudo genes on the plasmids, the linear
chromosome is not known to contain a significant proportion of pseudo genes. Experimental
expression of BB_0027 (numbered BB_0028 in the publication due to being expressed from
a different isolate) and BB_0405 has been shown in OM vesicles of B. burgdorferi (Yang et
al., 2011), providing evidence that this sequence is a functional signal peptide recognised by
Borrelial machinery and the protein is exported to the OM.
Prediction of transmembrane β -barrel proteins predicted that all proteins with the exception
of BAPKO_0023, BB_0406 and BG0408 were transmembrane β -barrel proteins. The score
generated by these proteins was above the cutoff for classification as TM β -barrel proteins,
though this is in contrast to the graphical output for these three proteins, which clearly
showed eight membrane spanning domains, four extracellular loops and three periplasmic
turns (Figure 3.9 D). PRED-TMBB, like SignalP 4.1 is trained on Gram-negative proteins
and so it is possible that this was a false negative result. Visible in the sequence alignment
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(Figure 3.10) are aromatic residues present at least one end of each predicted TM spanning β -
sheet, these proteins would form the aromatic girdle, which is characteristic of TM β -barrel
proteins (Schulz, 2000). Some of the proteins predicted to be transmembrane β -barrel
proteins were predicted to have 9 strands (BAPKO_0026 and BG0027) (Figure 3.9 B &
Figure 3.10) which according to the principles of β -barrel proteins set out (Schulz, 2000) is
highly unlikely, no known OM proteins have an odd number of strands. An odd number of β -
strands would be unlikely from a biological standpoint as an even number of strands is likely
to be a restraint of the folding mechanism. Observation of the amino-acid sequences and
comparison with the BB_0027 which was predicted to have eight strands shows that the
change to amino-acid sequence is exactly the same in this area in all three sequences, with
three minor exceptions: positions 162, 176 and 181. In BAPKO_0026 and BG0027, position
162 is a serine and alanine respectively and a serine in BB_0027; this appears to have had no
affect on the prediction as two different residues produce the same strand. The other two
polymorphisms are serine (nine strands) to alanine (eight strands) and threonine (nine
strands) to alanine (eight strands). It is possible that the prediction algorithm is very sensitive
to changes in sequence. Upon looking at the sequence (Figure 3.9) it would appear that the
strands predicted for both eight and nine stranded proteins are viable, however the eight
stranded prediction is more likely as the strand size is consistent, as are the alternative
hydrophobic side-chains. Interestingly, the previous version of PRED-TMBB predicted eight
strands in all three of these proteins (data not shown). The graphical output (Figure 3.9 B)
shows a slight rise in the probability of a β -strand between the first two predicted strands.
Looking at the sequence (Figure 3.10) shows a possible TM β -sheet region flanked by
aromatic residues, however if this was a β -strand, all predicted turns would become loops and
vice versa, resulting in very short loops and long turns. According to the ten principles of β -
barrel building (Schulz, 2000) turns should only be a couple of residues in length, and loops
much longer, hence it is much more likely that the protein is eight stranded and the program
has predicted a turn in the middle of a strand, resulting in two short strands where only one
should be.
Proteins BAPKO_0571, BB_0543 and BG0553 were predicted to contain ten β -strands each.
This is possible as this is an even number of strands which matches the principles of β -barrel
construction (Schulz, 2000) and many β -barrel proteins are known to contain more than eight
strands. E. coli is known to contain a 300 residue ten stranded TM β -barrel known as OmpT
(Vandeputte-Rutten et al., 2001) and a twelve stranded TM β -barrel protein - Tsx, a
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nucleotide transporter protein (Hong et al., 2006). The length of the loop regions appears
shorter than other putative OmpA-like proteins; analysis of the sequence (Figure 3.10) shows
a number of aromatic residues where the aromatic girdle would be expected and residues with
small side-chains present on the inside of the barrel, however the protein sequence is
approximately 100 amino-acids shorter than the sequence of OmpT, making it unlikely that
the protein is ten stranded.
Models produced using Modeller v9.11 (Figure 3.13) are consistent with BAPKO_0422
being a transmembrane β -barrel protein, most likely an OmpA-like or OmpW-like protein.
There is a clear aromatic girdle present around either end of the predicted TM-spanning β -
barrel in addition to a large number of glycine residues present on the interior of the barrel.
The girdle in the predicted models are not completely composed of aromatic residues; nine of
sixteen residues are either tryptophan, phenylalanine or tyrosine. This is in approximate
agreement with OmpW from E. coli, which has eleven aromatic residues, and matches the
nine aromatic residues in OmpA from E. coli exactly, thus providing good evidence for the
accuracy of the model and the presence of an aromatic girdle within BAPKO_0422. The
models do, however show a discrepancy with the length of periplasmic turns; sometimes up
to several residues longer in the Borrelial protein.
BAPKO_0422 appears to have a peptide sequence too long to be similar to that of OmpX
(182 residues compared to 148), both the periplasmic turns and extracellular loops are much
longer than E. coli OmpX and when modelling unordered loops have a tendency to form in
the middle of a predicted β -strand. From the models produced it is apparent that the putative
OmpA-like proteins in Borrelia have TM spanning regions of similar length to those present
in E. coli. The homology models based on OmpA and OmpW have significantly fewer
internal H-bonds than OmpA or OmpW. This could be a result of a number of factors such as
the sequence in the models not being aligned correctly, the strands being too far apart for the
software to register interactions or incorrect prediction of the sheer number. It is also possible
that these proteins, while similar in structure to E. coli OmpA have different functions, such
as performing as pores. The sequences are different to those of E. coli OmpA-like proteins
and as such it is not guaranteed that the internal structures of the proteins would be similar.
Bioinformatic analysis suggests that the OmpA-like proteins identified in Borrelia are more
likely to be OmpX or OmpW than OmpA. OmpA in Gram negative bacteria is known to
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interact with the peptidoglycan layer present just beneath the OM, however the putative β -
barrels identified in Borrelia lack such a domain and the peptidoglycan layer is located much
closer to the cytoplasmic membrane. The inside of the barrel of BAPKO_0422 is predicted to
contain many glycine residues and resemble an inverse micelle, similar to OmpX, however
the loop regions are predicted to be much longer than OmpX, and more characteristic of
OmpW. As OmpW is a responsible for the passive uptake of hydrophobic nutrients (Hong et
al., 2006), not all bacteria have a requirement for this protein, in which case Borrelia may
contain OmpW or a related protein.
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Chapter 4. Cloning and preparation of OmpA-like protein for structural
studies
4.1 Amplification of genes for cloning
Genes encoding for putative OmpA-like proteins in B. afzelii; BAPKO_0026 and
BAPKO_0422, and B. garinii; BG0027 and BG0407 were amplified using nested PCR and
the primers in Table 2.5 & Table 2.6. No B. burgdorferi s.s. genes were amplified as no B.
burgdorferi s.s. DNA had been sourced at the time of amplification.
In a standard PCR reaction, there are three stages; initial denaturation, amplification cycle
and final extension. The initial denaturation step is the heating of the reaction mix to 95 °C
for five minutes. This denatures (or ‘unzips’) double stranded DNA, exposing the base
groups on each strand. Immediately after this amplification cycles commence. Each
amplification cycle consists of three stages; denaturation, annealing and extension.
• Denaturation – same as initial denaturation, but for thirty seconds rather than five
minutes
• Annealing – the reaction mix is cooled to a temperature a couple of degrees below
the lowest melting temperature (Tm) of the primers to enable primer binding
• Extension – the reaction mix is heated to 72 °C to enable Taq DNA polymerase
extension of the primers using the initial strand as a template
Standard PCR procedure is to repeat this amplification cycle twenty eight times before the
final extension stage of five minutes at 72 °C.
Nested PCR is a highly sensitive technique that uses two consecutive stages of PCR to
amplify the target region of DNA with a limit of detection comparable to that of real-time
PCR (Chacón and Ferreira, 2008). This enables amplification of a specific gene from a low
concentration sample in the presence of a high DNA contamination, in this case Borrelial
DNA in the presence of Ixodid tick DNA. The initial stage of nested PCR amplifies a
fragment of DNA slightly larger than the required target gene, the second stage then
amplifies the target gene from within the initial amplification (Chacón and Ferreira, 2008).
The amplification of two or more regions as carried out in nested PCR has been shown to
produce a higher sensitivity than when amplifying one region as in traditional PCR
(Grankvist et al., 1996, Zhang et al., 2007). The use of two primer pairs greatly reduces the
likelihood of amplification of an incorrect gene; the first round of amplification is susceptible
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to low-level amplification of non-specific gene fragments, but it is highly unlikely that these
fragments would be amplified by the second primer pair. The amplification process is
summarised in Figure 4.1
As nested PCR (nPCR) is at its simplest two full rounds of PCR using different primers, the
major difference is the number of cycles in the amplification phase. The annealing
temperature is varied depending on the Tm of the primers. The amplification stage is repeated
twenty times in the initial PCR using initial (or ‘outer’) primers and thirty five times in the
secondary PCR using secondary (or ‘inner’) primers.
Figure 4.1. The amplification of a target gene by nested PCR. A) double stranded genomic DNA (gDNA) with target
gene highlighted in red. B) Initial amplification: gDNA unzipped with primers bound (dark blue) and extended (light blue)
using gDNA as a template. C) DNA fragment comprising target gene and a large surrounding area. D) Secondary
amplification: Initial fragment has been unzipped and secondary primers (dark green) bound and extended (light green). E)
Final gene fragments. Once a strand has been replicated, this strand can then be used as the template for replication in the
opposite direction. The replication is cut short when the end of the strand is reached, thus producing a fragment. The result
of the amplification is a large number of fragments, the majority of which are concise fragments. The process is repeated
again, this time amplifying the target gene and only a small surrounding area, mainly from the synthesised fragments (light
blue). This step produces a large quantity of target gene (light green and red).
Housekeeping genes are required for maintenance of basic cellular function, and as such are
employed as positive controls for PCR amplifications. Housekeeping genes PepX and UvrA
(section 2.1.2) were selected and amplified using the primers in Table 2.4. BG0027 was
selected as an experimental amplification. For BG0027 reactions 1 & 2 the outer primer
pairing was G0027OF1/G0027OF2, and the secondary (inner) primer pairings were
G0027IF1/G0027IR1 and G0027IF2/G0027IR2 respectively (Table 2.5). The primary
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amplification used the annealing temperature 50 °C (housekeeping genes) and 60 °C
(BG0027), whilst all secondary amplification were carried out with an annealing temperature
of 52 °C. There was visible product of approximately the correct size (~660 bp) in both
housekeeping genes along with one of the target gene combinations (Figure 4.2),
demonstrating that the nested PCR method was effective. All gel analysis of PCR products
was carried out using a 2 % agarose gel as described in section 2.2.8.2.
Figure 4.2. Amplification of PepX, UvrA and BG0027 using nPCR. A) Lanes from L-R: 800 bp step ladder, PepX, UvrA,
BG0027 (1), BG0027 (2). B) L-R: 800 bp step ladder, PepX, UvrA, BG0027 (1), BG0027 (2)., BG0027 was selected at
random for experimental method testing. Three bright product bands are visible at approximately 650 – 700 bp. In addition a
faint, smaller PCR product at around 450 bp is visible in all three reactions. These are likely bands produced by non-specific
primer binding.
The absence of product in the initial amplification provided evidence that nPCR is required to
produce sufficient product. The failed amplification from reaction 1 for BG0027 indicates
that there was likely a problem with the primer Tm difference. Single-step PCR was attempted
using the secondary amplification pairs was conducted on the housekeeping genes and
BG0027 for the same number of inner amplification cycles (35) as nPCR, however there
were no products produced (Figure 4.3) confirming that nested PCR was required.
A - Initial Amplification B - Secondary amplification
800
750
700
650
600
550
500
450
400
350
300
250
200
150
100
800
750
700
650
600
550
500
450
400
350
300
250
200
150
100
Page | 133
Figure 4.3. Gel of 35 cycle PCR using secondary primers only. Mw is the 800 bp step ladder, lanes 1-4 are as follows:
PepX, UvrA, BG0027 (1), BG0027 (2). PCR conducted using an annealing temperature of 50 °C (housekeeping genes) and
60 °C (BG0027). Primers used were those used for secondary amplification previously (Figure 4.2 B) No PCR product was
produced from either of the housekeeping genes or the experimental amplifications.
Amplification of the orthologous gene BAPKO_0026 was carried out in the same manner, in
this case, primer pairs A0026OF1/A0026OR1 and A0026IF1/A0026IR1 yielded sufficient
amplification of the gene; though the annealing temperature had to be adjusted to 56 °C
(initial) and 59 °C (secondary) for optimum amplification.
BAPKO_0422 and BG0407 were not successfully amplified using initial primer
combinations and annealing temperatures, hence a broad screen was conducted using
multiple combinations of primary and secondary primers (Table 2.5) for each gene (Figure
4.4). Primer pairs with a Tm difference greater than 5 °C were not used. In all, six different
primer combinations were used for BG0407 and seven for BAPKO_0422. The annealing step
temperatures selected for this trial were 51 °C for the initial amplification and 59 °C for the
secondary amplification.
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Figure 4.5. An example the positioning of a forward overhang primer, A0422CF. In black text is the PCR product after
amplification of the gene with both initial and secondary primers. In red is the overhang primer, the black box is the
amplified product and the red arrow is the direction of amplification. The numbering of base pairs begins at the beginning of
the gene. Positioning of the primer in this way removes the signal peptide.
The majority of the primer matches with the DNA strand (and so will bind to the
complementary strand) however, the initial 11 bases do not. After amplification beginning
from this primer is complete, the reverse primer will bind to the amplified strand and
amplification will proceed along using the newly synthesised strand as a template, including
the former overhang. This will produce a complete restriction site ready for further
amplification and digestion. The primer was designed to overlap the start of the gene,
minimising the number of extra residues at the start of the protein, in some cases, extra bases
had to be added between the restriction site and the start codon in order to bring the sequence
into frame. PCR products with restriction sites were sent for sequencing (Source Bioscience,
Nottingham, UK). An example of sequencing results for BAPKO_0422 follows (Figure 4.6)
Figure 4.6. Results of BAPKO_0422 sequencing. Top - DNA was sequenced in the 5’-3’ direction on both the forward and
reverse strands using BA0422CF as primer. Some bases were not able to be automatically assigned and so were assigned
manually where possible. Bases that were unassigned are denoted as N. Bottom - Translation of sequenced DNA, the first
three residues of the protein sequence are highlighted grey and the last three light grey. Residues unable to be assigned are
denoted as X.
The gene sequence was translated to the amino-acid sequence using the ExPASy Translate
tool (Figure 4.7). This was BLAST searched to ensure that the correct gene had been
amplified.
XXXNXRLVTAQSKSKSMVEDDFDFEKLLAKEESVRRLFGIGFGIGYPLTNITISVPYVDIDLGYGGFVGLKPNNFMPYVVMGIDLLFKDEI
HKNTMISGGIGIGADWSKGSPEKSNENLEEDEQEDPQTSLSHQNRIGVVIPLXLESNFLPNKKIGVKAVAXXXTXTTFXXXXPFXXXXXXF
XXTGXXXIYIYXXXXXXSXXXKX
>BAPKO_0422_F
NNNNNNANNNAACANCAGGCTTGTTACTGCCCAATCAAAAAGCAAATCTATGGTTGAAGATGACTTTGACTTTGAGAAACTTCTTGCAAAA
GAAGAGTCTGTCCGCCGTTTATTTGGTATAGGCTTTGGGATTGGATACCCACTTACAAACATTACAATATCTGTTCCATATGTAGACATAG
ACCTTGGCTACGGAGGATTCGTTGGGCTTAAACCCAACAATTTCATGCCCTATGTTGTAATGGGAATAGACCTTTTATTTAAAGATGAAAT
ACATAAAAACACCATGATTTCCGGCGGCATTGGAATAGGAGCAGATTGGTCAAAAGGAAGCCCTGAAAAATCGAATGAAAACCTTGAAGAA
GACGAACAAGAAGATCCTCAAACATCTCTTTCTCATCAAAATAGAATAGGGGTTGTGATACCTTTGNCTTTGGAATCAAATTTTCTCCCTA
ATAAAAAAATTGGGGTTAAAGCTGTTGCTNCTANTGNAACTACNACAACATTTGNNNNNNCNNTGCCATTTGNATTNGCNNGANNTANTTT
CNNGTNCACGGGCNTNNGNNNTATATATATATATNGNNNANNNANNNNNANNTCCNNNAANNANAAAN
60 70 80 (base pairs)
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tr Q0SNA2
Q0SNA2_BORAP
Full=Uncharacterized protein; [Ordered Locus
Names = BafPKo_0408, BAPKO_0422;] [Borrelia
afzelii (strain PKo)]
201 AA
Score =  354 bits (909), Expect = 5e-96
Identities = 177/182 (97%), Positives = 178/182 (97%)
Query: 1 QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNITISVAYVDIDLGYGRFVGL 60
QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNI ISV YVDIDLGYG FVGL
Sbjct: 20  QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNIIISVPYVDIDLGYGGFVGL 79
Query: 61  KPNNFMPYVVMGIDLLIKDEIHKNTMISGGIGMGADWSKGSPEKSNENLEGDVNEDQQTS 120
KPNNFMPYVVMGIDLL KDEIHKNTMISGGIG+GADWSKGSPEKSNENLEGDVNEDQQTS
Sbjct: 80  KPNNFMPYVVMGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTS 139
Query: 121 LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI 180
LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI
Sbjct: 140 LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI 199
Query: 181 YI 182
YI
Sbjct: 200 YI 201
Figure 4.7. Amplified BAPKO_0422 BLAST result. Displayed is the BLAST result of translated gene searched against the
B. afzelii proteome showing the top hit Q0SNA2, which from the bioinformatic results (chapter 3) is the putative protein.
Q0SNA2 (also noted as BafPKo_0408 and BAPKO) There are five polymorphisms (turquoise) in the amplified gene
compared to that in the database.
Five polymorphisms were visible in the gene compared to the peptide sequence in the
UniProtKB database. The database sequence was sequenced from laboratory cultured
bacteria, whereas the gene amplified was from wild-type Borrelia.
4.2 Production of gene constructs
The amplified genes and pET-47b(+) were sequentially digested as described in methods
section 2.2.2. Once both digests had been completed the DNA fragments were purified using
a QIAquick PCR cleanup kit (Qiagen, Loughborough, UK). The concentration of DNA was
calculated.
pET-47b(+) was selected with the goal of expressing His-tagged proteins in the cytoplasm
without the signal peptide, hence the exclusion of the signal sequence by primer design.
Ligation reactions were carried out at pET-47b(+):gene ratios: 1:1, 1:3, 1:6 and 1:10.
Negative controls were included as described in section 2.2.5. When complete the reaction
mixes were used to transform NEB Turbo Competent E. coli cells which were plated onto
agar plates for antibiotic screening. Development of the method is included in the methods
(section 2.2.5).
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The two ligation ratios that proved most effective were 1:3 and 1:6. Colonies of E. coli
containing BAPKO_0422/pET-47b(+) were produced at both of these ratios, whilst colonies
of BG0407/pET-47b(+) were produced at the ratio 1:3. Multiple colonies from each plate
were selected and cultured overnight in 5 ml LB with kanamycin (as described in section
2.2.6). Potential constructs were extracted from the cultures using a QIAprep Spin Miniprep
Kit (Qiagen, Loughborough, UK) and eluted in 50 μ l nuclease free water. 2 μ l of each
potential construct digested using both restriction enzymes. The resulting DNA fragments
were analysed using a 2 % agarose gel (Figure 4.8).
Figure 4.8. Digested gene constructs. L-R 1 kbp step ladder, BAPKO_0422/pET-47b(+) constructs, BG0407/pET-47b(+)
constructs. Bands at approximately 600-700 bp are inserted DNA (white box) were excised from the construct by digestion.
Once it was confirmed by electrophoresis that two fragments were present at approximate
sizes (vector and inserted DNA) the BAPKO_0422 and BG0407 constructs were sent for
sequencing at Source Bioscience (Nottingham, UK). Sequencing was conducted using T7
primers in both the forward and reverse direction (Figure 4.9 & Figure 4.10).
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Figure 4.9. BAPKO_0422 gene sequence obtained from construct. Sequencing carried out at Source Bioscience
(Nottingham, UK) using the T7 promoter in the 5’-3’ direction. This sequencing data is much clearer than the sequencing of
just the gene. No manual adjustments to the data were necessary. Highlighted in green is the start codon, turquoise is the
His-tag, red denotes the HRV-3C cleavage site and grey the BAPKO_0422 coding sequence.
The sequenced construct DNA for BAPKO_0422 and BG0407 were translated using the
TRANSLATE program on EXPASY. This found that the BG0407 gene was out of frame
with the open reading frame of the plasmid (Figure 4.10); resulting from an error in primer
design - an extra base pair was required between the restriction site and gene to bring the
gene into the reading frame of the plasmid.
Figure 4.10. Translation of sequenced constructs. Top: BAPKO_0422 sequenced in the T7 forward direction, middle:
BAPKO_0422 sequenced in the T7 reverse direction, bottom: BG0407 sequenced in the T7 forward direction. Highlighted
in grey is the protein sequence, green is the start codon, the His-tag is turquoise and the HRV-3C cleavage site red. The His-
tag and HRV-3C cleavage site are not present in the same reading frame as the BG0407 gene. The cloning primers were
reanalysed and it was found that the forward BG0407 primer was incorrect, resulting in the gene being out of frame by one
base from the reading frame of the plasmid.
BG0407 FORWARD -SPLSGTRVPGSDQSKSKSMVEDDFDFEKLLAKEESVRRLFGIGFG
IGYPLTNITISVPYVDIDLGYGGFVGLKPNNFMPYVAAGIDLLFKDEIHKNTMISGGIGIG
ADWSKGSPEKSNEKLEEEEENEAQQVNSLQNRIGVVIRLPLVIEYSFLKNIVIGFKAVATI
GTTMLLGGPMSFEGARFNFLGTGFIKIYI-
BAPKO_0422 REVERSE MAHHHHHHSAALEVLFQGPGYQDPQSKSKTMVEDDFDFEKLL
EKEESVRRLFGIGFGIGYPLTNITISVAYVDIDLGYGGFVGLKPNNFMPYVVMGIDLLIKD
EIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSFL
KNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI-
BAPKO_0422 FORWARD MAHHHHHHSAALEVLFQGPGYQDPQSKSKTMVEDDFDFEKLL
EKEESVRRLFGIGFGIGYPLTNITISVAYVDIDLGYGRFVGLKPNNFMPYVVMGIDLLIKD
EIHKNTMISGGIGMGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSFL
KNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI-
0422 (1) gene with His-tag.
ATGGCACATCACCACCACCACCACTCCGCGGCTCTTGAAGTCCTCTTTCAGGGACCCGGGT
ACCAGGATCCGCAATCAAAAAGCAAAACTATGGTTGAAGATGATTTTGACTTTGAGAAACT
TCTTGAAAAAGAAGAGTCTGTGCGCCGTTTATTTGGCATAGGCTTTGGAATTGGATACCCA
CTTACAAACATTACAATATCTGTTGCGTATGTAGATATAGACCTCGGCTACGGAAGATTCG
TTGGGCTTAAACCCAACAATTTCATGCCCTATGTTGTAATGGGAATAGACCTTTTAATTAA
AGATGAAATACATAAAAACACTATGATTTCCGGCGGCATTGGAATGGGTGCAGATTGGTCA
AAAGGAAGTCCTGAAAAATCGAATGAAAACCTTGAAGGAGACGTAAATGAAGATCAACAAA
CATCTCTTGAAAATAGAATAGGGGTTGTAATAAGGCTACCTTTGGTAATAGAATACAGTTT
TCTTAAAAATATTGTAATTGGGTTTAAAGCTGTTGCTACTATTGGAACAACTATGCTATTT
GGAAACCCAATGTCATTTGAAGGAGCTAGATTTAATTTCTTGGGCACAGGCTTTATAAAAA
TATATATATAA
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The resulting protein sequence in frame with the His-tag was BLAST searched. The top hit
was BAPKO_0422 (named BAPKO_0408 from this strain) (Figure 4.11).
tr Q0SNA2
Q0SNA2_BORAP
Putative uncharacterized protein [BafPKo_0408]
[Borrelia afzelii PKo]
201 AA
Score =  358 bits (920), Expect = 2e-97
Identities = 179/182 (98%), Positives = 179/182 (98%)
Query: 1   QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNITISVAYVDIDLGYGGFVGL 60
QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNI ISV YVDIDLGYGGFVGL
Sbjct: 20  QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGYPLTNIIISVPYVDIDLGYGGFVGL 79
Query: 61  KPNNFMPYVVMGIDLLIKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTS 120
KPNNFMPYVVMGIDLL KDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTS
Sbjct: 80  KPNNFMPYVVMGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTS 139
Query: 121 LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI 180
LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI
Sbjct: 140 LENRIGVVIRLPLVIEYSFLKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKI 199
Query: 181 YI 182
YI
Sbjct: 200 YI 201
Figure 4.11. Top hit from the BLAST search of BAPKO_0422. Protein sequence used is that from Figure 4.10 minus the
His-tag, cleavage site and extra residues before the start of the protein. Polymorphisms between the cloned wild-type
sequence and the database sequence are highlighted in turquoise. Q0SNA2 was the third hit behind homologues E2JNC3 -
BafACA1_0410 and K4IYN5 – BafHLJ01_0440 each with scores of 361 and E-values of 5e-98. BafPKo_0408 is another
identifier for BAPKO_0422 from a different isolate.
The gene amplified and cloned into pET-47b(+) was determined as BAPKO_0422 with three
amino-acid polymorphisms compared to the sequence in the database. Two polymorphisms
seen in the sequenced gene (Figure 4.7) are not present in the construct gene. This is either
due to more accurate sequencing data from construct DNA or the presence of different strains
of wild-type B. afzelii in the tick and subsequent amplification of genes with polymorphisms.
4.3 Recombinant Expression of BAPKO_0422
4.3.1 Codon usage
E. coli K12 codon usage was compared to the sequence of BAPKO_0422 to determine if any
rare codons used by B. afzelii would prevent optimum expression. The genetic sequence of
amplified BAPKO_0422 including His-tag and HRV-3C cleavage site was compared against
E. coli K12 codon usage using the web based server - graphical codon usage analyser (gcua).
Five codons present in the gene (CTC, ATA, AGA, AGG and CTA) are rarely used in E. coli
K12 (Figure 4.12).
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Figure 4.12. E. coli K-12 codon usage in the B. afzelii gene BAPKO_0422. Codons with less than 20 % usage are
coloured grey and codons used less than 10 % are in red. There are a large number of rare codons present throughout the
gene, making it unlikely that any K12 based E. coli strain would be able to successfully overexpress BAPKO_0422.
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Due to the presence of rare codons in the gene, E. coli Rosetta (DE3) (Merck) were used for
expression. Rosetta cells contain tRNAs for six rare codons on a chloramphenicol resistant
plasmid to enable translation of almost all DNA sequences that contains rare codons. The six
rare tRNAs accounted for are AGG, AGA, AUA, CUA, CCC, GGA, five of which feature in
the gene sequence of BAPKO_0422.
4.3.2 Autoinduction
The ultimate goal was the production of an autoinduction protocol followed by purification
and refolding of large volume of protein. Autoinduction was the preferred method of
overexpression due to the potential to produce large quantities of protein. Initially however,
small scale expression trials took place using 50 ml cultures of BAPKO_0422 in LB and
IPTG induction to test the Rosetta cells and the purification technique. Expression induced by
0.1 mM IPTG produced very little protein whereas expression induced by 1 mM IPTG
produced larger quantities. Expression was accomplished using the protocol as described in
section 2.2.7.1. and confirmed by SDS-PAGE and western blot (not shown).
Expression by autoinduction was conducted in a total volume of 400 ml according to the
protocol detailed in section 2.2.7.2. The first attempt was unsuccessful. This was later
determined to be due to the addition of the 5052 (glucose and lactose) component prior to
autoclaving, resulting in caramelisation of the sugars. To counter this, 5052 was filter
sterilised (0.45 μ M) and added after autoclaving of the base media. NPS and MGSO4 were
also filtered and added after autoclaving to prevent compound degradation. The second
expression was also unsuccessful, so the shaking speed was increased to 200 rpm and the foil
seal removed to increase aeration of the culture. These changes resulted in a large quantity of
protein being expressed, as confirmed by SDS-PAGE (Figure 4.13).
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Figure 4.13. Expression of BAPKO_0422. Whole cell lysates were run on an SDS-PAGE to determine expression of
BAPKO_0422. Lane 1 - The large band at approximately 23 kDa (red box) is expressed BAPKO_0422. Lane 2 - Expression
of E. coli with no expression construct.
4.4 Purification and refolding of BAPKO_0422
4.4.1 Purification of inclusion bodies
Development of the lysis buffer and insoluble protein separation protocols was a substantial
process; initially the harvested cell pellet was resuspended in 1x PBS and lysed by sonication
for three minutes before washing. From visual inspection it appeared that lysis was
incomplete. Varying sonication pulse lengths were tried before the initial resuspension buffer
was switched from PBS to 0.3 M NaCl, 50 mM Tris-HCl at pH 8 and one hour incubation on
ice with 0.4 mg/ml lysozyme was added prior to the sonication step. This modified protocol
proved adequate for lysing the volume of cells present in < 50 ml IPTG induced cultures.
Autoinduction cultures however contained much larger volumes of cells, which were not
completely lysed by the protocol for ITPG induction, hence the concentration of lysozyme
was increased to 1 mg/ml and sonication time increased to two minutes total pulse.
Detergents such as Triton X-100 are often added to buffers to assist in the lysis of cell
membranes. Initially this was not considered an option as many detergents are used to
solubilise membrane proteins from inclusion bodies (Seddon et al., 2004) and as solubilising
the protein would mean refolding, it was preferable to leave the protein in inclusion bodies
until purification. A trial was conducted using 0.1 % (v/v) Triton X-100 added to the lysis
mw
(kDa)
260
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110
80
60
50
40
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20
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buffer as Triton X-100 is not generally used for membrane protein refolding. Lysis was much
more efficient with the addition of Triton X-100 and SDS-PAGE analysis confirmed that the
protein was still present in inclusion bodies. The inclusion bodies were solubilised in FPLC
buffer A (Table 2.2) after three salt washes to remove soluble proteins (described in section
2.2.9) and the soluble and insoluble fractions analysed by SDS-PAGE and Western Blot
(Figure 4.14).
Figure 4.14. Separation of inclusion bodies. A) SDS-PAGE. B) Western blot. Cells were harvested from an autoinduction
culture, lysed and the soluble and insoluble fractions separated as previously described. (A) Protein standard ladder
(Novagen), 1,2,3 - initial salt wash fractions, 4 - secondary salt wash fraction, 5 - insoluble fraction solubilised in 8 M urea.
(B) Protein standard ladder (Novagen), 1 - initial salt wash fraction, 2 - secondary salt wash fraction, 3 - insoluble fraction
solubilised in 8 M urea. As the initial salt wash fractions were all very similar, only one was run on the western blot.
Highlighted in red is a band of approximately the expected size for BAPKO_0422. No BAPKO_0422 was present in either
salt washes (soluble fractions). The gel used was a pre-cast 4 – 12 % (w/v) Bis/Tris run as described (section 2.2.8). A large
number of proteins have been removed by the salt wash steps although several remained in the insoluble fraction and were
present on the SDS-PAGE as faint bands. The secondary band at approximately 50 kDa that produced a positive result on the
Western blot is either caused by an E. coli protein bound to BAPKO_0422 or a BAPKO_0422 dimer.
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4.4.2 IMAC purification & refolding
Cells from expression cultures were lysed and protein harvested from inclusion bodies as
described in section 2.2.9. Initial buffers for resolubilisation of inclusion bodies and IMAC
purification contained 8 M urea instead of 6 M GuHCl as this was the most common
denaturant used in the literature. However, this resulted in very low binding of protein to the
column with a large amount of protein remaining in the flow through (Figure 4.15).
Figure 4.15. IMAC Chromatogram of purification of BAPKO_0422 in inclusion bodies solubilised with 8 M urea.
Flow rate used was 1 ml/min-1. Sample was loaded in 8 M urea, 0.3 M NaCl, 30 mM Tris-HCl, pH 8 and run with this buffer
until the baseline returned to 0. The large peak from 20 to approximately 50 minutes is the loading peak of protein that did
not bind to the column. Protein was eluted by buffer containing 0.3 M imidazole, 8 M urea, 0.3 M NaCl, 30 mM Tris-HCl,
(pH 8). The small peak at around 105 minutes (red arrow) is the eluted protein, followed by the peak caused by absorbance
of light by imidazole. Only a minute fraction of protein bound to the column, hence protocol optimisation was required.
In an attempt to increase the binding capacity, the pH of all buffers was varied (7, 8 and 9),
and the NaCl concentration also varied (0.1, 0.3, 0.5 and 1 M). This included the buffer in
which the inclusion bodies were resuspended. None of these changes or combinations of
changes made any noticeable difference to the binding. The column was also cleaned with 0.5
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M NaOH, stripped of nickel using 10 mM EDTA and recharged with freshly made and
filtered (0.45 μ m) 100 mM NiSO4, but again no increase in binding was found. The
denaturant was switched from 8 M urea to 6 M GuHCl at pH 8, this showed an increase in
protein binding (Figure 4.16).
Figure 4.16. IMAC Chromatogram of purification of BAPKO_0422 in inclusion bodies solubilised with 6 M GuHCl.
This chromatogram shows elution of the peak once the denaturant had been switched to GuHCl. When compared to the
previous chromatogram the peak eluted had a higher absorbance and was wider (red arrow), indicating that more protein had
bound to the column. The peak at approximately 15 ml was found to be non-specifically bound protein by SDS-PAGE, and
the large peak to be pure BAPKO_0422 (data not shown). Both conductivity and % buffer B are plotted on the secondary
axis.
After this improvement, the pH and NaCl concentration were altered, but again to no avail.
After searching the literature it was observed that glycerol was added to the sample and
loading buffers to reduce hydrophobic interactions (Bane et al., 2007). Glycerol was added to
the sample and the 6 M GuHCl loading buffer (FPLC buffer A) to give a total 10 % (v/v),
which resulted in an increase in protein binding (Figure 4.17).
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Figure 4.17. IMAC Chromatogram of purification of BAPKO_0422 in inclusion bodies solubilised with 6 M GuHCl
with the addition of 10 % (v/v) glycerol. The loading stage (0-400 ml) is longer than usual due to this being a sample that
did not bind on a previous purification attempt. The peak at approximately 530 ml is due to weakly bound proteins eluting.
The peak at approximately 640 ml (red arrow) is bound BAPKO_0422 being eluted by the addition of an imidazole-
containing buffer (6 M GuHCl, 0.3 M NaCl, 30 mM Tris, pH 8). Both conductivity and % buffer B are plotted on the
secondary axis.
The final attempt at increasing binding affinity was the addition of 1 mM EDTA to the lysis
buffer. As the E. coli were being cultured in LB and autoinduction media, there was a large
number of metal ions present for growth. It was speculated that these metal ions could be
strongly binding the His-tag, preventing the His-tag binding to the nickel on the column and
so the chelating agent EDTA was added. EDTA is used for stripping the nickel atoms from
the column, it was important that the EDTA never reached the column, hence its presence in
the lysis buffer. The EDTA was removed along with soluble proteins before the sample
reached the column, preventing the nickel being stripped from the column. Addition of
EDTA produced a minor increase in binding affinity of BAPKO_0422.
Development of the refolding protocol proceeded in conjunction with attempts to increase the
binding affinity for the column. The small yield that was obtained was shown to be pure by
SDS-PAGE (Figure 4.20) and so on-column refolding was attempted (Figure 4.18).
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The β -barrel domain of E. coli OmpA has been shown to spontaneously refold in detergent at
room temperature (this was also trialled with BAPKO_0422 in this research and estimated to
be true by SEC), however it was decided that a one-step purification & on-column refold
would be preferable to minimise purification steps. The on-column refolding protocol for
BAPKO_0422 protein was adapted from (Ito et al., 2003), which used a gradual decrease in
denaturant to achieve on-column refolding. Initially, three refold buffers were planned (Table
2.2), this would leave the protein in 1 M GuHCl before gradient elution which would further
dilute the denaturant. A fourth RF buffer (the same composition as SEC buffer, Table 2.2)
was added to completely eliminate GuHCl from the sample. Initially upon the exchange of
one refold buffer to another, the column was left for half hour to equilibrate. Experimentation
with equilibration times found that this equilibration step was not necessary for proper
refolding and so removed, speeding up the process. During the refold process, no protein
eluted from the column and a large peak was detected upon the addition of the imidazole-
containing elution buffer (Figure 4.18).
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Figure 4.18. IMAC Purification and on-column refold of BAPKO_0422. A small volume of previously purified
BAPKO_0422 was loaded onto the column and refolded. The change in refolding buffers is represented in the conductivity.
At approximately 160 minutes the conductivity peaks, this is the due to washing with buffer RF1 (4 M GuHCl, 0.3 M NaCl,
30 mM Tris, pH 8). Each decrease and plateau that follows is the exchanging of buffer. The GuHCl component decreased
with each new buffer (6 M, 4 M, 2 M, 1 M and 0 M) The NaCl and Tris concentrations remained constant and 0.1 % (w/v)
LDAO was included with the 4 M GuHCl buffer and all those used thereafter. BAPKO_0422 elution was a result of the
introduction of an imidazole-containing elution buffer (0.1 % (w/v) LDAO, 0.5 M imidazole, 0.5 M NaCl, 50 mM Tris-HCl,
pH 8).
4.4.3 SEC Purification
The column was prepared and calibrated as described in section 2.2.11. BAPKO_0422 was
concentrated to a volume of 1 ml using a 10,000 mwco before SEC. SEC was conducted
using a flow rate of 0.3 ml/min with fractions collected every 3 ml. Fraction collection began
after approximately 5 ml of buffer had run through the column. BAPKO_0422 eluted at
approximately 11 ml (Figure 4.19), which equates to a molecular weight of approximately 40
kDa. As has been noted, SEC cannot be used to accurately determine the mw of a membrane
protein due to the binding of an unknown number of detergent molecules. However the
expected mass of BAPKO_0422 (~23 kDa) added to the approximate mass of an LDAO
micelle (~17 kDa) results in a total mass of ~40 kDa, equivalent to that calculated from the
elution volume using the calibration curve (section 2.2.11).
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Figure 4.19. SEC Chromatogram of BAPKO_0422. Screenshot of SEC chromatogram from PrimeView software shows a
total elution on the X-axis. The red dashes are fraction numbers. 0.3 ml BAPKO_0422 in 0.1 % (w/v) LDAO, 0.3 M NaCl,
30 mM Tris (pH 8) at a concentration of approximately 5 mg/ml was loaded. The clear peak at approximately 34.5 ml total
volume was shown to be pure BAPKO-0422 by SDS-PAGE. Based on the elution volume of 11 ml and the calibration curve
(Figure 2.5) this equates to a molecular weight of approximately 40 kDa.
Analysis of the protein peak was conducted by SDS-PAGE (Figure 4.20) and the protein
found to be pure.
Figure 4.20. SDS-PAGE of purified BAPKO_0422. L-R: Sharp unstained protein standard (Novex), insoluble protein
fraction, protein purified by IMAC, empty well, protein purified by SEC. The insoluble protein fraction had a small number
of proteins present besides BAPKO_0422. These were all removed by IMAC. In addition there appears to be no anomalous
migration of the protein despite being boiled in SDS. BAPKO_0422 showed minimal absorbance at 320 nm, indicating no
protein aggregation.
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4.5 Discussion
The use of nested PCR (nPCR) was important for specific amplification of genes from the
samples provided by Dr. Gabi Margos. As these DNA samples are extracted from whole
ticks, Borrelial DNA was present in very small concentrations compared to tick DNA. As
described in section 4.1 amplification of genes with inner amplification primers (targeting
only the gene) was unsuccessful, therefore nested PCR using both primer pairs was necessary
to achieve the sensitivity required. During amplification by nested PCR there were several
instances of non-specific amplification (Figure 4.4), this was not unexpected as the high
concentration of tick DNA and the relatively low Tm of primers used results in a high
probability of non-specific primer binding. The main amplification was of the desired genes,
which were excised from the gel where necessary and purified. An alternative to using nPCR
would have been to use pure Borrelial DNA such as that provided by Dr Volke Fingerle,
however this DNA was not obtained until after the genes had successfully been amplified.
A BLAST search of the translated sequence of amplified BAPKO_0422 shows 97 % identity
with that of BAPKO_0422 from B. afzelii PKo. Some residues differ between the two
sequences, such polymorphisms are expected as the DNA was extracted from different
isolates. The region towards the C-terminus shows many unassigned residues (denoted as X)
as the sequencing become unreliable towards the end, hence the sequencing was carried out
in both directions.
Restriction digestion of the DNA fragments and plasmid vector proved problematic. Control
digestions found that both dilute (1 in 5) and neat HindIII fully digested the vector, whereas
neither neat or dilute BamHI accomplished complete digestion under recommended
conditions. A doubling of the BSA concentration in conjunction with using neat enzyme
stock in the BamHI digest resulted in almost complete digestion. Re-ligation of singly
digested vector was conducted as a positive control, this required a doubling of ATP and T4
DNA ligase concentration to be successful. Ligation of doubly digested insert to vector also
needed optimising. Various ratios were used as described in the methods (section 4.2). The
ligation temperature was varied: 15 °C, 20 °C, 23 °C, 33 °C and 37 °C, as was the incubation
times: 1, 1.5 and 2 hours. The various temperatures tried were suggested by the
manufacturer’s instructions and from troubleshooting forums. The conditions under which
ligation as successful (albeit with a low success rate) were: incubation at 23 °C for 1 hour
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with the addition of shaking at 120 rpm using doubled ATP and T4 ligation concentration.
Shaking was added in an attempt to encourage more movement in the reaction and increase
interactions between molecules. The addition of more base pairs to the 5’ end of the each
restriction primer (ideally a total minimum of six bases should be included) would result in
the improved efficiency of the restriction enzyme as many restriction enzymes inefficiently
cleave restriction sequences near the ends of a DNA fragment, in particular those generated
by PCR amplification (Sambrook et al., 2000). Alternatively a different cloning approach that
did not require the use of restriction enzymes such as blunt-end or TA cloning would be used
as this would remove the need for restriction digestion entirely. Blunt end cloning however
may result in genes inserted backwards (which would require sequencing to confirm), and
both techniques have the potential to insert multiple copies of the gene.
Analysis of the protein sequences of the constructs translated from sequencing data (Figure
4.10) highlighted an error in the forward primer for addition of restriction sites to BG0407;
the protein sequence was not in the same reading frame as the His-tag, meaning that the
protein was not expressed. The BAPKO_0422 construct was produced in frame with the His-
tag. A BLAST search of the protein sequence to be expressed found an excellent match for
BAPKO_0422, with three polymorphisms. The first two polymorphisms I42T and P46A are
predicted to be on the inside of a β -strand; both polymorphisms result in a smaller side-chain
protruding into the centre of the barrel, potentially altering the inner H-bonding networks.
The third predicted polymorphism F77I is predicted to be present at a residue forming part of
the aromatic girdle, substituting a phenylalanine for an isoleucine; this is not ideal for the
girdle, however both OmpA and OmpX from E. coli have an isoleucine present in the girdle,
hence this is not an unreasonable substitution. It is also possible that the prediction of β -
strand locations is not entirely correct.
The codon usage by BAPKO_0422 was checked for rare codons (Figure 4.12) and it was
found that several codons not used by E. coli K12 were present in the gene sequence. Hence
E. coli Rosetta (DE3) cells (Merck) were used. Induction of expression by IPTG was
successful using standard lab protocols, however expression by autoinduction required an
increase in shaking from 120 rpm to 200 rpm and removal of the foil seal; an increased
incubation time and amplified proliferation of E. coli requires much more sample aeration.
Standard E. coli BL21 cells used as a negative control produced no expression under the
same conditions, validating the necessity of Rosetta cells.
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Purification of BAPKO_0422 by IMAC suffered primarily from low binding efficiency of the
protein to the column. A variety of alterations were made to the buffer composition and
protocol in an effort to increase binding. Increasing or decreasing the pH and the
concentration of NaCl of the loading buffer either individually or in tandem had no effect on
binding. Switching the denaturant from urea to GuHCl had the effect of increasing protein
binding slightly. The addition of 10 % (v/v) glycerol inhibit non-specific interactions also
resulted in increased binding, as did the inclusion of 1 mM EDTA in the lysis buffer. This
was done as the autoinduction media contained metal ions and EDTA is a strong chelating
agent. The EDTA would therefore strip any metals that had bound the His-tag, which would
block binding to the Ni-NTA column. Columns from Qiagen and GE Healthcare were used as
bought and also stripped and recharged with freshly made NiSO4; the brand of column and
state of nickel had no discernible effect on binding affinity. BAPKO_0422 was eluted
through the use of 0.3 M imidazole, although 1 M imidazole was used to determine if there
was any strongly binding protein that was not eluting under the influence of 0.3 mM
imidazole, hence creating the appearance of weakly binding protein. This was not the case.
Optimisation suggested that either the His-tag was not properly exposed due to aggregation
formed by hydrophobic interactions, or that the His-tag was being hindered somehow by
being present at the N-terminus of the protein. It is more likely that the protein was not in an
optimal position at the N-terminus as hydrophobic interactions should have been disrupted by
the addition of glycerol. A different purification method such as ion exchange may have more
success due to the large positive charge present (His-tag) or perhaps a different tag such as a
SUMO-tag could be used.
It was possible to refold BAPKO_0422 in LDAO on the benchtop as described (section
2.2.10.2). However, a protocol for refolding of the protein on the column was conducted to
increase purification efficiency. This was achieved using a system of buffers to lower the
denaturant concentration in the presence of an introduced detergent. Initially the each
refolding buffers were equilibrated on the column and left to sit for 30 minutes to allow
refolding to occur. Optimisation of the method found that this was unnecessary and that the
buffers could be loaded and once equilibrated the next buffer loaded. In the future the next
optimisation step would be to trial a gradient from 6 M to 0 M GuHCl using just two buffers;
this would save preparation time and provide further automation for the process. The
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successful refold of protein by both methods was confirmed (after SEC) by Circular
Dichroism (chapter 5).
Size exclusion chromatography is a technique used to separate proteins based on the
molecular weight and overall size and shape. The elution volume can be used to calculate the
molecular weight of the protein based on a calibration curve of proteins of known size and
shape. In the case of BAPKO_0422, SEC was used to obtain an estimation of sample purity
and not an accurate approximation of molecular weight. As BAPKO_0422 is a TM protein
and requires detergent to ‘protect’ the hydrophobic core, a large unknown amount of
detergent binds the hydrophobic region in an unknown configuration (section 2.2.16.3, Figure
2.7). Thus the overall size, shape and molecular weight of the protein-detergent complex is
unknown, preventing accurate calculation of the molecular mass or oligometric state. Asharp
peak was present, suggesting that at least a portion the protein was pure; however the peak
was followed by several smaller peaks. This is potentially a result of differing numbers of
detergent molecule binding the hydrophobic region, with a large number forming something
similar to a complete micelle and the later eluting molecules having fewer detergent
molecules bound. There should be no molecules smaller than ~10 kDa present as the sample
was concentrated by centrifugation using a 10,000 Da mwco concentrator. A very rough
approximation of molecular weight was calculated using the elution volume of the peak and
assuming that a full LDAO detergent micelle formed around the hydrophobic core. From the
calibration curve (section 2.2.11, Figure 2.5) it was approximated that the protein and LDAO
micelle were present in a 1:1 ratio. Analysis of the absorbance of BAPKO_0422 at 320 nm
showed very little absorbance, suggesting minimal aggregation.
Chapter 5. Structural and functional studies of BAPKO_0422
5.1 Circular dichroism
Protein circular dichroism (CD) is the measure of the difference in absorbance of right and
left handed circularly polarised light over a range of wavelengths by an optically active
sample, and the use of this data to calculate the percentage composition of protein secondary
structure (Kelly et al., 2005). CD is an important technique in determining the secondary
structure of proteins as it can be carried out in a variety of buffers under denaturing
conditions, allowing for observation of conformational changes (due to ligand binding,
temperature or the presence of denaturants for example) and differences in structure between
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mutants (Greenfield, 2006, Kelly et al., 2005). Whilst CD is a low resolution technique
compared to X-Ray crystallography and NMR spectroscopy, the ability to calculate the
overall percentage composition of protein secondary structure using CD is a useful technique
to aid the determination of high resolution structures by providing preliminary data with
regards to the structure and stability (Kelly et al., 2005).
The paths of left-handed (L) and right-handed (R) polarised light trace out circles (hence
circular polarised light), and are 90 ° out of phase with each other (Greenfield, 2006).
Assuming that the magnitudes of L and R are equal to each other, when viewed from the
front, this wave appears as two equal length circular vectors, one left handed and one right
handed (Figure 5.1 A (I), blue circle). The addition of the vectors produces planar polarised
light (red arrows, Figure 5.1 A (I)). This occurs when L and R are absorbed equally by
samples, or not at all (achiral molecules). This does not produce a CD signal. However,
unequal absorption of L and R by optically active samples results in the plane of the light
wave being rotated upon addition of the vectors creates an ‘elliptical’ polarisation (red
ellipse, Figure 5.1 A (II) & Figure 5.2) (Kelly et al., 2005). This is the origin of the CD effect
(Greenfield, 2006).
Figure 5.1. The CD effect. A) Left and Right polarised light in the plane of polarised radiation. (I) – both L and R have the
same polarisation magnitude, which when combined generate planar polarised light (red arrows). (II) L and R are polarised
to different degrees, producing an elliptically polarised signal (red dotted line). B) Absorption and CD spectra, 1 – L
absorbed more than R, 2 – R absorbed more than L, 3 – an achiral molecule, from which no CD signal is observed. Diagram
based on (Kelly et al., 2005).
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Figure 5.2. Addition of L and R polarised light of different magnitudes. A) Right-handed polarised light, B) R absorbed
more than l, addition of the two vectors results in elliptically polarised light and the CD signal, C) Left-handed polarised
light.
The generated CD signal is reported in many units, the most common of which are;
differential absorbance ( Δ A), molar circular dichroism ( Δ ε ), degrees of ellipticity ( θ ), and
molar ellipticity [ θ ]. The CD signal is calculated using the equation:
∆ = −
Equation 3. Calculation of Δ A. AL and AR are the absorption of left and right handed polarised light respectively. For
achiral molecules, Δ A = 0 as the absorption of R and L will both be 0, this is ore applicable to small chemical molecules
however.
Degrees of ellipticity is defined as the tangent of the ratio of the minor to major elliptical axis
(Greenfield, 2006). The magnitude of θ  varies depending upon the concentration of protein in
the sample and path length. Hence molar ellipticity [θ ] is more commonly used; molar
ellipticity is the CD signal corrected for concentration and path length (∆A / (molar
concentration x path length)) and has units of degrees cm-2 dmol-1 (James and Wallace,
2009). The CD spectrum of a sample is obtained by CD signal as a function of wavelength
(Kelly et al., 2005).
Different structural elements of proteins have different characteristic CD spectra (Figure 5.3).
α -helices have negative peaks at 208 and 222 nm and a positive peak at 193 nm, β -sheets
have a negative peak at 218 nm and a positive peak at 195 nm, proteins that are disordered
give a very low ellipticity signal above 210 nm and have a negative peak at approximately
195 nm (Greenfield, 2006). The CD signals characteristic of each type of secondary structure
arise due to differential absorption by the peptide bond (amide chromophores) between
residues that are either chiral or present in chiral environments created by different types of
ordered folding (Kelly et al., 2005). The peptide bond has two electron transitions that
contribute to CD signal, one at ~220 nm and the second at ~190 nm.
Figure 5.3. Example CD spectra. A
representation of three main secondary 
More detailed secondary structure CD 
dashed line; anti-parallel β -sheet, dotte
random coil.
A
n example of far UV CD spectra of various secondary
structure spectra (Nelson and Cox, 2008) reported as mol
spectra (Kelly et al., 2005) reported as molar ellipticity. 
d line; type I β -turn; cross and dashed line, extended 31-
B
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5.1.1 Circular dichroism of BAPKO_0422
The N-terminal domain of E. coli OmpA has previously been analysed (Figure 5.4 - white
squares). This provided a known reference spectra for a small TM β -barrel.
Figure 5.4. CD spectra of E. coli OmpA TM domain. White squares denote the N-terminal β -barrel domain from E. coli
(Sugawara et al., 1996). The negative peak occurs at approximately 215 nm and the positive peak at 200 nm. The peaks
occur at wavelengths expected for predominantly β -stranded proteins (Greenfield, 2006). The white and black circles
represent the CD spectra of whole OmpA purified in octyl-POE and SDS respectively.
CD data from BAPKO_0422 was collected using a JASCO J-810 spectropolarimeter at the
University of York as described in section 2.2.14 at two different concentrations (Figure 5.5
& Figure 5.7) in an effort to obtain as much data as possible. Data was processed using the
online web server DichroWeb (Lobley et al., 2002, Whitmore and Wallace, 2004, Whitmore
and Wallace, 2008) which uses a selection of algorithms to calculate the % secondary
structure present. The algorithms CDSSTR and SELCON3 were chosen for analysis.
CDSSTR discounts proteins from the reference sets that are not relevant to the experimental
protein (Compton and Johnson, 1986), while SELCON3 analyses and refines the results as
analysis progresses (Sreerama et al., 1999). Both of the algorithms used a set of reference
spectra for comparative analysis. There were several reference sets to choose from, sets 4 and
7 were selected as they were optimised for data in the range 190 - 260 nm (Janes, 2008), the
same range of data which was acquired for BAPKO_0422.
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Figure 5.5. CD of 0.33 mg/ml BAPKO_0422. Spectra collected at 20 °C in 0.1 % (w/v) LDAO, 0.3 M NaCl, 30 mM Tris-
HCl, pH 8. Once the H[T] voltage crosses 600 V (dashed green line) the data at lower wavelengths becomes unusable as the
data greatly varies. Data was acquired at a protein concentration of 0.33 mg/ml in 0.1 % (w/v) LDAO, 0.3 M NaCl, 30 mM
Tris-HCl, pH 8) between wavelengths of 190 - 260 nm, however data is only useable above 198 nm. The overall shape of the
experimental data up to this point (195 – 260 nm) is characteristic of β -stranded protein and very similar to that of E. coli
OmpA (Figure 5.4). Data was acquired in triplicate, shown is a representative trace.
The spectra produced (Figure 5.5) has the same shape and has peaks at similar wavelengths
as the E. coli N-terminal domain (Figure 5.4). The experimental data was submitted to the
online server Dichroweb and analysed using algorithms SELCON3 and CDSSTR with
reference datasets 4 and 7. The results are displayed below (Table 5.1), with the predicted fit
of the calculated secondary structure percentages plotted with the experimental data (Figure
5.6).
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Figure 5.6. Plots of BAPKO_0422 DichroWeb analysis. Green lines show experimental data, blue lines show data
calculated by the algorithms to fit the calculated secondary structure. The pink lines are the difference between the two
spectra. A) and B) are plots from SELCON3 analysis using reference datasets 4 and 7 respectively. Each reference set is
comprised of a majority of soluble globular proteins, with few transmembrane β -barrel proteins. The experimental data
varies greatly from the calculated spectra, suggesting a poor fit of the data (Whitmore and Wallace, 2004). (C) and (D) are
plots produced by CDSSTR using reference datasets 4 and 7 respectively (Janes, 2008). Whilst there is a difference between
the experimental and calculated data, the difference is not as large as that between the experimental and expected data in (A)
and (B), which suggests a more accurate calculation of % secondary structure.
Each algorithm produced a theoretical CD spectra for a protein with the % secondary
structure calculated (Figure 5.6). CDSSTR was preferred as this discounted reference sets
dissimilar to OmpA; β -barrel proteins are under-represented in the reference sets, hence
CDSSTR analysis should be more accurate. SELCON3 was used as a comparison which took
into account all reference datasets.
The H[T] exceeded 600 V before data at 190 nm had been obtained and so data was acquired
at a second concentration; BAPKO_0422 was diluted to 0.166 mg/ml in an effort to acquire
data at lower wavelengths and run again (Figure 5.7).
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C D
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Figure 5.7. CD spectra of 0.166 mg/ml BAPKO_0422. Spectra acquired at 20 °C in 0.1 % (w/v) LDAO, 0.3 M NaCl, 30
mM Tris-HCl, pH 8. The dashed green line at 600 V highlights the point at which the CD signal becomes unreliable. The CD
data obtained up to that point is indicative of β -stranded secondary structure with the peaks at approximately the same
wavelengths as the N-terminal domain from E. coli OmpA.
As with the spectra obtained at 0.33 mg/ml, (Figure 5.5), this spectra has the same shape and
has peaks at similar wavelengths as the E. coli N-terminal domain (Figure 5.4). The data
obtained were analysed using the online server DichroWeb using the algorithm CDSSTR in
conjunction with reference sets 4 & 7 (displayed along with analysis of data acquired at 0.166
mg/ml in Table 5.1). Analysis of the data plots also produced comparisons of the calculated
spectra to the experimental spectra (Figure 5.8).
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Figure 5.8. CDSSTR analysis of BAPKO_0422 at 0.166 mg/ml. The experimental data is a very close fit to the Mean
residue ellipticity calculated from the data, suggesting a good fit of the results.
The results from 0.33 mg/ml and 0.166 mg/ml data were averaged (Table 5.1).
Conc
(mg/ml) Algorithm
Reference
set Helix1 Helix2 Strand1 Strand2 Turns Unordered Total
0.33
SELCON 4 -0.012 0.012 0.297 0.189 0.226 0.244 0.956
SELCON 7 -0.010 0.013 0.295 0.190 0.229 0.239 0.956
CDSSTR 4 0.00 0.05 0.31 0.14 0.20 0.30 1
CDSSTR 7 0.00 0.02 0.26 0.14 0.21 0.36 0.99
Average - -0.006 0.024 0.291 0.165 0.216 0.286 0.976
Total CDSSTR 0.33 0.035 0.425 0.205 0.33 -
0.166
CDSSTR 4 0.01 0.07 0.23 0.14 0.22 0.33 1
CDSSTR 7 0.00 0.03 0.23 0.13 0.18 0.41 0.98
Average - 0.005 0.05 0.23 0.135 0.20 0.37 0.99
Total 0.166 0.055 0.365 0.20 0.37 -
-
Averaged CDSSTR
data 0.045 0.395 0.203 0.35 0.99
Table 5.1. Results from DichroWeb analysis. The helix and strand columns are split into regular (1) and distorted (2)
categories (Sreerama et al., 1999). Despite SELCON3 being expected to give different results to CDSSTR, the percentages
are in reasonable agreement with very low helical content and a large fraction of β -stand/turn. Nevertheless SELCON3
results have not been included in the average data. Averaging the 0.33 mg/ml data calculated by CDSSTR reveals that over
40 % of the structure is β -stranded and approximately a third is unordered. Analysis of 0.166 mg/ml data using CDSSTR and
reference sets 4 and 7 calculated a smaller percentage of β -strand and higher percentage of turns and unordered secondary
structure compared to data at 0.33 mg/ml.
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Analysis of the calculated secondary structure percentages found that BAPKO_0422 is
approximately 40 % β -sheet, 20 % turn and 35 % unordered. This is consistent with an OM-
spanning protein.
OM-spanning β -barrel proteins are expected to remain stable above 100 °C (Sugawara et al.,
1996), hence CD spectra were obtained at increasing temperatures (45 °C to 90 °C in 15 °C
increments) to observe the thermal stability of the protein (Figure 5.9 & Table 5.2).
Figure 5.9. CD spectra of BAPKO_0422 at various temperatures. Protein analysed at a concentration of 0.166 mg/ml and
at five different temperatures. The data sets are cut off where the H[T] exceeded 600 V.
Each of the spectra has a shape similar to that of the N-terminal OmpA domain (Figure 5.4)
with peaks at the same wavelengths.
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Temp. (°C) Reference
set Helix1 Helix2 Strand1 Strand2 Turns Unordered Total
20 4 0.00 0.05 0.31 0.14 0.20 0.30 1
20 7 0.00 0.02 0.26 0.14 0.21 0.36 0.99
45 4 0.01 0.05 0.26 0.13 0.22 0.32 0.99
45 7 0.00 0.02 0.25 0.13 0.20 0.39 0.99
60 4 0.00 0.06 0.25 0.13 0.25 0.30 0.99
60 7 0.00 0.02 0.20 0.11 0.18 0.47 0.98
75 4 0.01 0.07 0.24 0.12 0.27 0.28 0.99
75 7 0.00 0.03 0.21 0.11 0.21 0.42 0.98
Table 5.2. DichroWeb analysis of BAPKO_0422 at varying temperatures. The data obtained at each temperature was
analysed using CDSSTR using reference sets 4 and 7. The 20 °C data is that analysed previously (Table 5.1). Data obtained
at 90 °C could not be analysed by the online server. The percentage β -strand has decreased by approximately 13 % once the
protein reaches 75 °C.
Overall there is very little change in secondary structure with heating; only a gradual decrease
in the % β -stranded structure with heating. This is not unexpected as the purified N-terminus
of E. coli OmpA has been shown to be stable at 100 °C (Sugawara et al., 1996).
The reference datasets 4 and 7 used by SELCON and CDSSTR are based predominantly on
soluble globular proteins, with few representative membrane proteins. As BAPKO_0422 is
predicted to be a membrane spanning beta barrel, it would be informative to compare the CD
spectra with a similar protein. To this end theoretical CD spectra of E. coli OmpA, OmpW
and OmpX were calculated using the DichroCalc webserver (Bulheller and Hirst, 2009). The
wavelength range was set to 190 – 260 nm with 0.5 nm steps to match the experimental data
obtained from BAPKO_0422 (Figure 5.10).
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Figure 5.10. Predicted CD spectra of known OM proteins from E. coli. Spectra generated from the .pdb files for 1BXW
(OmpA), 1QJ8 (OmpX) and 2F1T (OmpW) using the online webserver DichroCalc (Bulheller and Hirst, 2009). Compared
to the experimental BAPKO_0422 data collected at 0.166 mg/ml (Figure 5.7) the overall shape of the curve is very similar,
with the most negative value approximately one third the value of the peak.
The predicted spectra all have positive and negative peaks at approximately the same
positions as the N-terminal E. coli domain (Figure 5.4) and BAPKO_0422 (Figure 5.5, Figure
5.7 and Figure 5.9); OmpX however is predicted to have peaks (both positive and negative) a
couple of nm lower than both OmpA and OmpW.
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5.2 SEC-MALLS
Size Exclusion Chromatography-Multi Angle Laser Light Scattering (SEC-MALLS) was
used to determine the oligomeric state of BAPKO_0422 in solution. This is achieved using
the protein concentration (c), a constant (K), the difference between intensity of light at zero
angle and scattered ( Δ LS) and dn/dc (the refractive index increment of the protein which
relates changes in refractive index (RI) to protein concentration). K is dependent on the RI of
blank buffer, wavelength used, the scattering angle and distance between scattering and the
detector. The dn/dc value for BAPKO_0422 in detergent was not known, hence the default
value for soluble proteins of 0.187 ml/g was used.
A sample of BAPKO_0422 was concentrated to 4 mg/ml in 0.1 % (w/v) LDAO, 0.3 M NaCl,
50 mM Tris-HCl, pH 8.0 and centrifuged at 14,500 rpm in a bench top centrifuge for 15
minutes to remove any protein aggregates. 150 µl of sample was loaded onto the SEC-
MALLS system.
Figure 5.11. SEC-MALLS trace of BAPKO_0422. Data was acquired at a concentration of 4 mg/ml in SEC buffer. The
gray highlighted area was selected for analysis. Light scattering is measured on the primary axis along with UV absorbance
at 280 nm.
Separation was achieved using three Agilent PL Aquagel-OH (40, 50 and 60) SEC columns
linked sequentially. The UV trace showed elution at approximately 58 minutes (Figure 5.11).
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The span of the peak from 58.006 to 60.256 minutes was analysed assuming a dn/dc value of
0.187 ml/g with manually adjusted background levels for all light scattering detectors. This
produced a molecular weight of 22.96 kDA (± 9 %), which corresponds with the expected
molecular weight of the protein including His-tag as calculated using the ExPASy ProtParam
tool - 22.68 kDA (Gasteiger et al., 2005). The polydispersity was calculated to be 1.001 (± 12
%), showing that the protein is monomeric under the conditions tested.
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5.3 Small Angle X-Ray Scattering
X-Rays are plane waves, which have a regular waveform with a distinctive sinusoidal shape
(Figure 5.12) (Blow, 2002). When X-Rays pass through matter, scattering by electrons
occurs. The electrons resonate with the frequency of X-rays passing through the objects and
emit coherent secondary photons or wavelets (Jacques and Trewhella, 2009) which interfere
with each other (Glatter and Kratky, 1982). The electron may oscillate with the same
frequency as the X-ray and radiate an X-Ray photon of the same energy and wavelength in a
random direction, whilst remaining in phase. The two possible outcomes are constructive and
deconstructive interference (or coherent and incoherent scattering) (Jacques and Trewhella,
2009). Interaction of an X-ray with electrons may also result in atomic transitions within the
atom and the release of photons with lower energy than the original X–ray, leading to
incoherent scattering (Blow, 2002).
Figure 5.12. The sine wave of an X-ray. A basic representation of an uninterrupted X-ray.
Both X-Ray crystallography and SAXS take advantage of an inverse relationship between
scattering and the molecules. In structure determination by X-Ray crystallography the inverse
relationship is between the spacing of unit cells in the crystal (real lattice) and the spacing of
reflections on the detector (reciprocal lattice); enabling calculation of the atomic distances in
real space (Rhodes, 2000). In SAXS the particle size is inversely proportional to the angle at
which X-Rays are scattered, facilitating calculation of the particle size (Glatter and Kratky,
1982).
Wavelength - λ (nm)
Amplitude
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Small Angle X-Ray Scattering (SAXS) is an analytical technique used to study structural
features of colloidal size (Glatter and Kratky, 1982). As stated the scattering of X-rays by
particles in solution or a solid object is the product of an inverse relationship between the size
of the particle and the angle of scattering (Figure 5.13) (Glatter and Kratky, 1982). As SAXS
is conducted in solution, the rotational averaging of X-Ray scattering limits the resolution of
the data obtained, however analysis of SAXS data is capable of producing precise
information about the size and shape (Jacques and Trewhella, 2009).
Figure 5.13. Scattering angle relative to particle size. A) A small spherical particle. B) A large spherical particle.
Assuming the waves scattered from the two points at an angle of 2θ have a distance of 1 λ . In a larger molecule, the distance
of 1 λ  will occur at narrower scattering angles, hence the inverse relationship between particle size and scattering angle.
Image based on (Glatter and Kratky, 1982). In homodisperse solutions, the scattering intensities of the particles will
accumulate.
The scattering pattern produced by SAXS is described by the intensity (I) as a function of the
amplitude of the scattering vector (q) (Jacques and Trewhella, 2009).
= 4
Equation 4. Small angle scattering as a function of q. 4 π sin θ / λ represents the intensity of small angle scattering (I).
5.3.1 Control analysis (lysozyme)
A control experiment using 10 mg/ml lysozyme was used as a protein standard to establish
that proper background subtraction has been performed. Poor background subtractions can
lead to significant sources of error (Jacques and Trewhella, 2009), in addition different
methods of background subtraction have different sources of error, hence multiple
background subtractions should be used. The background was measured using different
buffers (both with and without LDAO) and through the use of lysozyme as a control standard.
Close agreement in the background scattering in conjunction with a linear Guinier plot and
A
1 λ
2 θ
B
1 λ
2 θ
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“well-behaved P(r) function” is strongly indicative of a monodisperse system (Jacques and
Trewhella, 2009).
In order to determine the effect of detergent on the scattering pattern data was collected from
buffer containing 0 % (w/v), 0.1 % (w/v) and 0.01 % (w/v) LDAO (buffer compositions
Table 2.2). The salt background (0 % detergent) scattering pattern was subtracted from data
sets of both buffers and so the contribution of salt to scattering patterns was observed. This
was found to be negligible. Scattering data produced by 10 mg/ml Lysozyme in two buffers
with different concentrations of LDAO (0.1 (w/v) & 0.01 %(w/v)) (Figure 5.14 A & B and C
& D respectively) was obtained in duplicate over a period of 24,000 seconds.
Figure 5.14. Scattering produced by 10 mg/ml Lysozyme in 0.1 and 0.01 % (w/v) LDAO. All data is averaged after
software background scattering subtraction. Blue data has had the scattering from a water background automatically
subtracted, green data has had background scattering from buffer subtracted. A) 0.1 % (w/v) LDAO - Plot of raw scattering
intensity of lysozyme. B) 0.1 % (w/v) LDAO - Guinier plot, C) 0.01 % (w/v) LDAO - Plot of q vs scattering intensity. D)
0.01 % (w/v) LDAO - Guinier plot data was acquired in duplicate over a period of 24,000 seconds per acquisition, data
plotted on both graphs is the average of both acquisitions minus the background scattering recorded (not shown). Plots were
normalised through the subtraction of the average scattering intensities at high q. All data sets shown were collected in
duplicate, averaged and corrected for thermal background. There is a visible difference at low q in the intensity of scattering
produced by lysozyme when different background data sets are used, highlighting that the detergent contributes to observed
scattering and must be accounted for. Analysis using water analysis in B appears to have a small upturn at low q2, suggesting
aggregation of the sample; this may be an artefact produced by not accounting for detergent scattering.
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5.3.1.1 Calculating the radius of gyration (Rg) of lysozyme
From the scattering pattern, many analyses can be conducted; primarily calculation of the
radius of gyration (Rg). The Rg provides information about the mass distribution within a
particle and is defined as the root-mean-squared distance of all elemental scattering volumes
from their centre of mass weighted by scattering densities (Jacques and Trewhella, 2009);
providing a measure for the spatial size of the particle (Glatter and Kratky, 1982). Simply put,
the Rg is the distance in a rotating system between the point at which it is rotating and the
point at which the mass about the axis will be concentrated. Objects with the same volume
but different shapes will have different Rg values (Jacques and Trewhella, 2009). The Rg of a
spherical molecule can be calculated using the slope of the Guinier plots by application of the
Guinier approximation at low q using the following equation:
= √−3
Equation 5. Calculating the radius of gyration for a spherical object from a Guinier plot. m = the slope of the line. The
radius of gyration for a sphere was calculated as the protein-detergent complex was calculated as this was deemed to give the
most accurate result. As the scattering patterns are rotationally averaged the best estimate for radius of gyration would be
one that affords equal weighting in all directions (spherical Rg). This gives the Rg in nm so a 10 x multiplication is required
to convert to Å
From the raw data, information about the state of the solution is available; any upturn in the
data at low q2 on a Guinier plot is a good early indicator of protein aggregation, whilst a
downturn can be symptomatic of interparticle interference (Jacques and Trewhella, 2009).
The Rg for lysozyme was calculated using the slope of the Guinier plots (Table 5.3) and
Equation 5. Calculation of the Rg from lysozyme was found to vary depending on the
background scattering subtracted (Table 5.3).
Buffer Background scattering Rg (Å)
0.1 % (w/v) LDAO Water 19.0
0.1 % (w/v) LDAO Detergent 15.6
0.01 % (w/v) LDAO Water 17.4
0.01 % (w/v) LDAO Detergent 15.6
Table 5.3. Calculated Rg of lysozyme. The radius of gyration for lysozyme was calculated using the slope of the Guinier
plots (Figure 5.14 B & D) after any upturn in data and Equation 5. The Rg was found to be the same when using each
detergent background-subtracted data. However when the Rg is calculated using water background-subtracted data the Rg is
different depending on the concentration of LDAO. This highlights the necessity to compensate for the scattering produced
by detergent molecules/micelles.
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The use of detergent-background subtracted data gives a more precise value, remaining the
same despite differing buffer concentrations, confirming the detergent contribution to the
scattering pattern. The Rg for lysozyme calculated by PRIMUS (part of the ATSAS data
package) in 0.01 % (w/v) LDAO detergent background-subtracted was 15.4 Å (data not
shown), and 15.5 Å for lysozyme in 0.1 % (w/v) LDAO (data not shown) both of which are
in close agreement with the detergent background subtracted data in Table 5.3 above.
Averaging the four Rg values with detergent background subtraction gives an Rg for
lysozyme in LDAO of 15.53 ± 0.02 Å. The error quoted is the standard error of the mean.
The Rg for lysozyme obtained from both detergent background-subtracted samples is in
relatively close agreement with previous experimental data; 16.3 Å at 20 °C (Arai and Hirai,
1999).
5.3.1.2 Evaluation of the particle distance distribution function
The particle distribution function - P(r) - is an indicator of the quality of the data and amount
of protein aggregation. The P(r) is obtained through a Fourier transform of the raw scattering
data (Jacques and Trewhella, 2009). Aggregated samples may give one or more small peaks
at high R values and samples experiencing interparticle interference may reach 0 at Dmax
(distribution at longest particle dimensions) values smaller than expected. Dmax is selected
upon input of the data into GNOM (defined as Rmax) and if Dmax reaches 0 abruptly it is
likely that the value needs increasing. The P(r) function is also an indicator of interparticle
distances (particle overlap); if there are multiple peaks or a shoulder on a peak this is an
indicator that the particles are overlapping in solution (Roe, 2000).
GNOM is an indirect transform program for interpretation of small angle scattering data
(Svergun, 1992). The data submitted to PRIMUS was run through GNOM and plotted as a
reciprocal space fit (Figure 5.15). Default parameters were used except those stated in section
2.2.15.2. The Rg calculated from the reciprocal space fit (Figure 5.15) is 16.39 Å, which is in
very strong agreement with the published value of 16.3 Å (Arai and Hirai, 1999).
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Figure 5.15. GNOM reciprocal space fit of 10 mg/ml lysozyme. Data collected in 0.1 % (w/v) LDAO, 0.3 M NaCl, 30
mM Tris-HCl, pH 8). The smooth blue line (Ireg_LYS.dat-1-4) is the GNOM fit to the data, the other blue line is the
experimental data (Jexp_LYS.dat-1-1) and the red line is the experimental input points used for regularisation
(Jexp_LYS.dat-2-2) (Svergun, 1992). ‘q’ is designated ‘s’ in the program. The fit of the GNOM plot to the experimental data
is in close agreement.
Scattering curves are used to generate the particle distance distribution function P(r) and size
distribution function D(R) for mono and poly-disperse systems respectively; this conversion
is capable of compensating for data that has been subjected to ‘smearing’ by distortion from
the instruments. As all samples in this research were expected to be monodisperse (confirmed
by the calculated P(r) functions) P(r) was used. P(r) is obtained by Fourier inversion of the
scattering data (Glatter and Kratky, 1982). The conversion requires several parameters,
including two that are important in obtaining a good P(r): ALPHA and Dmax. GNOM
automatically calculates various values for ALPHA (a regularisation parameter) and plots the
distribution of various alpha values against the quality of the solution (Svergun, 1992). The
larger the alpha, the more attention paid to the smoothness of the solution, and less attention
to fitting the experimental data. Dmax as previously mentioned is the maximum expected
particle size (or the distance between particles at which no overlap is expected (Roe, 2000))
Figure 5.16 & Figure 5.17 show the calculated P(r) for lysozyme using three different values
for Dmax to determine the correct one for use.
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Figure 5.16. P(r) of lysozyme in 0.1 % (w/v) LDAO with a Dmax of 50. Error bars have been automatically calculated and
incorporated into the plot. There is no secondary peak at high R suggesting that there is either no or little aggregation in the
sample. The plot reaches 0 at a steady rate, indicating that Dmax of 50 is a good estimate and the lack of further peaks
suggests no particle overlap.
Figure 5.17. P(r) plots of lysozyme in 0.1 % (w/v) LDAO with Dmax values 40 & 60. A) Dmax of 40; B) Dmax of 60. With a
Dmax value of 40 the plot reaches 0 abruptly, indicating that the value is too small; a value of 60 results in a curve that results
in a negative P(r) at high values, indicating that this value is too large.
One of the final outputs is a rating for the solution calculated with regards to the data. Here
the total estimate value calculated was 0.898, indicating a “GOOD” solution. There is a
disagreement of 0.9 Å between the Rg calculated manually and by PRIMUS and that
calculated by GNOM. As is visible in Figure 5.15 the data set has some values that do not fit
the curve at low q (s), and the data in general becomes more varied as q approaches 0.2.
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5.3.1.4 Evaluation of the model
DAMSEL and DAMSUP were used to evaluate the fit of molecular envelopes by comparison
to an averaged solution created using all ten of the generated models (Table 5.4). If any
models were too different from the average they were discarded and not used for the rest of
the analysis.
Solution Average DAMSEL
comparison NSD
Include/discard for
DAMSUP
DAMSUP
superimposition NSD
value
F 0.498 Reference Reference
E 0.509 Include 0.498
I 0.510 Include 0.495
H 0.510 Include 0.494
D 0.514 Include 0.493
J 0.514 Include 0.488
B 0.516 Include 0.492
C 0.520 Include 0.495
A 0.521 Include 0.503
G 0.544 Discard -
Table 5.4. DAMSEL comparison of lysozyme molecular envelope solutions. The overall mean NSD (section 2.2.14.2) for
all models was 0.516 and the variance 0.012; giving NSD limits for accepting models of 0.492 and 0.540. All of the models
with the exception of solution G fit within this range. All solutions except for G were included for further analysis. Each of
the solutions shown in Figure 5.18 that were accepted by DAMSEL (include/discard column) were superimposed onto
solution F (being used as a reference sample) and the NSD values relative to this reference were calculated.
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The control analysis using lysozyme was a success. The scattering caused by detergent was
compensated for by the software, the Rg calculated was very close to that in the literature and
an accurate molecular envelope was generated.
5.3.2 Experimental analysis, BAPKO_0422
Data for BAPKO_0422 was collected at two different concentrations to provide information
about the quality of the sample. If the sample is of good quality (e.g. monodisperse and
devoid of interparticle interference) the calculated Rg should remain consistent regardless of
protein concentration; an increase in Rg with an increase in concentration is indicative of
protein aggregation, whilst a decrease in Rg with an increase in concentration is a sign of
interparticle interference (Jacques and Trewhella, 2009). Figure 5.21 shows an example of
the scattering pattern obtained from BAPKO_0422 in SAXS 0.1 % (w/v) LDAO buffer.
Figure 5.21. Scattering pattern produced by BAPKO_0422 in solution. Data collected in house on a Bruker
NANOSTAR over a period of 65,000 seconds at a concentration of 10 mg/ml in 0.1 % (w/v) LDAO SAXS buffer.
5.3.2.1 Calculation of the Rg for BAPKO_0422
SAXS data was acquired for BAPKO_0422 at concentrations of 6 and 10 mg/ml in 0.1 % (w/v) LDAO, 0.3 M NaCl,
30 mM Tris-HCl, pH 8.
Figure 5.22 shows raw data and Guinier plots from BAPKO_0422 at a concentration of 6
mg/ml. The dataset is plotted twice; normalised using a thermal background (Figure 5.22 A)
and normalised manually to 0 with the aggregation data upturn at low q and noise at high q
removed (Figure 5.22 C). Each dataset has been converted to a Guinier plot (Figure 5.22 B
and D respectively).
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BAPKO_0422 is predicted to be a barrel shaped molecule, however the Rg was calculated
assuming a spherical molecule. However the Rg was calculated assuming the molecule was
spherical to give an approximation of particle size.
Figure 5.22. SAXS data obtained from 6 mg/ml BAPKO_0422. A) and C) are plots of the scattering. (A) shows the
calculated thermal background (red), (C) has been manually adjusted to a baseline of approximately 0. B) and D) are the
respective Guinier plots of (A) and (C). (B) was produced using data with the calculated thermal background subtracted. The
dark blue data in plot (B) is discounted in the Rg calculation as the slope suggests slight aggregation.
The Rg was calculated for BAPKO_0422 at 6 mg/ml assuming a spherical molecule from
each Guinier plot - 18.2 Å (Figure 5.22 B) and 18.6 Å (Figure 5.22 BD). The difference
between the two is very small as the upturn in data at low q (Figure 5.22 B, dark blue data)
which would have affected the slope of the line has been discarded from analysis. The raw
data and Guinier plots for BAPKO_0422 at 10 mg/ml are presented in Figure 5.23. The 10
mg/ml dataset was plotted in three ways (Figure 5.23); normalised using a thermal
background (Figure 5.23 A), normalised to 0 by manual subtraction (Figure 5.23 C) and (C)
with the data at low q removed (Figure 5.23 E). Guinier plots of each have been produced.
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Figure 5.23. SAXS data obtained from 10 mg/ml BAPKO_0422. A), C) and E) are plots of the raw scattering, A includes
the thermal background (red line), (C) has had the data manually normalised to a baseline of 0 and truncated at high q, (E) is
(C) with data truncated at low q. B), D) and F) are Guinier plots produced from (A), (C) and (E) respectively. The dark blue
data points in (B) are not included in the Rg calculation, in addition, (B) has had the thermal background subtracted. E is the
same dataset as (C) with the first 12 data points removed as the angle of the slope indicated aggregation.
The Rg calculated using the slope of the Guinier plot Figure 5.23 B was 22.1 Å, compared to
that of 21.4 Å from Figure 5.23 D (the upturn in data at low q2 was not included). The Rg
calculated from Figure 5.23 F was 21.4 Å. As with 6 mg/ml datasets, the calculated Rg from
10 mg/ml datasets are in close agreement, this is however a rough approximation as
0
2000
4000
6000
8000
10000
12000
0.0 1.0 2.0 3.0
In
te
n
sit
y
q (nm-1)
10 mg/ml raw data
OmpA
Thermal
background
-2.0
0.0
2.0
4.0
6.0
8.0
10.0
0.0 0.5 1.0 1.5 2.0 2.5
ln
 
(I)
q2 (nm-2)
10 mg/ml Thermally adjusted Guinier plot
0
100
200
300
400
500
600
700
800
0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
In
te
n
sit
y
q (nm-1)
10 mg/ml normalised raw data
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
0.0 1.0 2.0 3.0 4.0
ln
 
(I)
q2 (nm-2)
10 mg/ml normalised Guinier plot
0
50
100
150
200
250
300
0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
In
te
n
sit
y
q (nm-1)
10 mg/ml normalised and truncated raw data
0.0
1.0
2.0
3.0
4.0
5.0
6.0
0.0 1.0 2.0 3.0 4.0
ln
 
(I)
q2 (nm-2)
10 mg/ml normalised and truncated Guinier plot
A B
C D
E F
Page | 181
evidenced by the 3 Å difference between the Rg values. Rg can be calculated more accurately
by GNOM from the P(r) function, which encompasses the whole dataset rather than a small
section, rather than from the slope of a small region of data points from a Guinier plot
(Jacques and Trewhella, 2009). GNOM was used to calculate the Rg from one 6 mg/ml
dataset (Figure 5.22 A) - henceforth denoted as 6TT (6 mg/ml data, adjusted for Thermal
background and Truncated - data at low q removed), and two datasets from 10 mg/ml data -
Figure 5.23 C, 10N (10 mg/ml data, manually Normalised, data at low q left in) and 10NT
Figure 5.23 E (10 mg/ml data, manually Normalised and Truncated - data at low q removed).
The calculated Rg values are presented in Table 5.5.
I(0) is the scattering intensity at zero-angle, although this cannot be distinguished from X-
rays that pass through the sample unscattered; this value can however be extrapolated
(Jacques and Trewhella, 2009). I(0) is proportional to sample concentration, and
inconsistencies can indicate imperfections in the sample. A decrease in the I(0):concentration
ratio with an increase in concentration suggests interparticle interference (generally observed
in conjunction with a decrease in Rg). An increase in I(0):concentration ratio indicates
concentration dependent aggregation or oligomerisation.
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Program Parameter 6TT 10N 10NT
MANUAL Rg (Å) 18.6 21.4 21.4
PRIMUS
Rg 17.7 ± 0.03 21.8 Å ± 0.04 23.1 Å ± 0
sRg limits 0.857 to 1.21 1.177 to 1.704 1.152 to 1.58
I(0) 116.86 338.94 368.41
Quality 76 % 24 % 41 %
Notes - AGGREGATED -
GNOM
Highest ALPHA 0.3796E+01 0.4045E+02 0.1449E+02
Total estimate 0.617 0.452 0.881
Rated REASONABLE REASONABLE GOOD
Reciprocal space Rg
(Å) 21.50 27.91 21.81
I(0) 0.1460E+03 0.5694E+03 0.3412E+03
Real space Rg (Å) 21.50 ± 0.247 27.85 ± 0.032 21.81 ± 0.215
I(0) 0.1460E+03 ±0.1890E+01
0.5693E+03 ±
0.1742E+01
0.3412E+03 ±
0.3763E+01
Table 5.5. PRIMUS and GNOM analysis. Included in this table are the various Rg values and parameters computed by
PRIMUS and GNOM for each of the three datasets: 6 mg/ml normalised and truncated (6TT), 10 mg/ml normalised (10N)
and 10 mg/ml normalised and truncated (10NT). The calculated Rg values differ between PRIMUS and GNOM due to the
methods of calculation. Comparing the real space Rg and I(0) values of datasets 6TT and 10NT calculated by GNOM; the
real space Rg value remains constant with an increase in concentration, however the I(0) value more than doubles. An
increase in these values is indicative of aggregation, however as only the I(0) increases, aggregation is assumed to not be too
high. The 10NT data was not processed further as the data suggested aggregation.
The Rg for the 10N dataset increased considerably from the 6TT dataset, suggesting that this
data was aggregated. However the Rg calculated from 10NT data showed good agreement
with 6TT Rg. The 10N dataset was discounted from analysis due to the Rg and I(0) compared
to 6 mg/ml data indicating aggregation and GNOM pronouncing the data to be “Aggregated”,
indicating that 10 mg/ml is probably reaching the solubility limit of the protein.
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5.3.2.2 Evaluation of the particle distance distribution function
The datasets acquired at both 6 and 10 mg/ml were run through GNOM using a Dmax of 70 Å
for calculation of P(r) (Figure 5.24). The plots do not reach 0 at a steady slope like the
control lysozyme experiment. This is indicative of particle overlap potentially caused by the
flexible His-tag at the N-terminus.
Figure 5.24. GNOM fit and P(r) plots of BAPKO_0422 datasets. A) dataset 6N; B) dataset 10NT. The smooth blue line
(Ireg) is the GNOM fit to the data, the other blue line is the experimental data (Jexp) and the red line is the experimental
input points used for regularisation (Jexp) (Svergun, 1992). ‘q’ is designated ‘s’ in the program. The fit of the data to
predicted models is good for datasets 6NT and 10NT. The P(r)function for both suggests that even at a distance of 70 Å
there is still particle overlap; this is likely due to either the N-terminal His-tag or flexible loop regions.
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Each of the molecular envelopes (Figure 5.25) was evaluated using DAMSEL and DAMSUP,
which found that all solutions were acceptable (Table 5.6).
Solution Average DAMSEL
comparison NSD
Include/discard for
DAMSUP
DAMSUP
superimposition NSD
value
F 0.523 Reference Reference
C 0.537 Include 0.437
E 0.537 Include 0.512
B 0.538 Include 0.532
A 0.539 Include 0.488
J 0.548 Include 0.542
H 0.550 Include 0.559
D 0.555 Include 0.521
I 0.564 Include 0.562
G 0.579 Include 0.550
Table 5.6. DAMSEL comparison of 6TT molecular envelope solutions. The overall mean NSD for all models was 0.547
and the variance 0.016; giving NSD limits for accepting models of 0.515 and 0.579. All of the models fit within this range
and so all were included for further analysis. Each of the solutions shown in Figure 5.25 was accepted by DAMSEL (third
column from left above) and a molecular envelope created by superimposition onto solution F. The NSD values relative to
this reference were calculated.
The molecular envelopes (F
DAMFILT (Figure 5.26 A - C
& E).
Figure 5.26. 6TT molecular envelope
refined molecular envelope; C) DAMFI
for ease of visibility). DAMFILT has tri
rounder body of electron density and 
molecular envelope relatively well, alt
BAPKO_0422 is predicted to have long
be due to a slightly longer periplasmi
accommodate the peptide chain. D) CRY
experimental data; E) the fit of the D
solution that does not fit the experimenta
The DAMAVER averaged sol
core. DAMMIN used this ‘st
mg/ml dataset (Figure 5.27
excellent overall fit of the solut
A
D
igure 5.25) were averaged by DAMAVE
) and the fit to the data plotted using CRYSO
s after refinement. A) DAMAVER averaged molecular 
LT molecular envelope with 1BXW crystal structure for c
mmed away density at the edges of the DAMAVER averag
a more pointed region at the bottom of the model. 1BX
hough the loop regions make the structure larger than th
er loops than 1BXW. The small region of density at the bo
c turn, or the His-tag; although this is unlikely as the 
SOL plot of the fit of the molecular envelope generate
AMFILT solution to the experimental data. DAMAVER 
l data, the DAMFILT solution however is reasonable.
ution was used by DAMSTART to produce
art-file’ to produce the final molecular env
A & B). CRYSOL evaluation (Figure 5.27
ion to the data.
B C
E
Page | 186
R, refined using
L (Figure 5.26 D
envelope; B) DAMFILT
omparison (coloured red
ed solution resulting in a
W fits in the generated
e region of density and
ttom of the model could
density is too small to
d by DAMAVER to the
as expected produced a
 a model of fixed
elopes from the 6
C) showed an
Figure 5.27. DAMMIN refined molecu
A) and top down B) views are shown 
accessible surface, coloured red for eas
was produced in CRYSOL and the prod
(ChiSQRT value 1.914). The molecular 
there is the possibility that the barrel of BA
A
B
C
lar envelope 6TT. DAMMIN refinement of the molecular 
with and without the crystal structure of 1BXW for comp
ier visibility). C) shows the fit of the model (green) to the
uced molecular envelope fits very well, indicating a good r
envelope appears to be too short and shallow to properly fi
PKO_0422 is a ‘squashed’ barrel similar to OmpX.
Page | 187
envelope. Here the front
arison (showing solvent
 experimental data. This
epresentation of the data
t the structure, although
5.3.2.4 Production o
The GNOM output file from the
molecular envelopes (Figure 5
0.0072
0.0073
Figure 5.28. Molecular envelopes gen
slow annealing. The fit score is includ
appears to be two major types of solut
whilst solutions (B), (C), (E) & (I) appe
a good fit score is highly unlikely to be a
and detergent molecules bound around th
A B
E F
I
f molecular envelope using dataset 1
 10 mg/ml dataset (10NT) was used to pro
.28).
0.0071 0.0072
0.0072 0.0070
0.0070 0.0074
erated from dataset 10NT. Analysis was repeated ten tim
ed underneath each solution, and all solutions have an e
ion to the data; solutions (A), (D), (F), (G) and (H) are ro
ar to have a region of density at the bottom (as viewed). So
n accurate solution. The expected protein shape is a barrel w
e centre of the barrel. The diamond shaped solutions may a
C D
G H
J
Page | 188
0NT
duce the following
0.0070
0.0070
es using DAMMIF with
xcellent fit score. There
ughly diamond shaped;
lution (J), despite having
ith flexible loop regions
ccount for this.
Page | 189
The similarity of generated solutions was compared using the DAMSEL component of
DAMAVER. The DAMSEL output file was run through DAMSUP to produce molecular
envelopes superimposed over the reference model and NSD values for each (Table 5.7).
Solution Average DAMSEL
comparison NSD
Include/discard for
DAMSUP
DAMSUP
superimposition NSD
value
H 0.559 Reference Reference
A 0.574 Include 0.507
B 0.574 Include 0.519
I 0.581 Include 0.494
F 0.586 Include 0.501
D 0.594 Include 0.510
G 0.595 Include 0.482
E 0.602 Include 0.575
C 0.603 Include 0.527
J 0.907 Discard -
Table 5.7. DAMSEL comparison of 10NT molecular envelope solutions. The calculated mean NSD value for all ten
solutions was 0.617, with a variation of 0.103. Any solutions with an NSD more than twice the variance away from the mean
are discarded, in this case the NSD outer limits for accepting solutions are 0.411 and 0.823; hence solution (J) was
discounted from following analysis. The DAMMIF generated molecular envelope models were superimposed onto the
reference solution (molecular envelope (H) - Figure 5.28) and the NSD values relative to this calculated. Solution (J) was
discarded as it did not fulfil the criteria in DAMSEL
Solution J was discarded due to the difference in shape, despite having a score equivalent to
those of the other solutions.
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5.4 Crystallisation trials of BAPKO_0422
To solve the structure of proteins using X-ray diffraction patterns the growth of ordered
protein crystals is required. This occurs when the protein molecules adopt either one or more
(generally not more than two) identical orientations and interact non-covalently in the process
of solidifying (Rhodes, 2000). The orientations of, and interactions between are repeated
throughout the crystal. The smallest repeating ‘pattern’ is known as the unit cell.
Crystallisation of proteins can be achieved using various methods; traditionally through the
slow, controlled precipitation of protein molecules in a ‘mother-liqueur’; non-denaturing,
aqueous conditions including organic and ionic compounds and polymers such as poly-
ethylene glycol (PEG) (Rhodes, 2000). The gradual evaporation of water from the drop
decreases the total volume, increasing the concentration of protein molecules, forcing them
closer together; this supersaturates the drop with protein and enabling spontaneous nucleation
to occur Figure 5.31. Rapid precipitation of protein samples results in unordered protein
crystals from which no data can be obtained (Rhodes, 2000).
Figure 5.31. Theoretical protein crystallisation phase diagram. For a protein crystal to grow, the protein molecules need
to supersaturate the drop to the point where spontaneous nucleation can occur (circled green). A) Protein undersaturated,
hence the drop should remain clear. B) Solubility limit reached when the protein is in equilibrium with precipitant. C)
Metastable zone, supersaturation of protein is high enough to support growth of protein crystals, but not high enough to
support spontaneous nucleation. If a form of seeding is being used, this is the ideal zone. Drops in this zone are also clear. D)
Labile supersaturation zone, spontaneous nucleation of protein molecules can occur in this zone. E) Highly supersaturated
precipitation zone. Protein is present in too high concentration leading to amorphous precipitate. Figure adapted from
(Bergfors, 2003).
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The formation of protein crystals is a trial and error process, not only dependent on the
concentrations of protein and precipitant, but also on incubation temperature, mother liqueur
pH, age of the protein, and ionic strength of the precipitation. Optimisation of the conditions
to improve either the crystal size or diffraction is conducted by inducing slight variation in
these factors, which can either enhance or hinder crystal formation; in addition impurities in
the sample and high concentrations of precipitant can either prevent crystal formation or
result in precipitation out of solution (Rhodes, 2000).
Various method exists for enhancing crystal quality besides optimisation of precipitants.
Nucleation points for crystal growth can be created through the use of crystals broken down
into small pieces (macroseeding) or submicroscopic pieces (microseeding); strands of hair
and grains of sand have also been used to provide focal nucleation points (Bergfors, 2003).
Some proteins require the addition of ligands to assist in crystallisation; these can include
detergents in membrane proteins, or heavy metal cofactors; this can also be used to determine
the interactions of proteins with said ligands or metals. Ligands and cofactors can also be
applied to the protein crystals by ‘soaking’ (Rhodes, 2000).
5.4.1 Known crystallisation of TM β -barrel proteins from E. coli
The structures of N-terminal E. coli OmpA, and E. coli OmpW and OmpX have been solved
by X-ray crystallography (Pautsch and Schulz, 1998, Pautsch et al., 1999, Vogt and Schulz,
1999, Pautsch and Schulz, 2000, Hong et al., 2006). Conditions used to grow these crystals
are included in Table 5.8. These conditions may provide a guideline for protein
concentrations and crystallisation conditions.
OmpA OmpX OmpW
Detergent 0.6% (w/v) C8E4 0.6% (w/v) C8E4 0.1% (w/v) LDAO
Concentration mg/ml 20 20 9
pH 4.5 4.6 8.5 9
Salt 1.4 M (NH4)2SO4 - 0.2 M (NH4)2SO4 0.3 M (NH4)2SO4
Buffer 0.1 M ammonium
acetate
0.1 M acetate 0.1 M Tris 0.1 M Bis-Tris
propane
Additives 3.8 % (v/v) 2-propanol 25 % w/v PEG 3350 17 % w/v PEG 3350
1.8 % (w/v)
hexyldimethylaminoxide
58 % (v/v) methyl-
pentanediol
0.5 % (w/v) C8E4
Table 5.8. Known crystallisation conditions of β -barrel proteins. Data acquired from (Pautsch and Schulz, 1998, Pautsch
et al., 1999, Vogt and Schulz, 1999, Pautsch and Schulz, 2000, Hong et al., 2006).
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5.4.2 Vapour diffusion crystallisation trials
Refolded BAPKO_0422 in 0.1 % (w/v) LDAO was concentrated to 10 mg/ml (as determined
by Bradford Assay) through the use of a 10,000 mwco centrifugal concentrator. Crystal
screening was carried out using 24 condition Clear Strategy Screens (CSS) screens I and II
(made in house, buffered at pH 4.5 and 8) and a 96 condition Memb-PASS Crystallisation
Screen (Jena Bioscience, Jena, Germany). Different drop sizes were used (1 and 2 µl)
consisting of protein and well solution in a ratio of 50:50 and the trays incubated at 20 °C.
Eight CSS crystal screens were set up; CSS I at pH 4.5 and pH 8, and CSS II and pH 4.5 and
pH 8. These were done in duplicate, at protein concentrations of 2 and 10 mg/ml. The Memb-
pass screen was set up in four 24 well plates at 10 mg/ml. All screens were observed under
the microscope immediately after set up and weekly thereafter for any precipitates,
aggregations, phase separations and crystals. For CSS screens I and II the well solution
consisted of 0.9 ml precipitant and 0.1 ml pH buffer. 0.4 ml Memb-PASS well solution was
used neat (no pH buffer required). The conditions in the CSS screens are included (Table 5.9
& Table 5.10), conditions in the Memb-Pass screen are included in the Appendix 8.3.
CSS I
1 2 3 4 5 6
A 0.3M NaAc
25 % (w/v) PEG
2Kmme
0.2M Li2S04
25 % (w/v) PEG
2Kmme
0.2M MgCL2
25 % (w/v) PEG
2Kmme
0.2M KBr
25 % (w/v) PEG
2Kmme
0.2M KSCN
25 % (w/v) PEG
2Kmme
0.8M NAFormate 25
% (w/v) PEG 2Kmme
B 0.3M NaAc
15 % (w/v) PEG 4k
0.2M Li2S04
15 % (w/v) PEG 4k
0.2M MgCL2
15 % (w/v) PEG 4k
0.2M KBr
15 % (w/v) PEG 4k
0.2M KSCN
15 % (w/v) PEG 4k
0.8M NAFormate 15
% (w/v) PEG 4k
C 0.3M NaAc
10 % (w/v) PEG 8K
10 % (w/v) PEG 1K
0.2M Li2S04
10 % (w/v) PEG 8K
10 % (w/v)m PEG 1K
0.2M MgCL2
10 % (w/v) PEG 8K
10 % (w/v)m PEG 1K
0.2M KBr
10 % (w/v) PEG 8K
10 % (w/v)m PEG 1K
0.2M KSCN
10 % (w/v) PEG 8K
10 % (w/v)m PEG 1K
0.8M NAFormate 10
% (w/v) PEG 8K
10 % (w/v)m PEG 1K
D 0.3M NaAc8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
0.2M Li2S04
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
0.2M MgCL2
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
0.2M KBr
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
0.2M KSCN
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
0.8M NAFormate
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
Table 5.9. CSS I screen. Protein screen that is optimised to minimise the production of salt crystals whilst screening a broad
range of precipitants. The screen is used in conjunction with CSS II at two pHs; Tris at pH 8 and Sodium Acetate at pH 4.5.
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CSS II
1 2 3 4 5 6
A
1.5M (NH4)2SO4 0.8M Li2SO4 2M NaFormate 0.7M KH2PO4 0.2M CaAcetate 25 %(w/v) 2Kmme
0.2M CaAcetate 15 %
(w/v) 4K
B
2.7M (NH4)2SO4 1.8M Li2SO4 4M NaFormate 1M KH2PO4
0.2M CaAcetate 10 %
(w/v) PEG 8K
10 % (w/v) PEG 1K
0.2M CaAcetate
8 % (w/v) PEG 20K
8 % (w/v) PEG
550mme
C
40 % (w/v) MPD 40 % (w/v) butane-1,4-diol
10mM CdCl2 20 %
(w/v) 4k
0.15M KSCN 20 %
(w/v) 550mme
0.15M KSCN 20 %
(w/v) 600
0.15M KSCN
20 % (w/v) PEG 1.5K
D 35 % (w/v)
Isopropanol -
10mM NiCl2
20 % (w/v) PEG 4k
0.15M KSCN
18 % (w/v) PEG 3350
0.15M KSCN
18 % (w/v) PEG 4K
0.15M KSCN
15 % (w/v) PEG 6K
Table 5.10. CSS II screen. 24-well protein screen used in conjunction with CSS I screen, this screen is designed to cover
other commonly used precipitants. Jeffamine was not available in the department, so well D2 was set up using the the pH
buffer only. The screen is used with two different pH buffers; Tris at pH 8 and Sodium Acetate at pH 4.5.
The Memb-pass screen uses a range of polyethylene glycol (PEG) solutions and differing
concentrations throughout. Full details of all Memb-pass conditions can be found in appendix
8.3.
Two weeks after setup crystals were found (Figure 5.32) in the following conditions (Table
5.11).
Screen Well pH Drop size(µl)
Protein
concentration
(mg/ml)
Conditions Crystals
CSS I A5 8 1 2 0.2 M KSCN, 25 %(w/v) PEG 2Kmme
Three small crystals,
multiple microcrystals
CSS I D5 4.5 1 10
0.2 M KSCN, 8 %
(w/v) PEG 20K, 8 %
(w/v) PEG 550mme
Three thin crystal plates,
Two roughly
square crystals
Table 5.11. Results of initial crystal screening. All other conditions investigated resulted in either a clear drop, some
protein aggregation or varying levels of protein precipitating out of solution.
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Figure 5.32. Salt crystals obtained from CSS I and II. Crystals were obtained from CSS I condition A5 at pH 8 and CSS I
condition D5 at ph 4.5. KSCN was present in both conditions.
The crystals were frozen in well solution with the addition of 20 % (w/v) glycerol and X-ray
images collected at the University of Leeds. The crystals were found to be salt crystals
(results not shown).
Both CSS screens and the Memb-PASS screen were repeated at protein concentration of 5
mg/ml in 0.1 % (w/v) LDAO and the trays checked every weeks. After several months
crystals were found in several Memb-PASS conditions (Figure 5.33).
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Figure 5.33. Crystals grown by vapour diffusion. A) & B) pointed elliptical shaped crystals growing from a single point in
precipitant A1 containing 48 % (v/v) PEG 400, 100 mM sodium citrate, 210 mM sodium acetate and 1.12 % (v/v) glycerol,
pH 4.5; C) elliptical shaped crystal grown in precipitant B5 – 38 % (v/v) PEG 550 MME, 100 mM ADA, 140 mM Sodium
Bromide, pH 6.5.
These were also found to be salt crystals.
A B
C
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5.4.3 In meso crystallography
Lipid cubic phase (LCP) crystallography uses a complex mixture of hydrated monoolein
(MO), water, protein, detergent, and precipitants to grow membrane protein crystals (Ai and
Caffrey, 2000). Hydrated MO forms a variety of phases dependent upon the level of
hydration. The phase from which protein crystals are produced is known as the cubic
mesophase, hence LCP can also be referred to as in meso crystallography (Ai and Caffrey,
2000).
The cubic phase produced is essential to crystal growth, therefore any precipitants and/or
additives that are introduced must not destabilise the cubic phase (Ai and Caffrey, 2000).
Detergents that are stabilising the protein are likely to be incorporated into the cubic phase
along with the protein (Ai and Caffrey, 2000). The cubic phase consists of bicontinuous
curves (Nollert, 2005) and has been shown to aid in the formation of membrane protein
crystals, described in more detail below (Figure 5.34).
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Figure 5.34. Formation of crystals in the lipid cubic phase. The events purported to take place within in meso
crystallisation begin with the protein (blue molecules) being reconstituted into the cubic phase (orange). The protein
molecules diffuse into the lattice of increasing crystal phase (centre of the figure) through the sheet-like (or cubic) phase,
sometimes retaining a small number of detergent molecules (purple). Once congregated, the protein molecules may form
layered stacks or a regular array through the coalescing of detergent/lipid molecules, forming polar contacts between (in this
case) loop regions. This process is triggered by phase separation, which in turn is a result of the addition of precipitant, upon
which it is energetically favourable for protein molecules to cluster together in flattened regions of the otherwise highly
curved cubic phase membrane (Nollert, 2005). The protein crystal grows as molecules are fed from a ‘reservoir’ of protein
molecules in the cubic phase (Cherezov et al., 2006). The protein is represented as a blue molecule, the detergent is purple
and the lipid comprises small orange ellipses with a tail. Figure from (Caffrey and Cherezov, 2012).
LCP crystallisation trials were conducted using monoolein to form a lipid cubic phase to with
the aim of enhancing crystallisation. LCP was conducted as described in section 2.2.17.4. The
majority of drops had dried out, however in one drop (condition A9) there was a significant
number of crystals (Figure 5.35).
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Figure 5.35. Crystals produced using In meso crystallisation. Both images are taken from the same drop. Memb-PASS
condition A9; 47 % (w/v) PEG 400, 170 mM ammonium sulphate with hydrated MO. The phase resulting from mixing of
MO with protein solution was too viscous to pipette, hence the phase was divided as best as possible. Once precipitant was
added the drop did not remain in the centre of the well, splitting into two, one in the centre and one at the edge. Several
crystals were produced in both although too small and thin to test-shoot and so an attempt was made to stain the protein
crystals with methylene blue, upon which the crystals promptly dissolved. This, along with the fact that it was highly
unlikely that the precipitant solution would form crystals indicates that the crystals were indeed protein.
Methylene Blue (0.005 % w/v) was added to the drop to stain the crystals, at which point the
crystals rapidly dissolved.
Further lipid cubic phase crystallisation trials used wells that were formed using a grid of
grease on the microscope slide. This technique was adjusted and repeated in larger volumes.
The LCP crystallography repeat crystallisation used MO (~60 % w/v) hydrated with protein
solution (~10 mg/ml) in a 3:2 ratio (section 2.2.15.3) with 1 µl A9 precipitant added and
sealed with a coverslip. This was done in triplicate and after two days, crystals were present
in two of the drops (Figure 5.36).
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Figure 5.36. Crystals grown from In meso crystallography. All drops were set up using precipitant A9. Images A), B) and
C) are from the same drop. (B) and (C) were taken at an increased magnification. (A) contains large thin rectangular crystals
to the left of the drop; smaller unordered crystals in the centre of the drop and at the bottom and top right; and what appears
to be a hexagonal phase formed from the MO on the right side of the drop.
The crystals were plate-like and difficult to manipulate. In order to differentiate between salt
and protein they were stained using methylene blue. Unfortunately the stain dissolved the
crystals. Crystal growth using In meso crystallography was shown to be highly reproducible.
A
DC
B
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5.5 Discussion
Circular dichroism is a commonly used technique used to determine the secondary structure
composition of folded proteins in solution. CD is a non-destructive technique (provided that
the protein is not heated, or is, but is thermally stable) that is capable of using a small volume
of low concentration (less than ~ 1 mg/ml) protein. The JASCO J-810 spectropolarimeter
used was equipped with a Peltier device enabling rapid heating of samples for observation of
protein unfolding. While CD is capable of gathering information at a wide range of
wavelengths, this is dependent on the composition of buffers used. Impurities, along with
high salt, detergent or protein concentrations can rapidly increase the H[T] voltage above the
threshold (which varies from machine to machine), beyond which the data becomes
unreliable and unusable. The interpretation of the data obtained is subjective to the algorithm
and reference datasets used; the reference datasets are based predominantly on globular
proteins with membrane spanning proteins being significantly under represented. Table 5.1
shows slight differences in data analysed using the algorithms SELCON3 and CDSSTR with
two different datasets (4 and 7), Table 5.2 show slight differences in data analysed using the
CDSSTR algorithm and the same two reference sets. CDSSTR was selected over SELCON3
due to CDSSTR selectively discounting proteins from the reference sets that are not relevant
to the experimental protein. As β -barrel membrane proteins are underrepresented in the
reference sets, CDSSTR will therefore result in a more accurate calculation than SELCON3.
Calculation of the secondary structure from CD spectra of BAPKO_0422 at various
concentrations and temperatures was carried out using the online webserver DichroWeb
(Lobley et al., 2002, Whitmore and Wallace, 2004, Whitmore and Wallace, 2008). Data was
acquired down to 195 nm before the H[T] voltage exceeded the acceptable threshold of 600
V, this was potentially due to the concentration of detergent and salts in the buffer. It would
have been advantageous to have repeated data acquisition in the buffer used for SAXS that
contained 0.3 M NaCl, 3 mM Tris and 0.1 % (w/v) LDAO.
The known CD spectra of the N-terminal domain of E. coli (Figure 5.4) is very similar in
shape to that obtained from BAPKO_0422 (Figure 5.5) To obtain an initial estimate of the
expected CD spectra for OmpA-like proteins the .pdb files for 1BXW, 2F1T and 1QJ8 were
submitted to DichroCalc (Bulheller and Hirst, 2009) for calculation of the theoretical curve.
The locations of the CD signal peaks (positive peak at approx. 196 nm and negative peak at ~
Page | 203
220 nm) of OmpA, OmpW and OmpX from the theoretical calculated data are very close to
the positions expected (Greenfield, 2006).
The % secondary structure was calculated (Table 5.1) to be 40 % β -strand, 20 % β -turns and
33 % unordered. This is approximately what was expected for a TM β -barrel protein,
however the H[T] value exceed the acceptable threshold at around 198 nm. The algorithm
CDSSTR and reference sets 4 & 7 are designed for data within the range 195 - 260 nm, hence
the concentration was lowered, allowing acquisition of data to a wavelength of 195.5 nm.
Potential causes of the early surpassing of the upper threshold are likely to be the purity of
buffer components and / or the concentration of detergent.
Heating the protein sample (0.166 mg/ml) to five different temperatures including 20 °C
(Figure 5.9) yielded an increase in the intensity of the negative peak at 45 °C. The remainder
of the CD spectra visually changed very little from temperature to temperature and there was
no visible depreciation in the peaks. As temperature increases, CD spectra of many globular
proteins tend towards increasing disorder (Figure 5.1 A, black line) as secondary and tertiary
structure break down due to unfolding events (Corrêa and Ramos, 2009). It was expected that
as the temperature increased the spectra of BAPKO_0422 would become more similar to that
expected of a random coil, however the overall β -strand shape remained, suggesting that the
protein is not globular and has a high degree of thermostability. Analysis of the samples using
the CDSSTR algorithm in conjunction with reference set 7 showed a slight increase in %
unordered structure and decrease in % β -strand as the temperature increased, while analysis
with reference set 4 only showed a decrease in % β -strand. This suggests the BAPKO_422
has high thermal stability. High thermal stability is a common feature of OmpA-type
membrane spanning proteins. Intrinsic tryptophan fluorescence and CD studies demonstrated
that E. coli OmpA maintained native secondary structure and a compact fold up to 80 °C
(Sugawara et al., 1996).
Analysis of the CD data provided evidence for the protein being folded and containing 36 -
43 % β -strands, approximately 20 % turns and 33 - 37 % loop regions, which in conjunction
with the thermostability of BAPKO_0422 is indicative of a β -barrel protein.
SEC-MALLS was used to estimate the molecular weight of BAPKO_0422 in detergent
micelles and determine the oligomeric state. The protein is putative a TM protein and has
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detergent molecules bound in one of several potential forms (section 2.2.16.3, Figure 2.7).
SEC-MALLS uses static light scattering and the refractive index to calculate the weight-
averaged molecular mass, and therefore the oligomeric state. It is possible to calculate the
mw and oligomeric state using the equation described in section 5.1.2 using a cuvette and the
appropriate instruments without coupling to SEC, however SEC-coupling is preferred as any
aggregates are separated ensuring a monodisperse sample and as all measurements made are
the differences between buffer and buffer with protein sample, a continuous flow guarantees
that the buffer composition is exactly the same for both the reference and experimental
samples, allowing accurate determination of the baselines for all detectors (Slotboom et al.,
2008).
Present on the SEC-MALLS trace is a peak on the shoulder of the UV absorbance. This is
indicative of smaller molecules eluting after the main peak, this is possibly due to a second
species in the sample (shown to not be the case by SDS-PAGE) or smaller amounts of
detergent binding to the protein. The standardised dn/dc value of 0.187 ml/g for proteins
(Slotboom et al., 2008) was used for the calculation of the molecular weight of
BAPKO_0422. Manual adjustment of the baselines for the light scattering detectors resulted
in the molecular weight of 22.96 ± 9 % kDa, well within the error limits of the expected mw
calculated using ProtParam hosted on ExPASy: 22.68 kDA (Gasteiger et al., 2005). This
result highlighted provided evidence that BAPKO_0422 was monomeric and present as a
monodisperse solution under the condition tested (0.01 % (w/v) LDAO).
SAXS is a low resolution technique requiring small volumes of sample. Approximately 0.15
ml BAPKO_0422 concentrated to approximately 10 mg/ml was used to provide further
characterisation of BAPKO_0422 by calculating the radius of gyration and a molecular
envelope showing the size and shape of the electron density. Whilst capable of providing a
valuable insight into the overall shape of the molecule, one limitation is that there are
multiple possible solutions to the molecular envelope calculation that fit the data equally
well. This is compensated for by the comparison and averaging of numerous the solutions.
The data can be plotted as a Guinier plot, which can be used as a good early indicator of the
quality of the data; an upturn in the data at low q2 indicates protein aggregation, whilst a
downturn points to interparticle interference (Jacques and Trewhella, 2009). The Rg can be
calculated using the slope of the line as an early estimation of the minimum dimension of the
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protein. A more accurate Rg is calculated from the P(r) plot; obtained through Fourier
transform of the data.
SAXS data collection times vary depending on the strength of scattering produced by the
sample. Initial test data acquisitions were done in triplicate to determine if X-ray damage had
any effect on the quality of data obtained. A comparison of 3 datasets acquired sequentially
on the same sample revealed no detectable change in scattering, suggesting that radiation
damage would not be significant over the experimental time period.
To determine the effect of LDAO concentration on scattering, the scattering of 10 mg/ml
lysozyme in two buffers (0.3 M NaCl, 30 mM Tris, pH 8.0) containing 0.1 % and 0.01 %
(w/v) LDAO was measured. The concentration of LDAO was shown to increase the overall
scattering (Figure 5.14) at both concentrations, this was compensated for in both cases by
subtraction of a buffer-detergent blank, as evidenced by the RG calculations in table 20.
Therefore buffer containing 0.1 % (w/v) LDAO was used for acquisition of BAPKO_0422
scattering as this was the buffer in which the protein resided after SEC. The Rg for lysozyme
was calculated to be 15.6 Å from the Guinier plot and 16.39 Å from the P(r) using GNOM;
the latter of which is in close agreement with that in the literature (Arai and Hirai, 1999),
confirming the statement from (Jacques and Trewhella, 2009) that the Rg from Guinier
analysis should be taken as a preliminary calculation and should be more accurately
determined from the P(r). Calculation of the P(r) was conducted using three different values
for Dmax to determine the accuracy of the initial value, 50 Å, chosen for the maximum width
of the protein molecule. The values used for comparison, 40 Å and 60 Å were too small and
too large respectively, indicating that a good choice had been made. The P(r) plot provides
important information about the oligomeric state and quality of the protein sample. A plot
with a Dmax of 50 Å produced a smooth bell-shaped curve, indicating that there was no
sample aggregation or interparticle interference (Jacques and Trewhella, 2009), and that at a
distance of 50 Å there was no particle overlap (Roe, 2000).
From the GNOM output ten molecular envelopes were generated (Figure 5.18), evaluated
(table 21) and averaged (Figure 5.18) to produce a molecular envelope. Analysis of the
predicted scattering plot of this averaged molecular envelope (Figure 5.19 D) showed that it
was a poor fit or the data, hence the regions of low occupancy and loosely connected atoms
removed, which provided a much better fit of data (Figure 5.19 E). To produce a more
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accurate molecular envelope the averaged model was used to produce a fixed core of high
occupancy atoms with a substantial number of connections for production of a new molecular
envelope. The resulting molecular envelope was slightly larger than the lysozyme molecule
and appeared to have a slightly larger cleft than the structure (Figure 5.20 A & B, displayed
with lysozyme showing the solvent accessible surface). However this may be due to the
structure being determined from a rigid protein crystal and not freely floating in solution; the
scattering of the molecular envelope is an excellent fit to the data (Figure 5.20 C).
SAXS datasets were collected for BAPKO_0422 at concentrations of 6 mg/ml and 10 mg/ml.
Each dataset had detergent background scattering removed by the software and was
normalised to 0. Of the two datasets obtained for BAPKO_0422 the 10 mg/ml showed a
exponential increase in scattering at low q, which is indicative of aggregation. This data set
was run through initial analysis twice; once unaltered and once with the aggregated portion of
the data removed. The 6 mg/ml dataset was used as is.
Analysis of the Guinier approximation of the Rg for each of the three datasets calculated the
Rg to be 18.6 Å from the 6 mg/ml data and 21.4 Å from both the 10 mg/datasets (table 22),
however the Rg increased with the increase in concentration, and the I(0) increased
disproportionately to the increase in concentration, both are which are signs of aggregation.
Calculation of the Rg by GNOM however, found that there was no significant increase.
PRIMUS, which did the automatic calculation noted that the full 10 mg/ml dataset was
“aggregated” (table 22). Calculation of the Rg from the P(r) plot using GNOM showed very
similar Rgs for the 6 and 10 (aggregation removed) mg/ml datasets, although with a
difference between the two larger than the calculated errors. The whole 10 mg/ml dataset had
an Rg and I(0) much larger than the other two, hence was discarded. GNOM automatically
evaluates the solution calculated, finding the 6 mg/ml to be a “reasonable solution” and the
10 mg/ml to be a “good solution”. The I(0) increased with increasing concentration, but
slightly more than proportionally. However as the scattering from very large protein
aggregates was omitted from the calculation and hence did not contribute to the calculated
solution, the data was good.
The P(r) function of BAPKO_0422 at both concentrations was plotted with various Dmax
values (data not shown) and the value 70 Å found to produce the best result for both datasets.
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There is a ‘tail’ present towards high R on plots at both concentrations, this was considered to
be an artefact of overlap caused by the peptide chain containing the His-tag.
The generated molecular envelopes from both datasets (Figure 5.25 & Figure 5.28) all had
scores below 0.0074. The lower the score, the better; 0.0070 was the lowest score obtained by
a solution from BAPKO_0422 data. Molecular envelopes generated from the lysozyme data
had similarly low scores. These scores suggested an excellent fit to the data, although
comparison of these solutions to the average model (Table 5.4) resulted in solution J (Figure
5.28) being discarded due to the region of density protruding from the side. Each set of
solutions was averaged and refined.
The molecular envelope produced from averaging the BAPKO_0422 6 mg/ml dataset (Figure
5.26 A) was analysed for fit to the data (using a predicted scattering curve) by CRYSOL and
found to be a very poor fit (Figure 5.26 D). This was refined using DAMFILT as with the
lysozyme data and this produced a solution that had a very good fit to the experimental data,
apart from at high q (labelled in the figure as s) (Figure 5.26 E). In addition there was a small
region of density present at what was assigned the bottom of the solution. The solution was
globular with a single protrusion at the designated “bottom”. The molecular envelope of a β -
barrel might be expected to resemble a cylinder, however the refined electron density map
calculated by DAMFILT revealed a globular structure with a single protrusion. This
protrusion could be due to the extended N-terminus with a hexa-His-tag and the HRV-3C
recognition sequence. This may be confirmed by recollecting SAXS data after His-tag
cleavage by HRV-3C protease. The globular structure (as opposed to a cylinder) may be due
to associated detergent molecules producing increased electron density surrounding the
barrel. The crystal structures of E. coli OmpA and OmpW revealed several tightly associated
detergent molecules per molecule (PDB accession codes (1BXW & 2F1T).
A fixed core of density was prepared from the averaged model and a further molecular
envelope developed. This resulted in the solution showed in Figure 5.27. The molecular
envelope is smaller and more compact, missing a region of density at the bottom, preventing
the OmpA structure from fitting within. The ‘squashed’ barrel of OmpX however, would fit.
The density towards the top of the model fits in line with having longer loop regions on one
side and shorter on the other, however the region of density at the bottom is still there. This
solution is an excellent fit compared to the experimental data (Figure 5.27 C).
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The averaged molecular envelope from the 10 mg/ml dataset (Figure 5.29 A) had a predicted
scattering curve that was very different to that of the recorded data (Figure 5.29 D), providing
more support for the fact that simply averaging generated solutions was not accurate. As with
the 6 mg/ml dataset the refined solution produced by DAMFILT (Figure 5.29 B and C) fitted
the data much better (Figure 5.29 E). This molecular envelope contained more density at the
bottom of the model than that of the refined 6 mg/ml solution. The structure of OmpA does
not account for this, however BAPKO_0422 is predicted to have longer periplasmic turns
than OmpA, hence this area may be a result. In addition there is much less unoccupied
density at the top and at the sides of the structure, suggesting a tighter fit to E. coli OmpA.
The solution generated by modelling based on a fixed core (Figure 5.30 A & B) has a curve
very similar to that of the experimental data (Figure 5.30 C) and has very few regions of
electron density that are not filled. This is not as ‘squashed’ as the molecular envelope
produced from the 6 mg/ml data and is more similar to OmpA or OmpW, not OmpX. The fit
of OmpA within the molecular envelope is much tighter, although there is still given for the
loop regions to be flexible.
Most parameters were left at the default values, however some had to be specified, for
instance Dmax had to be specified in production of P(r) plots. In generating the initial
molecular envelopes adjustment of parameters such as the symmetry and anisometry affected
the results. The symmetry was set to the default value of P2 (no symmetry), changing this to
P2 with unknown anisometry, however resulted in a molecular envelope shaped like an
elongated hexagon with a tail either side. Changing anisometry to prolate with P2 symmetry
resulted in a solution with a similar overall shape to that of a two-armed spiral galaxy. These
were both deemed good fits to the data despite being unrealistic, and served to impress the
importance of selecting the correct parameters for the protein. Even when the parameters are
matched well, it is still possible that unrealistic solutions can be generated (as with solution J,
Figure 5.28), hence it is important to generate multiple solutions and average them. The
averaged solution produced by DAMAVER has been shown by CRYSOL in analysis of all
datasets in this research to not be accurate to the experimental data, whereas the solution
produced by DAMFILT is much more accurate.
The molecular envelope of BAPKO_422 generated by SAXS is comparable to other 8-
stranded membrane spanning proteins of known structure, in particular OmpX. The data
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suggests the existence of a protrusion at the periplasmic end of the barrel which is consistent
with the N-terminal tag of 37 amino acids. The larger globular domain may represent the
region exposed on the cell exterior where longer loops are predicted (Figure 3.13).
These loop regions may interact with factor H and possibly other host factors e.g. factor I or
factor D. Given the analogous relationship with the OmpW, OmpX and the multifunctional
OmpA, it is highly likely that these proteins have multiple roles within the Spirochaete,
which may include maintaining cell shape, transport of ions or hydrophobic molecules and
ligand binding. It is possible that the proteins homologous to BAPKO_0422 fulfil some or all
of these roles, and / or are responsible for factor H binding in different hosts.
To increase the chances of successfully crystallising BAPKO_0422, different screens and
methods, each with its own advantages were used. The CSS screens are standard screens
designed to produce protein crystals whilst having a significantly lower chance of producing
salt crystals. The Memb-PASS screen (Jena Bioscience) was used as it was specifically
designed to screen a wide range of membrane protein crystallisation conditions, the majority
of which contained a large concentration of PEG, this however is in contrast to the conditions
previously found to produce crystals of BAPKO_0422 (section 5.2.1). Lipid cubic phase
crystallography was chosen as the lipid mesophase has been reported as being an ideal
environment for the growth of membrane protein crystals, this is however difficult to set up,
made even more so by the fact that the laboratory lacked the recommended apparatus.
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Chapter 6. Conclusions & Future Directions
6.1 Conclusions
The aim of this research was to identify and characterise a family of transmembrane β -barrel
proteins in Borrelia that had implications for increasing the knowledge of the Spirochaete’s
virulence and immune evasion mechanisms.
Several factors suggest that Borrelia, like Gram-negative bacteria such as E. coli may contain
small, OmpA-like β -barrel TM proteins. Both have in common: a double membrane
structure, a peptidoglycan layer (of differing thicknesses and positions within the periplasmic
space) and the numerous lipoproteins. More substantial evidence is provided by the presence
of: an orthologue to a component of the β -barrel assembly apparatus (BamA, BB0795)
(Lenhart and Atkins, 2009) and orthologues of SecA CM secretion apparatus (Guina et al.,
1998). BamA is one of a complex of proteins that includes BamB through BamE (Lenhart
and Atkins, 2009) present in the outer membrane of E. coli and N. meningitidis that
comprises the β -barrel assembly machine (BAM) responsible for the folding and orientation
of OM proteins. A BamA orthologue (BB0795) was recently identified in B. burgdorferi s.s.,
providing evidence for the presence of machinery responsible for the assembly of OM β -
barrel proteins in Borrelia (Lenhart and Atkins, 2009). The membrane-spanning domain in
this BamA orthologue shares 18.5 % identity with BamA from E. coli. SecA in E. coli is a
protein responsible for export of OM proteins through the CM in E. coli (Guina et al., 1998).
With the similarities in ultrastructure, and the presence of these OM protein assembly and
folding mechanisms it is logical to assume that Borrelia may contain small OmpA-like TM
β -barrel proteins. A large number of non-essential Borrelial surface exposed proteins are
encoded on plasmid genes (Steere, 2001), such as virulence factors (i.e. BbCRASPs).
Proteins essential for bacterial function and survival are encoded on the chromosome, (i.e.
OmpA from E. coli). Putative OmpA-like proteins identified in Borrelia are encoded on the
chromosome.
The bioinformatic analysis conducted within chapter 3 of this research provides evidence for
the presence of four small membrane spanning β -barrel proteins in each of the species of
Borrelia analysed. A total of 12 protein homologues were predicted to be putative TM β -
barrel proteins similar to the OmpA protein family. As was evidenced by the results from
FFAS03 searching, the Borrelial OmpA-like proteins have very low sequence similarity (10 -
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15 %) to the currently known Omps from other Gram-negative bacteria. This level of
similarity is indicative of remote homology, which may be expected given the remote
relationship between Borrelia and E. coli; an example of this is the orthologue of E. coli
BamA in Borrelia. PRED-TMBB predicted that the majority of putative OmpA-like proteins
identified would contain eight TM β -strands, SignalP predicted that the majority of proteins
would have a signal peptide and FFAS03 found similarities between OmpA/W and the
identified proteins. Homology modelling using OmpA and OmpW from E. coli as templates
showed that with careful alignment the sequence for BAPKO_0422 formed β -barrel proteins
with an aromatic girdle.
BAPKO_0422 was shown to exist as a monomer in 0.1 % (w/v) LDAO by size exclusion
chromatography, SEC-MALLS and SAXS. The monomeric state in detergent gives further
credence to the possibility that it is an OmpA-like protein (OmpA is known to readily refold
in detergent).
Secondary structure analysis of BAPKO_0422 by circular dichroism showed that the protein
was approximately 35 - 40 % β -sheet (Table 5.1 & Table 5.2) which is comparable to known
TM β -barrel proteins (OmpA/X/W). Data acquisition was however limited to 195 nm. Data
acquired at a lower wavelength might yield a more accurate calculation as the reference
datasets and algorithm were optimised for data up to and including 190 nm.
Generation of a molecular envelope from SAXS data concurs with SEC-MALLS showing
that the protein is present in a monomeric state. The molecular envelope generated fits the
solvent accessible surface of E. coli OmpA and OmpW with only the loop regions protruding
outwards. As the loop regions are flexible the molecular envelope accounts for an average of
positions. The techniques and software used to produce this molecular envelope were
validated by the use of lysozyme as a positive control.
Crystallisation of BAPKO_0422 was attempted with mixed success. Crystals were obtained
from lipid cubic phase crystallography, but were not of diffraction quality. Optimisation of
these conditions again met with varying success, with dehydration of the drop producing
clusters of unordered crystals combined with a majority of clear protein drops suggesting that
a higher protein concentration was the way forward. Unfortunately due to the difficulties in
obtaining pure protein, there was not enough time to attempt this. However the growth of 2D
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crystals shows that it is possible to grow crystals of native BAPKO_0422 without the need
for mutation to increase contact surfaces as in the crystallisation of E. coli OmpA and OmpX
(Pautsch et al., 1999).
It is highly likely that the putative Borrelial OmpA-like proteins have multiple functions
within the cell such as maintaining cell structure and/or functioning as a pore. A study in
2009 identified that one of the putative OmpA-like proteins identified in this research,
BG0407 had the capacity to bind human complement regulating protein fH (Bhide et al.,
2009), although humans are an accidental host for Borrelia. The Spirochaete did not evolve
for infectivity of humans as ticks in their natural habitat rarely encounter humans. The fH
binding proteins (i.e. CRASPs) are more likely to have evolved for binding fH in birds and
small mammals, hence it is possible that different groups of fH binding proteins (CRASPs,
Erps, Omps) evolved to bind fH in different species.
The Bhide (2009) study speculated that BG0407 was a protein with two N-terminal coiled-
coil motifs, however the data acquired throughout this research provides evidence for
BAPKO_0422 being a small TM β -barrel protein. The bioinformatic studies and topology
predictions predict that the protein will have a signal peptide and will form an 8-stranded TM
β -barrel. Each of the twelve homologues identified are currently classed as putative
uncharacterised proteins (ExPASy). The fact that the protein is soluble in LDAO and
monomeric as shown by SEC-MALLS is more evidence for BAPKO_0422 being a
membrane protein. The SAXS generated molecular envelope is of the right size and shape to
account for a barrel-shaped protein with flexible regions. Each piece of the puzzle fits with
the conclusion that BAPKO_0422 (and the family identified within this research) are ~ 20
kDa TM β -barrel proteins. Due to the differences between BAPKO_0422 and E. coli
OmpA/W, namely the lack of a periplasmic N-terminal domain the name proposed for this
family of proteins is OmpB.
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6.2 Future directions
The discovery of this novel family of small eight stranded membrane spanning β -barrel
proteins is significant as this is the first time proteins belonging to the OmpA-like
superfamily have been identified in the Spirochaete Phylum. Leptospira and Treponema have
a related double membrane structure and a conserved β -barrel assembly machinery (BamA)
orthologue therefore it is possible that these bacteria also contain proteins belonging to the
OmpA-like superfamily. Future work could be directed towards using HMM searches in an
attempt to identify these proteins in other Spirochaetes. As high-resolution structural data of
Borrelial OmpA-like proteins becomes available this will enable improvement of the HMM
profile by inclusion of these proteins.
To facilitate this, it would be beneficial to produce vector-constructs of the remaining
putative OmpA-like homologues and attempt to produce high resolution structures. This
would also provide an insight into the potential function of these proteins.
For improvement of cloning efficiency a different cloning technique such as blunt-end or TA
cloning would be used, although this would introduce the possibility of the gene being
inserted backwards, it would remove the need for restriction enzymes; some of which were
found to be inefficient during this research. For these new constructs the His-tag could be
switched to the C-terminus of the protein, which may allow more efficient folding, or
different protein tags such as a SUMO-tag could be used.
Borrelia have numerous exposed proteins already known to bind fH (such as CRASPs, Erps);
a vital defence mechanism for invading pathogens, as fH binding acts as an ‘off-switch’ for
AP activation of the complement immune system. Evidence suggests that the Borrelial
OmpA-like proteins identified in this study may bind fH from humans and/or various other
hosts. It remains a possibility that the interactions between fH and BG0407 identified by
Bhide et al (2009) may be a non-specific interaction. Isothermal titration calorimetry could be
used in conjunction with ALBI assays to evaluate the potential interactions of BAPKO_0422
and homologues with human fH and calculate the binding affinity and specificity of any
interaction. High-resolution structural data such as a cocrystal structure would provide further
insight.
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Lipid-cubic phase crystallography showed promising results and trials at varying protein
concentrations in a range of detergents would be likely to successfully grow crystals.
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Chapter 8. Appendix
8.1 Redundancy reduced lists of known OM proteins
A redundancy reduced list of known Outer Membrane Proteins acquired from ProDom
OMPs with 40% redundancy reduction
Sequences kept: 23 out of 167
Reduction: 13% of original set kept
>Q9RM69_ERWCA#29#207 Q6W821_SHISO#29#195 Q6PNM6_SHIBO#29#195
Q3Z3G4_SHISS#29#195 OMPA_ECOLI#29#195 OMPA_ECO57#29#195
Q9L6J0_ECOLI#29#195 Q49P73_ECOLI#29#195 Q49P71_ECOLI#29#195
OMPA_SHIDY#29#200 Q32HV0_SHIDY#29#199 Q8CW76_ECOL6#58#227
Q83RX2_SHIFL#29#198 Q31YM0_SHIBO#29#198 Q49P72_ECOLI#29#199
Q5PGD5_SALPA#29#199 Q57QT3_SALCH#29#199 OMPA_SALTY#29#199
OMPA_SALTI#29#199 Q52JK5_ENTSA#29#195 OMPA_ENTAE#29#197
OMPA_KLEPN#17#191 Q7N602_PHOLL#29#209 OMPA_SERMA#29#207
OMPA_YERPS#29#203 OMPA_YERPE#29#203 Q6D6D4_ERWCT#29#212
YTGGKLGVSQFHDTGFYGNGYTDVNNNPIKSKLGAGAFVGYQANPYLGFEMGYDWLGRMKYAGSTANPADSASLKAQGIQLAAKLSYPVLPDLD
VYTRLGGMVWRVDTHADRSGNHLNNDDTGVSPLAAIGIEYAIDKNWATRVDYQWVS
NIGDAGTVGARPDNMLMSVGLSYRFGQDD
>Q6PSK4_PASTR#28#221 Q8RJD0_HAEGA#29#211 Q8RML8_HAEGA#29#211
Q8RMM2_HAEGA#29#211 Q8RMM0_HAEGA#29#211 Q8RMM1_HAEGA#29#211
Q8RML9_HAEGA#29#211 Q5FY67_HAEGA#29#211 Q8RJ58_HAEGA#29#206
Q6TRS4_HAEGA#29#210 Q6IV12_HAEGA#29#210 Q6GUB7_PASMU#29#218
Q9CMN1_PASMU#29#220 Q6GUB4_PASMU#29#220 Q6GUB5_PASMU#29#220
Q6GUB8_PASMU#29#204 Q6GUB6_PASMU#29#215 Q8VPL3_PASMU#29#215
O51841_ACTAC#29#213 Q9S5J9_ACTAC#29#213 Q65T85_MANSM#39#236
OMP52_HAEIN#29#219 OMP51_HAEIN#29#219 Q4QLD3_HAEI8#29#225
OMP53_HAEIN#29#225 Q65T83_MANSM#29#213 Q6XAX7_PASHA#27#228
Q6XAX6_MANGL#27#228 Q6XAX8_PASHA#27#228 Q6XAX4_MANGL#27#228
Q6XAY0_PASHA#27#233 Q6XAY1_PASHA#27#233 Q6XAY2_PASHA#27#233
Q6XAX9_PASHA#27#234 Q6XAY3_PASHA#27#235 Q6XAY6_PASHA#27#239
Q9RQ28_PASHA#27#239 Q6XAY4_PASHA#27#239 Q6PSJ7_PASTR#28#225
Q6PSK1_PASTR#28#224 Q6PSK5_PASTR#28#224 Q3EF13_ACTSC#29#219
YVGAKAGWASFHDGISQIDHKNGGKYGINKNSVTYGAFVGYQIIDNLAAEVGYEYFGRVRGLEQTKAGGSKKTFRHSAHGTTIALKGNYEVISG
LDTYAKAGIALVNNSYKTVNVDTKVPTKTSRFQSSLILGAGVEYAITPSLGARIEY
QWLNNAGKASYATLRRMGVEGSDYRPDISSVSAGLTYRFGQGAA
>Q5DYH6_VIBF1#21#185
YLGGQVGVSHFLGACSSNAIECKNYVTGGGLYGGYQFNSWFALEGSWHDYGSPKTFYGVGDGYYSNATGVDLSVKLSLPVTDNLDLYAKGGAAY
NYLSVSGNDNVHLGMFESDSSIDDIWEIGAEYALAPNWSLRFGTSIIDGIGNAKTG
KSDLYFTSLGLTYKF
>Q8E832_SHEON#33#191
YAGAGLGQGHYSNGSNPQSYDSVRDRFAGSVYLGYQVNPYLAPELSYQFLGSAYANYEQGQISGDFQQVVLAARFGYPLTTSLYPYVKVGGAGW
FGDSEGLRSGSERGFSPIVAAGVEYAFTPRLSGRLEHQYTDSLGADSIGYTDHHLT
TLGLSWRFG
>P96773_HAEDU#126#257
KGDLNRQFKHTAHGANLSLKPSYEILPNLDVYGKVGMGLVRNDYKFILDLQSKDQHVKDETKLHTLKPSLLLGTGVEYAITPELALRTEYQYLN
KAGNLYKAAKYKNISTSLAYAPDIHSVSVGLSYRFGQG
>O31154_VIBCH#24#173 Q87RL4_VIBPA#23#171
YVGGKVGKSWLDDACLAGQSCEDDDQVVGAFLGYQANKWLSLEAGYDYLGKFTAAGLNDEKVQAVTLAPKLSIPLTEGIALYGKVGGAYVDYGS
KDDYSYLGAAGLEFNTNHNVTMRLEYQNLTDINNDIVRARAETATLGIAYKFGGSE
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>Q87JK1_VIBPA#26#179 Q8D6H3_VIBVU#30#182 Q7MDC9_VIBVY#30#182
Q87GX9_VIBPA#27#181
YIGGKVGYNSLNDACYLNEPCDDDSFAAGMHIGYNFNEYVAAEYGVDYLGDFTANFKKPGLNTVDGDLWALTLAPKFNLPLTDSWNLFAKVGAA
YMMAGDEKDFVPTGSLGAEYKINYNWSLRAEYQRYQDMSDDIVDDMDSDFFGIGFN
YKFG
>Q44GL1_CHRSL#62#200
DVDDDDNTFKGFVGYNFNRYFATEAFYSDLGRVKLKGNGTANTDLESEAYGVSLVGKLPITQWFELFAKAGMAKWETDIDGNLGGASTDLEDND
GVDPVYGAGAQFNFKPFLVRAEYERYDFDSDYQIDSFTASVGWQF
>Q5FA01_NEIG1#20#175 Q9R2R1_NEIME#20#174 Q9RP16_NEIME#20#174
Q9RP18_NEIME#20#174 Q7AR60_NEIMA#23#174 P95372_NEIME#23#174
Q9RP17_NEIME#23#174 Q7DDM2_NEIMB#23#174 P96943_NEIME#23#174
P95371_NEIME#20#175 P95343_NEIGO#20#174
EGASGFYVQADAAHAKASSSLGSAKGFSPRISAGYRINDLRFAVDYTRYKNYKQAPSTDFKLYSIGASVIYDFDTQSPVKPYFGARLSLNRASA
HLGGSDSFSKTSAGLGVLAGVSYAVTPNVDLDAGYRYNYVGKVNNVKNVRSGELSA
GVRVKF
>Q3EI33_ACTSC#24#191
YVEGDAGYSKLRTSGGLSSKISDGSFSPSVAVGYKVNDWRFALDYTYYGKGDEGFGDLGGSGENEVKAYGFGLAAYYDFDLGTSLTPYLGARIS
ANHIKVNSDFNNASDYFHFSNSNTEFGYGAIAGVSYNFAPQWDLNVAAEYNRLGEV
RDVKVNQYGAKVGVRYTF
>Q3QBC3_9GAMM#28#162
AKGGYQWASDDSYKHSNPKGAIFGVSSGLQFSPAWSWDVGYQYHDDLKADATSVNVKAGLIESALRYDWYLQDNLSVYGRLGVAYWDMEKTHLS
SDKLDATGLSPLGEVGVNYNFTPNVRLSAGYQYIDSIGESN
>Q3QLJ4_9GAMM#38#150
ASGDGEGSSDGVGFGAYGGYNFNEWFGLEANLFASGDLGEDGVDVGAGALTFTPKFTYHFNDTFSAFAKVGVASMAVVVDYGPFDADYTGWGLT
WGVGVNAALTEKLNLRLSY
>Q3GMA6_9GAMM#36#179
YVGAKVGQFDLDVDGADDPTAYGVYAGYNFDPNFGMEAEFVGSDDADYRGGDIDAKTYGAYGTYRYAFPNTGLYAKGKLGVARTEIEATGTSPA
GFYNGSNKDTSLAGGVGLGYSVNPNFSVEAEYDKLGSDADLMTVGAQLKF
>Q6D3I0_ERWCT#17#171 Q3Z3X1_SHISS#19#171 Q32I92_SHIDY#19#171
Q323X9_SHIBO#19#171 OMPX_SHIFL#19#171 OMPX_ECOLI#19#171
OMPX_ECOL6#19#171 OMPX_ECO57#19#171 Q8XH17_SALTI#19#171
Q7CQV8_SALTY#19#171 Q5PG13_SALPA#19#171 Q57RC6_SALCH#19#171
OMPX_ENTCL#19#172 Q48427_KLEPN#25#170 Q83ZR1_ENTAE#25#171
Q8D0S1_YERPE#20#176 Q8ZDQ0_YERPE#18#174 Q669E5_YERPS#18#174
Q54470_SERMA#27#172 Q5J664_SERMA#27#172
GAGSAFAGQSTVTAGYAQGDAQGVQNKVKGFNLKYRYEQDNNPLGVISSFTYLEKNGSDDGFYSKGQYMGFTAGPAYRLNDWASLYGVVGFSHG
KVTSNNTNGQDNASNDDYGFTYGAGVQFNPIQDVALDVGYEQSRIRSVDVGAWAVG
VGYRF
>Q66AL7_YERPS#27#179 Q7N474_PHOLL#26#175 Q70AM3_YEREN#32#178
AIL_YEREN#32#178 Q7N473_PHOLL#27#181 Q8ZEI0_YERPE#27#179
ASNTVSFGYAQSTLKIDGEKIGKDNKGFNLKYRHELDSVLGIVASFTHTKQNYGMPGDSDGKRKVEYYSLMVGPSWRFNEFVSAYALIGATQGK
STHTKPRMVSNTVSKTSMGYGAGLQFNPVKHVAIDTAYEYAKIEDVKIGTWIVGVG
YRF
>Q8Z920_SALTI#29#174 Q9RFV4_SALTY#29#174 Q8ZRH3_SALTY#29#174
Q57SL6_SALCH#29#174 Q5PFY4_SALPA#29#174
SFGYAQTHLSSLKNSDSKDLRGFNFKYRYEFNETWGMLGSFTATRNEMENYTWKEGKLHKNGSDSVDYGSLMFGPTYRFNDYVSLYGNAGIATM
KFNKHSKEESFAYGAGVIFNPVKSISIDASWEASRFFAVDTNTFGVSVGYRF
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>Q8XBY9_ECO57#13#177 Q6DB56_ERWCT#23#182 Q9EUG9_SALEN#29#185
Q04817_SALTY#29#185 Q5PMG8_SALPA#31#185 Q8Z6B2_SALTI#31#185
Q57Q49_SALCH#31#185 PAGC_SALTY#31#185 Q6WPL6_ECOLI#13#177
Q7AAV5_ECO57#18#182
SAGYAQSKVQDFKNIKGVNLQYRYEWDSPVSVVGSFSYMKGDWADSHRDEADDFYRHQADIKYYSFLAGPAYRLNDYISFYGLVGISHTKAKGD
YEWRNSVGADESDGYLSESVSKKSTDFAYAAGVIINPWGNMSVNVGYEGTKADIYG
KHSVNGFTVGVGYRF
>Q9XD46_VITS1#32#191
TVSIGYSHGKISGADKLNGVTAKYNYQFDQQPWGVMTNLTYMGGKQRNNITSSNQLYENDVDVDYYSAGVGPSYRINPNVNVYGVVGVAKADTK
GTQKQNRTGRIYNIDNIDTNVMYGAGVQYNPAPNWSVDVGYESSRVNDGYDKRSMN
AFNVGVGYRF
>Q8X428_ECO57#7#108 Q8FIF5_ECOL6#32#199 Q3Z1B4_SHISS#32#199
Q8FEX5_ECOL6#32#199 Q322C6_SHIBO#19#199 Q81ZK9_SHIFL#19#199
Q320M5_SHIBO#19#199 Q8X547_ECO57#19#199 Q8X282_ECO57#19#199
Q8X2A1_ECO57#19#199 Q8XEG5_ECO57#19#199 Q7AFX4_ECO57#19#199
Q687E7_9VIRU#19#199 Q6H9T1_9CAUD#19#199 Q8X281_ECO57#29#199
Q9EV15_ECO57#29#199 Q7DBL7_ECO57#29#199
SVMAGPSVRVNEWFSAYAMAGVAYSRVSTFXGDYLRVTDNKGKTHDVLTGSDDGRHSNTSLAWGAGVQFNPXESVAIDIAYEGSGSGDWRTDGF
IVGVGYKF
>O33796_SALTY#23#153 Q8ZQ85_SALTY#23#153 Q57QV9_SALCH#23#153
AGYKNTVSIGYAYTDLSGWLSGNANGANIKYNWEDLDSGFGAMGSVTYTSADVNNYGYKVGDADYTSLLVGPSYRFNDYLNAYVMIGAANGHIK
DNWGNSDNKTAFAYGAGIQLNPVENIAVNASYEHTSF
>Q7N5I2_PHOLL#43#182
LNGATLSYRYELDDQWGLLSSFTFAKGDEKETKYYTGEDLKYYSVMIGPTYRINDYISLYGQLGLSRINDKSTAHYSGGYIEKESTSKNTLGWG
AGFIINPTTNTSITAGYEGSRFSIKDGNEKDHLSTNGFNITVGYRF
>Q57K85_SALCH#72#178 Q8ZM87_SALTY#69#178 Q8Z3Y8_SALTI#72#178
GSQRYSDESSNGRVTTRYYSLLAGPSWKINNQLSLYSQVGPVLLHQRDHGINESDSKVGYGYSAGVAYTPVSNVAITLGYEGADFDATHNSGSL
NSNGFNLGVGYRF
>Q8ZQG1_SALTY#92#172 Q8D0Z7_YERPE#103#194 Q8ZCR3_YERPE#91#182
Q74SP4_YERPE#91#182 AIL_YERPS#91#182 Q8ZF58_YERPE#98#183
Q66BP0_YERPS#98#183
GPSYRFNEYLNAYVMAGLGHGHIDDKRDNSGKKTGFAYGAGVQINPVENIAINASYEYSRFSAYDSKVNAGTWVLGVGYSF
The second phase of redundancy reduction. After the initial reduction, each half of the list
was recombined and resubmitted. No more sequences were removed.
OMPs with 90 % redundancy reduction
Sequences kept: 68 out of 167
Reduction: 41% of original set kept
>OMPA_SHIDY#29#200
YTGAKLGWSQYHDTGFIDNNGPTHENQLGAGAFGGYQVNPYVGFEMGYDWLGRMPYKGSVENGAYKAQGVQLTAKLGYPITDDLDVYTRLGGMV
WRADTKAHNNVTGESEKNHDTGVSPVFAGGVEWAITPEIATRLEYQWTNNIGDAHT
IGTRPDNGLLSLGVSYRFGQGE
>OMPA_SALTI#29#199
YAGAKLGWSQYHDTGFIHNDGPTHENQLGAGAFGGYQVNPYVGFEMGYDWLGRMPYKGDNTNGAYKAQGVQLTAKLGYPITDDLDVYTRLGGMV
WRADTKSNVPGGASTKDHDTGVSPVFAGGIEYAITPEIATRLEYQWTNNIGDANTI
GTRPDNGLLSVGVSYRFGQQE
>Q52JK5_ENTSA#29#195
YAGGKLGWSQFHDTGFIPNDGPTHESQLGAGAFGGYQVNPYVGFEMGYDWLGRMPYKGDTVNGAFKAQGVQLTAKLGYPVTDDLDVYTRLGGMV
WRADSSSNIAGDDHDTGVSPVFAGGVEWAMTRDIATRLEYQWVNNIGDAQTVGARP
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DNGMLSVGVSYRFGQQE
>OMPA_ENTAE#29#197
YAGGKLGWSQFHDTGWYNSNLNNNGPTHESQLGAGAFGGYQVNPYLGFEMGYDWLGRMPYKGVKVNGAFSSQAVQLTAKLGYPITDDLDIYTRL
GGMVWRADSSNSIAGDNHDTGVSPVFAGGVEWAMTRDIATRLEYQWVNNIGDAGTV
GVRPDNGMLSVGVSYRFGQ
>OMPA_KLEPN#17#191
YAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTR
LGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNI
GDAGTVGTRPDNGMLSLGVSYRFGQ
>Q7N602_PHOLL#29#209
YTGGKLGWSQYHDVNFYGNGYTSAIGNGPTHKNQLGAGAFLGYQANPYLGFEIGYDWLGRMPYKGSVNNGAFKAHGFQMATKLSYPIMDDLDIY
TRLGGMVWRADSKATYSATNTHLKNHDTGVSPLAAIGVEYAITKDWATRLDYQWVN
NIGDAGSVGARPDNGLLSVGVSYRFGQDEAA
>OMPA_SERMA#29#207
YTGAKLGWSQYHDTGFYGNGYQNGIGNGPTHKDQLGAGAFLGYQANQYLGFELGYDWLGRMPYKGSVNNGAFKAQGVQLAAKLSYPIADDLDIY
TRLGGMVWRADSKANYGRTGQRLSDHDTGVSPLAAVGVEYALTKNWATRLDYQFVS
NIGDAGTVGARPDNTMLSLGVSYRFGQDD
>OMPA_YERPE#29#203
YTGGKLGWSQYQDTGSIINNDGPTHKDQLGAGAFFGYQANQYLGFEMGYDWLGRMPYKGDINNGAFKAQGVQLAAKLSYPVAQDLDVYTRLGGL
VWRADAKGSFDGGLDRASGHDTGVSPLVALGAEYAWTKNWATRMEYQWVNNIGDRE
TVGARPDNGLLSVGVSYRFGQEDAA
>Q6D6D4_ERWCT#29#212
YTGGKLGVSQFHDTGFYGNGYTGVNNNPIKSKLGAGAFVGYQANPYLGFELGYDWLGRMKYAGSTASNDDSASFKAQGIQLAAKLSYPVMPDLD
VYTRLGGMVWRADSHAATSVNTGTRADINNDDTGVSPLAAIGVEYAIDKNWATRVD
YQWVSNIGDAGTVGARPDNLLMSVGLSYRFGQDD
>Q9RM69_ERWCA#29#207
YTGGKLGVSQFHDTGFYGNGYTDVNNNPIKSKLGAGAFVGYQANPYLGFEMGYDWLGRMKYAGSTANPADSASLKAQGIQLAAKLSYPVLPDLD
VYTRLGGMVWRVDTHADRSGNHLNNDDTGVSPLAAIGIEYAIDKNWATRVDYQWVS
NIGDAGTVGARPDNMLMSVGLSYRFGQDD
>Q6IV12_HAEGA#29#210
YAGAKAGWASFHDGLNQFENSQNAYGTLRNSVTYGVFGGYQITDNFAVELGYDDFGRAKLRKGGETVIKHTNHGAHLSLKASYPVLEGLDVYAR
VGAALIRSDYKSTKRAESDYVMHEHSLKVSPVFAGGLEYNLPSLPELALRVEYQWV
NKVGRGEKDGSRVDYTPSIGSVTAGLSYRFGQ
>Q6GUB7_PASMU#29#218
YVGAKAGWASFHDSLNQFNDITEPATGFKRNSVTYGVFGGYQITDNFAVELGYDDFGRAKARATDPKTKETVDAAKHTNHGAHLSLKASYPVLD
GLDVYARVGAALVRSDYKVYDKEPADLSFLKRTHSTQVSPVFAGGLEYAFMPELAL
RVEYQWLNNVGKLKDAKGERVDYRPDIGSVTAGLSYRFGQ
>Q6GUB5_PASMU#29#220
YVGAKAGWASFHDGLNQAKYLEAPEATFGFKRNSVTYGVFGGYQITDDFAVELGYDDFGRAKLRIAETDQKARDVAKHTNHGAHLSLKASYPVL
DGLDVYARVGAALIRSDYKVYDHSDPAKLPQLKRTHSTQVSPVFAGGLEYAFMPEL
ALRVEYQWVNNVGKLKDVDGNRVDYRPDIGSVTAGLSYRFGQ
>Q6GUB8_PASMU#29#204
YVGAKAGWASFHDGLNQAKYLEAPEATFGFKRNSVTYGVFGEYQITDNFAVELGYDDFGRAKLRMAEKDQKAKDAAKHTNHGAHLSLKASYPVL
DGLDIYARVGAALIRSDYKVYDHSDPAKLPQFKRTHSTQVSPVFAGGLEYAFMPEL
ALRVEYQWVNNVGKVKDVLGERVDYR
>Q8VPL3_PASMU#29#215
YVGAKAGWASFHDGLNQIEYVSKTSFGSKRNSVTYGVFGGYQITDNFAVELGYDDFGRAKVRANSKTTAFDAAKHTNHGTHLSLKASYPLLDGL
DVYARVGAALIRSDYKLYAPLINKRLSPHFKITQVSPVFAGGLEYAFIPELTLRVE
YQWVNNVCKFEYADGQYADFRPDIGSVTAGLSYRFGQ
>Q9S5J9_ACTAC#29#213
YAGAKAGWASSHHGLNQFKQKGVSINRNSEAYGVFGGYQITDNFAVEAGYEYFGRSKAKVNGAQRFRHTAHGTTLALKASYPVLDNLDVYGRVG
AALIRSDYKVGQANKPDRYHNLKVSPVFAGGVEYAILPELALRAEYQWVSRVGNLG
RAEEKADRSARTIDYSPDIGSVAVGLSYRFGQGVA
>Q65T85_MANSM#39#236
YAGAKAGWASFHDGYTQYAEDGVGSHTKSVTYGVFGGYQIFNRDNLGLAVELGYDDFGRAALRTNGATSAKHTNHGAHLSLKPSYDLGALAPVL
SGLDVYGKVGAALVRSDYKVNDGYSYGFNKSDFADHSLKTSLLLGAGLEYALPSLP
ELAFRLEYQWLNKVGKLENANGTRFDYTPEIHSVTAGVSYRFGQGVAA
>OMP52_HAEIN#29#219
YAGVKAGQASFHDGLRALAREKNVGYHRNSFTYGVFGGYQILNQNNLGLAVELGYDDFGRAKGREKGKTVAKHTNHGAHLSLKGSYEVLDGLDV
YGKAGVALVRSDYKFYEDANGTRDHKKGRHTARASGLFAVGAEYAVLPELAVRLEY
QWLTRVGKYRPQDKPNTAINYNPWIGSINAGISYRFGQGAA
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>OMP51_HAEIN#29#219
YAGVKAGQASFHDGLRALAREYKVGYHRNSFTYGVFGGYQILNQNNLGLAVELGYDDFGRAKGREKGKTVVKHTNHGTHLSLKGSYEVLEGLDV
YGKAGVALVRSDYKLYNENSSTLKKLGEHHRARASGLFAVGAEYAVLPELAVRLEY
QWLTRVGKYRPQDKPNTALNYNPWIGSINAGISYRFGQGAA
>OMP53_HAEIN#29#225
YAGVKAGQGSFHDGINNNGAIKKGLSSSNYGYRRNTFTYGVFGGYQILNQDNFGLAAELGYDDFGRAKLREAGKPKAKHTNHGAYLSLKGSYEV
LDGLDVYGKAGVALVRSDYKFYEDANGTRDHKKGRHTARASGLFAVGAEYAVLPEL
AVRLEYQWLTRVGKYRPQDKPNTAINYNPWIGCINAGISYRFGQGEA
>Q65T83_MANSM#29#213
YAGARAGWASFHDGVDAFHNSDGLSAKKNSVTYGVFGGYQILNQNNFGLAVELGYDDYGRIRLIETDAKRGKFTNHGVNLSIKPSYEVLDGLDV
YARVGAALIRTDYKDYSIDAAGHSLKVSPTFAAGLEYALPILPELAMRLEYQWIEN
VGRDQKWSGYNDADFTPDIGAVTFGLSYRFGQGAA
>Q6XAX4_MANGL#27#228
YAGAKAGWASFHDGLTQFDHKDGGEFGINRNSVTYGVFGGYQILNQNNFGLATELGYDYFGRVRGNKTFEGENSDKRAAKHSAHGAHLSLKPSY
EVVPNLDVYGKVGVALVRNDYYVQQNVAKDSRIKAHNLKPSLLLGAGLEYAITPEL
AARVEYQYLNRVGNLDKAARKTANIEGTNFQYSPDIHSVSAGLSYRFGQGAA
>Q6XAY4_PASHA#27#239
YAGAKAGWASFHDGLTQFDNTYDYGSGINFGINFGINRNSVTYGVFGGYQILNQNNFGLATELGYDYFGRVRGNTTFSGDDKEKTAAKHSAHGA
HLSLKPSYEVVPNLDVYGKVGVALVRNDYYVQQHVDKDSRIKVHNLKPSLLLGAGL
EYAITPELAARVEYQYLNRVGNLDKAVRTTVGYLIPRGTNFQYSPDIHSVSAGLSYRFGQGAA
>Q6PSJ7_PASTR#28#225
YVGAKAGWATFHNDVNQFNSKYALDERYAGGPTAYGINRNSVTYGVFGGYQIIDNLAVELGYDYFGRVRGNVQVDEQDSKAVKHTAHGTHLSLK
PSYEVVSGLDVYGKVGAALVRNDYKNYVDQEKSHNLKTSLLLGAGLEYAITPALAA
RLEYQWLSNVGNFNKAESKENRLRNVTYRPDIHSVSAGLVYRFGQGAA
>Q6PSK5_PASTR#28#224
YVGAKAGWATFHHGVNQFNSKYANDERYSDGPTAYGINRNSVTYGVFGGYQIIDNLAVELGYDYFGRVRGNVGDRRAFKDTKHGAHISLKPSYE
VVSGLDLYGKVGAALVRNDYKDYYANGTKDKSHNLKTSLILGAGVEYAITPALAAR
LEYQWLSRAGNYGKAEAKAGNVTDLRYSPDAHSVSAGLTYRFGQGAA
>Q3EF13_ACTSC#29#219
YAGARVGWSAMHHGVDRIADQFVTDGGLNRNSVTYGVFGGYQILNQNNFGLAAELGYDFFGKTKADAAGYHAAHGASLALKPSYEIYPDLDVYG
KVGVALVRNMYKAETLSASGDAEKFNKTKASLILGAGVEYAILPELAARLEYQWLS
KAGNLDSALEDAGYNGTNARYSPDIHSVTAGLSYRFGQGAA
>Q6PSK4_PASTR#28#221
YVGAKAGWASFHDGISQIDHKNGGKYGINKNSVTYGAFVGYQIIDNLAAEVGYEYFGRVRGLEQTKAGGSKKTFRHSAHGTTIALKGNYEVISG
LDTYAKAGIALVNNSYKTVNVDTKVPTKTSRFQSSLILGAGVEYAITPSLGARIEY
QWLNNAGKASYATLRRMGVEGSDYRPDISSVSAGLTYRFGQGAA
>Q5DYH6_VIBF1#21#185
YLGGQVGVSHFLGACSSNAIECKNYVTGGGLYGGYQFNSWFALEGSWHDYGSPKTFYGVGDGYYSNATGVDLSVKLSLPVTDNLDLYAKGGAAY
NYLSVSGNDNVHLGMFESDSSIDDIWEIGAEYALAPNWSLRFGTSIIDGIGNAKTG
KSDLYFTSLGLTYKF
>Q8E832_SHEON#33#191
YAGAGLGQGHYSNGSNPQSYDSVRDRFAGSVYLGYQVNPYLAPELSYQFLGSAYANYEQGQISGDFQQVVLAARFGYPLTTSLYPYVKVGGAGW
FGDSEGLRSGSERGFSPIVAAGVEYAFTPRLSGRLEHQYTDSLGADSIGYTDHHLT
TLGLSWRFG
>P96773_HAEDU#126#257
KGDLNRQFKHTAHGANLSLKPSYEILPNLDVYGKVGMGLVRNDYKFILDLQSKDQHVKDETKLHTLKPSLLLGTGVEYAITPELALRTEYQYLN
KAGNLYKAAKYKNISTSLAYAPDIHSVSVGLSYRFGQG
>Q87RL4_VIBPA#23#171
YVGGKMGKSWLEDACVAGQSCDKDGSTLGAFVGYEFNDYIALEAGFDNVGDFDQTSFGGHVEAITLAPKFSLPITQDIALYGKVGGAYVMFDGK
DDYSYLGAAGVEFNLSQNVTARAEYQTITDISNNVSKAAGNSATLGVSFKFGGND
>O31154_VIBCH#24#173
YVGGKVGKSWLDDACLAGQSCEDDDQVVGAFLGYQANKWLSLEAGYDYLGKFTAAGLNDEKVQAVTLAPKLSIPLTEGIALYGKVGGAYVDYGS
KDDYSYLGAAGLEFNTNHNVTMRLEYQNLTDINNDIVRARAETATLGIAYKFGGSE
>Q7MDC9_VIBVY#30#182
YFGGKIGYVNLDDACYVSSPCDDDSAGFGLYYGYNFSKHISAELGIDLLGEHETNFSNGYFSEAKLAAYTLAPKFSLPLNEKLDAFAKIGAAYM
IYGDDKDLVPTGSLGLEYALTESFKARAEYQRYQDMSDDIVKDMDANFFGIGITYL
FGG
>Q87GX9_VIBPA#27#181
YIGGKVGMTTLDDACYLNSPCDDEAFGAGLHIGYDFTDFIGLEYGVDFLGDYKANFKSGASTVDTIDGNLTALTLAPKFNWHLNDSWNLFAKIG
GAYMMSEDEKDFVATGSLGAEYSIDRNWSVRAEYQRYQDMSDDVWDDMDANFFGIG
VNYKF
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>Q87JK1_VIBPA#26#179
YIGGKVGYNSLNDACYLNEPCDDDSFAAGMHIGYNFNEYVAAEYGVDYLGDFTANFKKPGLNTVDGDLWALTLAPKFNLPLTDSWNLFAKVGAA
YMMAGDEKDFVPTGSLGAEYKINYNWSLRAEYQRYQDMSDDIVDDMDSDFFGIGFN
YKFG
>Q44GL1_CHRSL#62#200
DVDDDDNTFKGFVGYNFNRYFATEAFYSDLGRVKLKGNGTANTDLESEAYGVSLVGKLPITQWFELFAKAGMAKWETDIDGNLGGASTDLEDND
GVDPVYGAGAQFNFKPFLVRAEYERYDFDSDYQIDSFTASVGWQF
>Q5FA01_NEIG1#20#175
EGASGFYVQADAAHAKASSSLGSAKGFSPRISAGYRINDLRFAVDYTRYKNYKQAPSTDFKLYSIGASVIYDFDTQSPVKPYFGARLSLNRASA
HLGGSDSFSKTSAGLGVLAGVSYAVTPNVDLDAGYRYNYVGKVNNVKNVRSGELSA
GVRVKF
>Q3EI33_ACTSC#24#191
YVEGDAGYSKLRTSGGLSSKISDGSFSPSVAVGYKVNDWRFALDYTYYGKGDEGFGDLGGSGENEVKAYGFGLAAYYDFDLGTSLTPYLGARIS
ANHIKVNSDFNNASDYFHFSNSNTEFGYGAIAGVSYNFAPQWDLNVAAEYNRLGEV
RDVKVNQYGAKVGVRYTF
>Q3QBC3_9GAMM#28#162
AKGGYQWASDDSYKHSNPKGAIFGVSSGLQFSPAWSWDVGYQYHDDLKADATSVNVKAGLIESALRYDWYLQDNLSVYGRLGVAYWDMEKTHLS
SDKLDATGLSPLGEVGVNYNFTPNVRLSAGYQYIDSIGESN
>Q3QLJ4_9GAMM#38#150
ASGDGEGSSDGVGFGAYGGYNFNEWFGLEANLFASGDLGEDGVDVGAGALTFTPKFTYHFNDTFSAFAKVGVASMAVVVDYGPFDADYTGWGLT
WGVGVNAALTEKLNLRLSY
>Q3GMA6_9GAMM#36#179
YVGAKVGQFDLDVDGADDPTAYGVYAGYNFDPNFGMEAEFVGSDDADYRGGDIDAKTYGAYGTYRYAFPNTGLYAKGKLGVARTEIEATGTSPA
GFYNGSNKDTSLAGGVGLGYSVNPNFSVEAEYDKLGSDADLMTVGAQLKF
>Q57RC6_SALCH#19#171
GTAVAATSTVTGGYAQSDAQGVANKMSGFNLKYRYEQDDNPLGVIGSFTYTEKDRTNGAGDYNKGQYYGITAGPAYRLNDWASIYGVVGVGYGK
FQTTDYPTYKHDTSDYGFSYGAGLQFNPMENVALDFSYEQSRIRSVDVGTWIAGVG
YRF
>OMPX_ENTCL#19#172
GTAVAATSTVTGGYAQSDMQGVMNKTNGFNLKYRYEQDNNPLGVIGSFTYTEKDRTENGSYNKGQYYGITAGPAYRLNDWASIYGVVGVGYGKF
QQTENQGLNRTASNSDYGFSYGAGMQFNPIENVALDFSYEQSRIRNVDVGTWIAGV
GYRF
>Q83ZR1_ENTAE#25#171
ATSTVTGGYAQSDMQGKANKAGGFNLKYRYEQDNNPLGVIGSFTYTEKDNTSNGTYNKGQYYGITAGPAYRLNDWASIYGVIGVGYGKFQNNNF
PNHKSDMSDYGFSYGAGMQFNPIENVALDFSYEQSRIRNVDVGTWIAGVGYRF
>Q669E5_YERPS#18#174
TAGSAFAGQSTVSGGYAQSDYQGVANKSSGFNLKYRYEWSDSQLGYITSFTHTEKSGFGDEAVYNKAQYNAITGGPAYRINDWASIYGLVGVGH
GRFTQNESAFVGDKHSTSDYGFTYGAGLQFNPAENVALDVSYEQSRIRNVDVGTWV
AGVGYTF
>Q54470_SERMA#27#172
STVSAGYAQGDFQGVANKADGFNLKYRYEFDNNPLGVIGSFTHLEKDGSQDGFYNKAQYNSISAGPAYRINDWASIYGLVGLGYGKFTTNAQNG
TSRHDTADYGFTYGAGLQFNPIENVALDVGYEQNRIRSVDVGTWNVGVGYRF
>Q5J664_SERMA#27#172
STVSAGYAQGDLQGVANKADGFNLKYRYEFDNNPLGVIGSFTHLEKNRSENGFYKKSQYDSITAGPAYRFNDWASIYGVIGVGYGKNIDNAQAG
GNKGGNSDYGFTYGAGLQFNPIENVALDVGYEQSRIRSVDVGSWNVGVGYRF
>Q6D3I0_ERWCT#17#171
GAGSAFAGQSTVTAGYAQGDAQGVQNKVKGFNLKYRYEQDNNPLGVISSFTYLEKNGSDDGFYSKGQYMGFTAGPAYRLNDWASLYGVVGFSHG
KVTSNNTNGQDNASNDDYGFTYGAGVQFNPIQDVALDVGYEQSRIRSVDVGAWAVG
VGYRF
>Q7N474_PHOLL#26#175
STISGGYAQSHVKFNGEKIDGNPKGKGFNLKYRYELDNNFGVISSLTYTHKGFDKFDVNYYSLMAGPAYRFNDYVSAYGMIGAARGEFEVPVLN
GSYTEGKSSVSYGLGLQFNPVPNWTIDTSYEYAKFNDARLGDLKVGTWVVGVGYRF
>AIL_YEREN#32#178
GYAQSHVKENGYTLDNDPKGFNLKYRYELDDNWGVIGSFAYTHQGYDFFYGSNKFGHGDVDYYSVTMGPSFRINEYVSLYGLLGAAHGKVKASV
FDESISASKTSMAYGAGVQFNPLPNFVIDASYEYSKLDSIKVGTWMLGAGYRF
>Q7N473_PHOLL#27#181
TISGGYAQSHVKVDGEKLDENPKGFNLKYRYELDNNFGVIGSFTLTHQGYDYYYGSSKIGTGDLDYYSLMAGPTYRFNEYVSVYGLVGAAHRKV
KGEFSAYGYDFEYKESKTSAAYGLGLQFNPMPNWVIDASYEYSKLGDFKVGTWVIG
AGYRF
>Q66AL7_YERPS#27#179
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ASNTVSFGYAQSTLKIDGEKIGKDNKGFNLKYRHELDSVLGIVASFTHTKQNYGMPGDSDGKRKVEYYSLMVGPSWRFNEFVSAYALIGATQGK
STHTKPRMVSNTVSKTSMGYGAGLQFNPVKHVAIDTAYEYAKIEDVKIGTWIVGVG
YRF
>Q8Z920_SALTI#29#174
SFGYAQTHLSSLKNSDSKDLRGFNFKYRYEFNETWGMLGSFTATRNEMENYTWKEGKLHKNGSDSVDYGSLMFGPTYRFNDYVSLYGNAGIATM
KFNKHSKEESFAYGAGVIFNPVKSISIDASWEASRFFAVDTNTFGVSVGYR
>Q6DB56_ERWCT#23#182
ATQTVSLGYAQAKVEDFKDLKGVTAKYHYQGDSALGIIGSFTYLGGKKDYNQSSIGFSSHESDDVKYYSLMVGPSYQINDVVSIYGLAGLGHAK
VKNSYNYTLPNQSGSESYSESKTKFAYGAGIQITPVANWAIDIGYEGTKIYEARVD
GFNIGVGYRF
>Q04817_SALTY#29#185
VSVGYAQSRIEHFKDIRGVNLKYRYEAQTPLGLMASFSWQSGKRGESGGIPGGMSWRDDVKATYWSLMAGPAVRVNELVSLYALAGAGTGRAEV
KERISMPGYNGRFTGSERRTGFAWGAGVQFNPVENVVIDLGYEGSKVGAAKLNGVN
VGVGYRF
>PAGC_SALTY#31#185
GYAQSKVQDFKNIRGVNVKYRYEDDSPVSFISSLSYLYGDRQASGSVEPEGIHYHDKFEVKYGSLMVGPAYRLSDNFSLYALAGVGTVKATFKE
HSTQDGDSFSNKISSRKTGFAWGAGVQMNPLENIVVDVGYEGSNISSTKINGFNVG
VGYRF
>Q8XBY9_ECO57#13#177
SAGYAQSKVQDFKNIKGVNLQYRYEWDSPVSVVGSFSYMKGDWADSHRDEADDFYRHQADIKYYSFLAGPAYRLNDYISFYGLVGISHTKAKGD
YEWRNSVGADESDGYLSESVSKKSTDFAYAAGVIINPWGNMSVNVGYEGTKADIYG
KHSVNGFTVGVGYRF
>Q9XD46_VITS1#32#191
TVSIGYSHGKISGADKLNGVTAKYNYQFDQQPWGVMTNLTYMGGKQRNNITSSNQLYENDVDVDYYSAGVGPSYRINPNVNVYGVVGVAKADTK
GTQKQNRTGRIYNIDNIDTNVMYGAGVQYNPAPNWSVDVGYESSRVNDGYDKRSMN
AFNVGVGYRF
>Q8FEX5_ECOL6#32#199
SAGYLQTHTDMPGSDDLKGINVKYRYEFTDTLGLVTSFSYANAKDEQKTHYSDTRWHEDSVRNRWFSMMAGPSVRVNEWFSAYAMAGMAYSRVS
TFSGDYLRVTDNKGKTHDVLTGSDDGRHSNTSLAWGAGVQFNPTESVAIDLAYEGS
GSGDWRTDGFIVGVGYKF
>Q6H9T1_9CAUD#19#199
GAPAWASEHQSTLSAEYLHASTNVSGSDDLNGINVKYRYEFTDTLGMVTSFSYAGDKNRQLTHYSDTRWHEDSVRNRWFSVMAGPSVRVNEWFS
AYAMAGVAYSRVSTFSGDYLRVTDNKGKTHDVLTGSDDGRHSNTSLAWGAGVQFNP
TESVAIDIAYEGSGSGDWRTDGFIVGVGYKF
>Q7DBL7_ECO57#29#199
STLSAGYLHASTNVPGSDDLNGINVKYRYEFMDALGLITSFSYANAEDEQKTRYSDTRWHEDSVRNRWFSVMAGPSVRVNEWFSAYAMAGVAYS
RVSTFSGDYLRVTDNKGKTHDVLTGSDDGRHSNTSLAWGAGVQFNPXESVAIDIAY
EGSGSGDWRTDGFIVGVGYKF
>Q8X428_ECO57#7#108
SVMAGPSVRVNEWFSAYAMAGVAYSRVSTFXGDYLRVTDNKGKTHDVLTGSDDGRHSNTSLAWGAGVQFNPXESVAIDIAYEGSGSGDWRTDGF
IVGVGYKF
>O33796_SALTY#23#153
AGYKNTVSIGYAYTDLSGWLSGNANGANIKYNWEDLDSGFGAMGSVTYTSADVNNYGYKVGDADYTSLLVGPSYRFNDYLNAYVMIGAANGHIK
DNWGNSDNKTAFAYGAGIQLNPVENIAVNASYEHTSF
>Q7N5I2_PHOLL#43#182
LNGATLSYRYELDDQWGLLSSFTFAKGDEKETKYYTGEDLKYYSVMIGPTYRINDYISLYGQLGLSRINDKSTAHYSGGYIEKESTSKNTLGWG
AGFIINPTTNTSITAGYEGSRFSIKDGNEKDHLSTNGFNITVGYRF
>AIL_YERPS#91#182
DGDFKYYSVTAGPVFRINEYVSLYGLLGAGHGKAKVSSIFGQSESRSKTSLAYGAGLQFNPHPNFVIDASYEYSKLDDVKVGTWMLGAGYRF
>Q66BP0_YERPS#98#183
YYSLMVGPSVHFNEFFSMYALLGIGHGKAKASVLGYGKKEEQDSLAYGVGMQFNPLNNIAIDASYEYAKLKNANIGTWVLGIGYRF
>Q57K85_SALCH#72#178
GSQRYSDESSNGRVTTRYYSLLAGPSWKINNQLSLYSQVGPVLLHQRDHGINESDSKVGYGYSAGVAYTPVSNVAITLGYEGADFDATHNSGSL
NSNGFNLGVGYRF
>Q8ZQG1_SALTY#92#172
GPSYRFNEYLNAYVMAGLGHGHIDDKRDNSGKKTGFAYGAGVQINPVENIAINASYEYSRFSAYDSKVNAGTWVLGVGYSF
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8.2 Sequence alignments used for homology model generation
Sequence alignments in the .pir format used by modeller 9.11
OmpA
>P1;1BXW
structureX:1BXW:1 :A:171 :A:OMPA:E COLI::
-APKDNTWYTGAKLGWSQYHDTGLINNNGPTHENKLGAGAFGGYQVNPYVG--FEMGYDWLGRMPYKGSVENGAY
KAQGVQLTAKLGY-P-I-T-D-D-LDIYTRLGGMVWRAD-TYSNVYGKNHDTGVSPV-FAGGVEYA-I-T-P-EI
ATRLEYQWTNN-IG-DAH-TIGT-RP-DNG--MLSLGVSYRFG*
>P1;0422
0422:1: : :182 : :OMPA:B AFZELII::
--QSKSKTMVEDDFDFEKLLEK---EESVR-----RLFGIGFGIGY-PLTNIIISVPYVDIDLGYGGFVGLKPNN
FMPYVVMGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSF
LKNIVIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI*
OmpW
2F1T (OmpW) from E. coli
-EAGEFFMRAGSATVRPTEGGGFSVTNNTQLGLTFTYMATDNIGVELLAATPFRHKIGTRATGDIATVHHLPPT
LMAQWYFGD-AS-SK-FRPYVGAGINYTTFFDNGFNDHGKEAGLSDLSLKDSWGAAGQVGVDY-LINR-DWLVNM
SVWYMDID-TTANYKLGGAQQHDSVRLDPWVFMFSAGYRFH*
>P1;0422
0422:1: : :182 : :OMPA:B AFZELII::
QSKSKTMVEDDFDFEKLLEK-EESVRRLFGIGFGIGY--P-LTNIIISVPYVDIDLGYGGFVGLKPNNFMPYVV
MGIDLLFKDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGD-VNEDQQ-TSLENRIGVVIRLPLVIEYSFLKNI
VIGFKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI--*
OmpX
>P1;1QJ8
structureX:1QJ8:1 :A:148 :A:OMPX:E COLI::
-----ATSTVTGGYAQSDAQGQ-MNKMGGFNLKYRYEEDNSPLGVIGSFTYTEKSRTASSGDY--NKNQYYGITA
GPAY-R-I-N-D-WA-SIYGVVGV-GYGK-FQTTEYPTYKNDT-SDYGFS---YGAGLQFNPMENVALDFSY
----E-Q-S-R-I-R-S-V-D--VGTWIAGVGYRF-*
>P1;0422
0422:1: : :182 : :OMPA:B AFZELII::
QSKSKTMVEDDFDFEKLLEKEESVRRLFGIGFGIGY-PLTN-IIISVPYVDIDLGYGGFVGLKPNNFMPYVVMGI
DLLF--KDEIHKNTMISGGIGIGADWSKGSPEKSNENLEGDVNEDQQTSLENRIGVVIRLPLVIEYSFLKNIVIG
FKAVATIGTTMLFGNPMSFEGARFNFLGTGFIKIYI*
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8.3 Conditions for membrane protein crystallisation screen
Screen used: Memb-PASS screen from JENA Bioscience.
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